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The role of the conserved histidine-187 located in the leucine loop of 
Escherichia coli uracil-DNA glycosylase (Ung) was investigated. The vector 
pUngH187D containing the ungH187D gene was unstable in E. coli ung and 
ung recA strains; thus, the protein was overproduced in wild type E. coli, 
purified to apparent homogeneity, and characterized relative to wild type 
Ung. Ung H187D differed with respect to specific activity, pH optimum, 
substrate specificity, DNA binding, inhibition by uracil analogs, and enzyme 
kinetics. Most notably, Ung H187D exhibited a 55,000-fold lower specific 
activity and a shift in pH optimum from pH 8.0 to 7.0. Under reaction 
conditions optimal for wild type Ung (pH 8.0), the substrate preference of Ung 
H187D on oligonucleotide substrates was U/G-25-mer > U-25-mer > U/A-25­
mer. However, Ung H187D processed these substrates at comparable rates at 
pH 7.0 with -3-fold stimulation in activity relative to the U-25-mer at pH 8.0. 
Ung H187D was less susceptible than Ung to inhibition by uracil, 6-amino 
uracil, and 5-fluorouracil but retained the ability to bind uracil-DNA 
glycosylase inhibitor (Ugi) protein. Using UV-catalyzed protein/DNA 
crosslinking to measure DNA binding affinity, the efficiency of Ung H187D 
binding to thymine-, uracil-, and apyrimidinic site-containing DNA was (dT20) 
= (dT19-U) _?_ (dT19-AP). Measurements of reaction kinetics at pH 8.0 with 
[uracil 3H] DNA indicated the kcat of Ung H187D was reduced 48,000-fold 
relative to Ung, while Vmax /Km was essentially unchanged. Steady state 
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Additionally, polyclonal antisera to Ung and Ugi were raised which 
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1. INTRODUCTION 
1.1  Uracil Residues in DNA 
1.1.1  Incorporation of Uracil Residues During DNA Synthesis 
Uracil is introduced into genomic DNA at low levels because 
deoxyuridine triphosphate (dUTP) is utilized efficiently by DNA polymerases 
in place of deoxythymidine triphosphate (dTTP) during DNA synthesis (12, 
28, 99). The incorporation of dUMP in place of dTMP results in UA basepairs 
(99). The level of uracil residue incorporation is dependent on the intracellular 
concentration of dUTP relative to dTTP (147). It is estimated that the 
concentrations of dUTP and dTTP in Escherichia coli are 0.51.IM and 1501.1M, 
respectively, resulting in the introduction of about 1 uracil nucleotide for 
every 300 thymine nucleotides incorporated (120). In bacteria, accumulation 
of dUTP results from phosphorylation of dUDP or deamination of dCTP by 
deoxycytidine triphosphate (dCTP) deaminase (98). Deoxyuridine 5'­
triphosphate nucleotidohydrolase (dUTPase) minimizes the intracellular dUTP 
pool by hydrolyzing dUTP to dUMP, which is used in dTTP biosynthesis, and 
pyrophosphate (120). The small amount of dUMP that becomes incorporated 
into DNA is rapidly excised by uracil-DNA glycosylase (Ung) in the first step 
of uracil-initiated base excision repair (20, 66, 69). 
1.1.2  Deamination of Cytosine 
1.1.2.1  Spontaneous Cytosine Deamination 
Deamination of cytosine residues results in the introduction of UG 
mispairs into DNA (32, 34). Deamination may be spontaneous or 2 
environmentally induced (17, 40, 70). The rate of spontaneous cytosine 
deamination is estimated to be 7 x 10-13 and 1 x 10'sec-1 for double- and 
single-stranded DNA, respectively (40). Because the rate of deamination is 
more than 100 times greater for single-stranded DNA, the genome may be 
more susceptible to deamination during transcription and replication, which 
involve transient denaturation of double-stranded DNA (70). 
1.1.2.2  Induced Cytosine Deamination 
Cytosine deamination may be induced by ultraviolet (UV) irradiation 
(132) or chemical modification (81, 119). Sodium bisulfite (18, 50), nitrous 
acid (78, 118), and strong alkali (139) are capable of promoting deamination 
reactions. Nitrous acid acts non-specifically, deaminating adenine and guanine 
as well as cytosine residues in single- and double-stranded DNA (118). In 
contrast, unpaired cytosine is exclusively targeted by sodium bisulfite (50). In 
addition, the rate of cytosine deamination increases with temperature, 
suggesting that uracil-DNA repair may pose a greater challenge for 
thermophilic organisms (70). 
1.1.3  The Effects of Uracil in DNA 
The introduction of uracil into DNA has negative biological 
consequences. Although uracil and thymine are structurally similar, the 
methyl group of thymine projects into the major groove of duplex DNA. This 
structural feature is absent when uracil replaces thymine in DNA. Thus, 
substitution of uracil for thymine may result in the disruption of protein-DNA 
interactions required for normal cell processes. For example, substitution of 
uracil for thymine at position 13 of the lac operator reduces the in vitro binding 
affinity of the lac repressor (37). This is also observed in E. coli dut ung where 
uninduced B-galactosidase is overproduced 20-fold when uracil residues 
accumulate in the bacterial genome (29). Similarly, the incorporation of uracil 
residues into restriction endonuclease recognition sites has been shown to 
reduce rates of cleavage by HpaI, Hindll and HindIII endonucleases (11). In 3 
addition to altering protein-DNA interactions and gene expression, the 
introduction of uracil residues into DNA may lead to mutagenesis. Duncan et 
al. observed 5-fold increase in mutation frequency of E. coli ung mutants by 
screening for resistance to nalidixic acid and rifampin, indicating that the ung 
alelle is a weak mutator in E. coli (33). Studies of trpA reversion frequencies in 
ung mutants revealed a 30-fold increase in GC-->AT transitions relative to 
ung+ E. coli (34). 
Although uracil is not a normal constituent of DNA, notable exceptions 
are the Bacillus subtilis bacteriophages PBS1 and PBS2. The double-stranded 
genomes of PBS1 and PBS2 contain uracil in place of thymine (131). In order 
for their AU-rich genomes to be replicated in a bacterial host containing 
mechanisms for eliminating uracil-containing DNA, the production of phage-
encoded uracil-DNA glycosylase inhibitor protein (Ugi) is induced upon 
infection to inactivate B. subtilis uracil-DNA glycosylase (41). 
1.2  Uracil-DNA Glycosylase 
Uracil-DNA glycosylase is a ubiquitous DNA repair enzyme that 
catalyzes the first step of uracil-initiated base excision repair (BER) (16, 26, 27, 
61, 65, 69). The enzyme hydrolyzes the N-glycosylic bond linking the uracil 
base to the deoxyribose phosphate backbone of DNA, resulting in free uracil 
and an apyrimidinic (AP) site (66, 69). E. coli uracil-DNA glycosylase shares 
significant amino acid sequence homology with its counterparts isolated from 
a wide range of biological sources, including human cells (85, 100, 110, 140). 
A comparison of the sequence between E. coli and human uracil-DNA 
glycosylase reveals 55.7% identical residues with 73.3% polypeptide similarity 
when conservative amino acid substitutions are considered (100). This 
striking degree of homology suggests structural and functional conservation 
as well. 4 
1.2.1  Escherichia coli Uracil-DNA Glycosylase 
E. coli uracil-DNA glycosylase was the first DNA glycosylase to be 
identified and purified to apparent homogeneity (66, 69). The ung gene was 
subsequently cloned and purification of overexpressed Ung allowed for 
extensive biochemical characterization (7, 31, 141, 142). Uracil-DNA 
glycosylase is a 229 amino acid protein with a deduced molecular weight of 
25,694 (7, 141). The enzyme does not require divalent cations or other 
cofactors for activity (69). Ung is specific for uracil in DNA and does not act 
on dUMP, dUTP, uracil in RNA, or 3'-terminal uracil residues in 
oligonucleotide DNA (69, 142). E. coli Ung also catalyzes the removal of 5­
fluorouracil from DNA; however, thymine and 5-bromouracil contain larger 
modifying groups which are sterically excluded from the uracil-binding pocket 
(68, 80). 
Uracil residues in single-stranded DNA are removed about twice as 
efficiently as those in double-stranded DNA substrate and UG mispairs are 
preferred 2.4-fold over U-A base pairs in oligonucleotide DNA (9, 69). 
Sequence context affects the rate of catalysis. In general, uracils within AT-rich 
sequences are recognized more efficiently than in GC-rich sequences (96). 
Consensus sequences for good and poor removal were 5'-(A/T)UA(A/T)-3' 
and 5'-(G/C)U(T/G/C)-3', respectively (96). The enzyme has a broad pH 
range with maximal activity detected at pH 8.0 (69). Ung has a Km value for 
dUMP residues in PBS1 DNA of -4 x 10' M (69). The enzyme is inhibited by 
free uracil and AP sites in DNA by noncompetitive and competitive 
mechanisms, respectively (69, 133). Glycerol at a concentration of 200 mM is 
reported to inhibit the Ung reaction rate by -50% (153). 
1.2.2  Mammalian Uracil-DNA Glycosylase 
1.2.2.1  Nuclear and Mitochondrial Uracil-DNA Glycosylase 
Uracil-DNA glycosylase activity has been isolated from nuclear and 
mitochondrial extracts of human cells (1, 16, 26, 27, 61). There has been 5 
some controversy as to the number, identity, and subcellular localization of 
mammalian uracil-DNA glycosylase (UDG). 
UDG activities have been purified to apparent homogeneity from rat 
liver nuclei and mitochondria (26, 27). The nuclear UDG was shown to have 
an apparent molecular weight of -33,000 while the mitochondrial form was 
smaller with a molecular weight of -20,000 (26). Furthermore, distinct 
biochemical properties were reported for the nuclear and mitochondrial forms 
of rat liver UDG. The apparent Km of the nuclear species for uracil in DNA 
was 0.51.IM with a turnover rate of approximately 10 uracils/min (27). In 
contrast, the mitochondrial species had an apparent Km of 1.1 iiM and 
turnover rate of 1000 uracils/min (27). Similar to their E. coli counterpart, 
both enzymes show a 2-fold preference for uracil residues contained in single-
stranded over double-stranded DNA, cleave uracil from UG mispairs about 
twice as efficiently as from UA base pairs, and display end product 
inhibition (27). 
Despite these kinetic differences, polyclonal antibody to human UDG 
recognized nuclear, mitochondrial, and cytosolic forms of the enzyme, 
indicating that the three forms share antigenic determinants (89, 125, 126). 
Cellular localization studies utilizing immunostaining and a cDNA clone of 
uracil-DNA glycosylase from human placenta suggested the mitochondrial 
and nuclear UDG were encoded by a single gene (126). Mitochondrial 
translocation was dependent upon a 77 amino acid N-terminal pre-
sequence (126). 
Cloning of the full length human LING gene revealed the presence of 7 
exons which code for the nuclear (UNG2) and mitochondrial (UNG1) forms of 
UDG (95, 100). The two forms are generated from unique promoters and are 
the result of alternative splicing (95). UNG2 (313 amino acids) is generated 
from the promoter PA and requires splicing of exon 1A into a consensus splice 
site located after codon 35 in exon 1B. UNG1 (304 amino acids) is initiated 
from promoter PB at codon 1 of exon 1B and does not require alternative 
splicing (95). Thus the two forms differ in their N-termini, which target UNG1 6 
and UNG2 for mitochondrial and nuclear translocation, respectively (95, 101). 
Their C-terminal 269 amino acids are identical and constitute the catalytic 
domain of the enzyme (95). 
To investigate subcellular localization of UDG in He La cells, fusion 
proteins between the green fluorescent protein (GFP) and the amino-terminus 
of either UNG1 or UNG2 were produced in vivo (87). The UNG1-GFP and 
UNG2-GFP fusion proteins were localized to the mitochondria and nuclei, 
respectively (87). Deletions of the first 20 amino acids of UNG2 abolished 
nuclear import (87). Transfection of the UNG-GFP constructs into NIH 3T3 
cells in the presence of [32P]orthophosphate revealed that UNG2 is 
differentially phosphorylated while UNG1 is unphosphorylated (87). The 
significance of this phosphorylation is currently unknown, but may play a role 
in mediating protein-protein interactions or regulating uracil-DNA glycosylase 
activity. 
Several investigators have reported that uracil-DNA glycosylase gene 
expression in human cells is cell cycle-regulated (45, 128). An examination of 
the promoter region of the UNG gene reveals the presence of E2F-, Sp1-, 
Ap2-, and c-Myc-binding elements which are known to be involved in the 
regulation of genes differentially expressed during the cell cycle (48). In freely 
cycling He La cells, total cellular UDG in early S phase was approximately 
doubled relative to levels in early G, and increased further during G2 phase to 
nearly 3-fold that of early G1(89). In synchronized HaCaT cells, the levels of 
mRNA of both UNG1 and UNG2 increased in late G1 /early S phase with a 
concomitant 4- to 5-fold increase in UDG activity in S phase relative to early G, 
phase (47). These results suggest that expression of the UNG gene prior to 
DNA replication is important for maintaining the integrity of the genome. 
1.2.2.2  Cyclin-Like Uracil-DNA Glycosylase 
A third species of mammalian UDG was cloned from a human T cell 
cDNA (85). This 36,000 molecular weight protein displayed uracil-DNA 
glycosylase activity on UA base pairs but showed limited amino acid 7 
homology to the E. coli or human uracil-DNA glycosylases described above. 
Rather, this enzyme was determined to share 23-30% identity (51% similarity 
considering conservative amino acid substitutions) with the cyclin A protein 
family (86). The gene encoding this cyclin-like uracil-DNA glycosylase 
contains 2 exons (86). The promoter region lacks TATA and CAAT boxes but 
contains an AP2 consensus site (86). Analysis of gene expression during cell 
cycling revealed that mRNA levels increase 3 to 4-fold in G1 phase (86). 
Caradonna et al. (15) utilized affinity purification to identify nuclear and 
mitochondrial species of UDG from He La extracts. Ugi-Sepharose affinity 
chromatography recovered a 30,000 molecular weight protein from 
mitochondrial fractions and two species corresponding to 36,000 and 30,000 
molecular weight from total cell extracts (15). Affinity-purified samples from 
nuclear extracts did not cross-react with antisera to the conserved UDG, 
suggesting that nuclear uracil-DNA glycosylase activity was not associated 
with the highly conserved form of human UDG (15). Rather, antisera 
generated against the cyclin-like UDG immunoprecipitated a mixture of 
proteins in the 36,000 molecular weight range from affinity-purified nuclear 
fractions, indicating that the cyclin-like form of UDG was the major nuclear 
species (15). Additionally, analysis of mitochondrial fractions indicated that 
the conserved UDG was targeted to the mitochondria where it underwent 
proteolytic processing (15). This was in contrast to reports which suggested 
that both nuclear and mitochondrial forms of UDG arise from differential 
splicing of transcripts encoded by a single UNG gene (125, 126). 
More recent work by Caradonna and coworkers demonstrated that all 
protein recovered by large scale affinity purification of uracil-DNA glycosylase 
activity from He La nuclear extracts corresponded exclusively to the UNG2 
gene product originally reported by Nilsen et al. (87, 95). The investigators 
suggest that this discrepancy may result because their original conclusions 
were based on cross-reactivity of nuclear and mitochondrial fractions with 
polyclonal antibody to the conserved UDG. This antibody preparation may 
have recognized epitopes at the N-terminus of the protein, which is variable 
between mitochondrial and nuclear forms of UDG, and thus was incapable of 8 
detecting the nuclear UNG2. Additionally, the cyclin-like form of UDG was 
not recovered to appreciable levels in this study (87). It is not clear why the 
cyclin-like UDG could not be detected in large scale Ugi-affinity purification 
when it had been previously identified in Ugi-affinity purified fractions, but 
this provides further evidence that UNG2 is the major source of nuclear uracil-
DNA glycosylase activity. 
1.2.3  Other Enzymes Exhibiting Uracil-DNA Glycosylase Activity 
1.2.3.1  Thymine-DNA Glycosylase 
Studies of He La cell nuclear extracts demonstrated that GT mispairs 
were excised from DNA and repaired to GC base pairs (150). Analysis of the 
reaction products indicated that free thymine and AP sites were generated, 
suggesting the presence of a thymine-DNA glycosylase (TDG) in human cells 
(150, 151). The enzyme was purified to homogeneity from He La cells and 
biochemically characterized (92, 93). The protein migrated with an apparent 
molecular weight of 55,000 in denaturing polyacrylamide gel electrophoresis 
(92). In addition to recognizing thymine residues, TDG also functions as a 
uracil-DNA glycosylase (93). TDG substrate specificity was determined to be 
Gil > GT >> CT > TT (92, 93). The enzyme was not active on AT or single-
stranded DNA, although it could cleave 5-bromouracil base paired with 
guanine (93). TDG is also reported to recognize 3,N4-ethenocytosine (EC) 
paired to guanine (46, 115) and thymine paired to O6- methyl guanine (122), 
2-amino-6-methylpurine (44, 122), and 6-thioguanine (44). TDG activity was 
not inhibited by the uracil-DNA glycosylase inhibitor protein Ugi (93). 
Subsequently, a 1232 by open reading frame (ORF) encoding the 
putative human TDG was cloned and expressed in vitro and in E. coli (91). 
TDG displayed no homology to any known enzyme (43). The recombinant 
enzyme had a predicted molecular weight of -46,000 but migrated 
anomalously at -60,000 during denaturing polyacrylamide gel electrophoresis 
(91). The substrate specificity of the recombinant TDG (rTDG) was identical to 9 
the cellular TDG activity previously identified (91). Polyclonal antisera to the 
rTDG inhibited both activities, suggesting that TDG is the only enzyme 
present in He La nuclear extracts capable of processing GT mispairs (91). It is 
unclear whether the 55,000 molecular weight species represents a degraded or 
processed form of rTDG. N- and C-terminal deletion mutants of rTDG 
identified a core region capable of processing GU but not GT mispairs, 
indicating that discrimination of thymine bases is localized to the N-terminal 
56 amino acids, while the central 249 residues are involved in catalysis (43). 
The extent of GT incision by TDG was 3-12-fold greater in CpG 
sequences as compared to TpG, GpG, and ApG sequences, suggesting that 
sequence context alters TDG activity (122). Kinetic analysis confirmed that the 
base pair 5' to the GT mismatch influences the rate of thymine hydrolysis 
(149). The kcat values for excision of GT mispairs containing 5' CG, TA, GC 
and AT base pairs were 0.91, 0.023, 0.0046, and 0.0013 min-', respectively 
(149). Additionally, it was determined that TDG can remove uracil from GU, 
CU, and TU base pairs more efficiently than from GT mispairs (149). Uracil 
was also removed from Ali base pairs by TDG, although the rate was slow, 
with kcat = 0.047 min-1 (149). In contrast, the kcat value for a GU mismatch in 
the same sequence context was 11 min-1 (149). 
Interestingly, studies revealed that each TDG molecule was capable of 
removing only one thymine molecule from DNA containing a GT mismatch 
because the enzyme binds tightly to the AP site formed in the reaction (148, 
149). Bound TDG interferes with AP site cleavage by human apurinic 
endonuclease 1 (HAP1) (148). However, HAP1 significantly increases the rate 
of dissociation of TDG from AP sites (148). Thus the interaction of TDG and 
HAP1 couples the first two steps of base excision repair in this system. 
These observations suggested a role for TDG in vivo. In mammalian 
cells, cytosine methylation in CpG sequences is involved in cell development 
and transcriptional regulation (35). Deamination of 5meC, which occurs at a 
faster rate than for cytosine, results in a GT mispair (36). Unlike uracil, 
thymine is a normal constituent of DNA. Thus, it was proposed that TDG 
evolved to address the problem of 5meC deamination by removing 10 
potentially mutagenic thymine bases from G-T mispairs in CpG regions (92, 
122, 150). Alternatively, the broad substrate range of TDG suggests that its 
biological function may be a secondary uracil DNA-glycosylase for the 
correction of GU mispairs from GC-rich regions of the genome (43, 93, 149), 
as these residues are poor substrates for UDG but the preferred substrate of 
TDG (96, 122, 149). 
1.2.3.2  Mismatch-Specific Uracil-DNA Glycosylase 
Although TDG displayed no homology to known enzymes, homologs 
were identified in E. coli and Serratia marcescens (43). Conservation is limited 
to the core region of TDG which encodes for GU mismatch specificity (43). 
The bacterial enzymes show greater than 30% amino acid sequence identity to 
this core region (43). The E. coli ORF encoding a putative 169 amino acid 
homolog of TDG was expressed in both rabbit reticulocyte lysates and E. coli 
and as expected, the gene product was active on GU mispairs but did not 
recognize GT mispairs (43). Additionally, the enzyme did not recognize AU 
or single-stranded U substrates and the activity was Ugi-insensitive (43). The 
bacterial enzyme was designated double-strand uracil-DNA glycosylase, and 
later referred to as mismatch-specific uracil-DNA glycosylase (MUG) (43). 
In vivo studies indicated that MUG is a biologically relevant DNA 
glycosylase. E. coli NR8051 (ung+) hydrolyzed both U and GU substrates and 
the hydrolysis was inhibited by Ugi (43). In contrast, E. coli NR8052, the 
isogenic ung strain, cleaved uracil from GU substrate exclusively and the 
activity was Ugi-insensitive (43). Additionally, Northern blot analysis 
demonstrated that a 700 nucleotide species cross-reacted with a MUG 
complementary DNA probe, indicating the gene is transcribed in vivo (43). 
The crystal structure of MUG free and in complex with duplex 
oligonucleotide containing a GU mispair has been determined (5). Despite a 
low level of amino acid sequence homology MUG displays striking structural 
similarity to uracil-DNA glycosylase (80, 103, 110, 116, 127), which explains 
the ability of two very divergent proteins to catalyze similar reactions. MUG 11 
is composed of a central 5-stranded (3-sheet flanked by a-helices (5). One face 
of the enzyme displays positive charge and is traversed by a DNA binding 
channel containing an active site pocket that penetrates the enzyme's core (5). 
This is very similar to the DNA binding groove and active site pocket of UDG 
(see "Section 1.2.4") (80, 110, 116, 127). MUG-DNA complex crystallographic 
data revealed that the uracil-containing DNA strand is bound by the enzyme 
such that the deoxyuridine is in an extrahelical position, which is a key 
structural feature of DNA bound to UDG (5, 80, 110, 116, 127). The gap in 
the DNA duplex formed by the extrahelical uracil is filled by Gly-143 and Leu­
144 (5). In addition Arg-146 inserts its side chain between the widowed 
guanine of the GU pair and the preceding cytosine (5). These three amino 
acids form a "wedge" that penetrates the base stack from the DNA minor 
groove (5). The wedge can be accommodated only if the uracil residue is 
extrahelical, thus suggesting a "push" mechanism for uracil recognition and 
binding (5). This is in contrast to UDG, which is predicted to utilize a "push­
pull" mechanism for uracil recognition (103). Specificity of MUG for GU 
mispairs may arise from interactions of Gly-143 and Ser-145 with the widowed 
guanine (5). These interactions can only occur in the absence of the base-
pairing partner and are absolutely specific for guanine (5). Despite 
conservation by MUG of several key residues involved in UDG binding to 
Ugi, a conserved UDG active site glutamine is replaced by isoleucine in MUG 
(5, 79, 110, 117). This glutamine makes two hydrogen bonds with Ugi Leu­
23 that cannot be formed by isoleucine (5, 79, 110, 117). This may explain the 
inability of Ugi to inhibit MUG activity. 
Thus, MUG appears to be a mechanistically and evolutionarily distinct 
class of uracil-DNA glycosylase. The role MUG plays in vivo is unknown at the 
present time but MUG may serve as a second line of defense against uracil 
residues in DNA, acting as a secondary uracil-DNA glycosylase activity to E. 
coli Ung. 12 
1.2.3.3	  Single-Strand-Selective Monofunctional Uracil-
DNA Glycosylase 
The most recently discovered class of enzymes exhibiting uracil-DNA 
glycosylase activity was identified by Haushalter et al. (49). AP site analog-
containing double-stranded oligonucleotides were designed to serve as 
synthetic inhibitors of DNA glycosylases in a whole-genome screen (49). By a 
process known as in vitro expression cloning, Xenopus laevis cDNA library 
clones were transcribed and translated in vitro and the resultant proteins were 
analyzed in electrophoretic mobility shift assays (EMSA) with the inhibitor 
oligonucleotides (49). The TD-12 clone was selected as a possible DNA 
glycosylase based on binding of inhibitor oligonucleotide in EMSA (49). The 
TD-12 ORF encoded a putative 281 amino acid protein with a predicted 
molecular weight of -31,000 (49). Its sequence contained no similarity to 
known proteins but extensive homology to a human ORF (270 amino acids) 
(49). The human and X. laevis ORFs were 60% identical and 71% similar, 
considering conservative amino acid substitutions (49). 
The in vitro transcription/translation reaction mixture containing the 
TD-12 ORF gene product cleaved uracil with equal efficiency from UA and 
UG base pairs (49). Additionally, single-stranded uracil-DNA was preferred 
-20-fold over double-stranded substrate by the Xenopus homolog; the human 
homolog also preferred single-stranded U, although to a lesser extent (49). 
GT mismatches were not a substrate for either enzyme (49). Mass 
spectrometry analysis of the reaction product demonstrated that AP site 
oligonucleotide was the primary end product, indicating that the enzyme was 
a true DNA glycosylase with no associated AP lyase activity (49). Thus, the 
enzyme was designated single-strand-selective monofunctional uracil-DNA 
glycosylase (SMUG1) (49). Fusion of human SMUG1 to GFP revealed that 
hSMUG was localized to the nucleus (49). The TD-12-encoded protein was 
overproduced in E. coli, purified, and biochemically characterized (49). Kinetic 
analysis revealed that the overall catalytic efficiency of xSMUG1 is 10- and 70­
fold lower than human UDG on single-stranded and double-stranded 13 
substrate, respectively (49). In comparison, the efficiency of xSMUG1 on UG 
mispairs was nearly identical to that of human TDG (49). 
PBS1 Ugi protein did not inhibit xSMUG1, which is not surprising based 
on its lack of similarity to UDG (49). Initially the lack of sequence similarity 
between SMUG1 and UDG was perplexing, given their functional similarity. 
However, closer comparison of the crystal structures of herpes simplex virus 
type-1 (HSV-1) UDG (see "Section 1.2.4") and E. coli MUG (see "Section 
1.2.3.2") revealed that two active site motifs are conserved by all three 
enzymes, which may explain the ability of structurally divergent enzymes to 
catalyze very similar reactions (49). Motif I in MUG has the sequence GINPG­
N9-F (5). Crystallographic evidence suggested that the asparagine at position 
3 functions in catalysis while the terminal phenylalanine stacks with the uracil 
base (5). The sequence of Motif I in HSV-1 UDG is GQDPY-N10-F, where the 
aspartic acid rather than asparagine was implicated in catalysis (116). 
Furthermore, tyrosine at position 5 sterically excludes thymine from the active 
site (116). In both E. coli and human UDG the Motif I sequence is GQDPY-N10­
F, which is identical to that of HSV-1 (110). Motif I in SMUG1 has the 
sequence GMNPG-N10-F, which more closely resembles MUG (49). SMUG1 
discriminates against thymine despite the presence of glycine at position 5 
(49). The sequence of the MUG Motif II is NPSGLS (5). Asparagine in position 
1 hydrogen bonds with uracil and the glycine residue hydrogen bonds with 
the guanine of the UG mismatch (5). The HSV-1, human and E.coli UDG 
Motif II sequence is HPSPLS (110, 116), which is similar to the SMUG1 Motif II 
sequence of HPSPRN (49). Thus, key structural features are conserved 
between these three classes of uracil-DNA glycosylases and the difference in 
these motifs may explain the selectivity of each enzyme for its substrate. 
The biological significance of SMUG1 in vivo is unclear at the present 
time. It may serve as a backup glycosylase to the conserved UDG or 
alternatively the selectivity of SMUG1 for single stranded DNA may indicate 
its involvement in the repair of transiently single-stranded regions of the 
genome that occur during transcription, recombination, and replication. 14 
1.2.3.4  Thermostable Uracil-DNA Glycosylases 
Because cytosine deamination is enhanced at high temperatures (70), 
thermophilic organisms are anticipated to face greater threats from cytosine 
deamination and therefore have greater needs for uracil DNA repair. Koulis 
et al. (59) screened cell extracts of seven hyperthermophilic microorganisms 
and determined that all possessed uracil-DNA glycosylase activity at 95°C. It 
was reported that these activities removed uracil from both single- and 
double-stranded DNA (59), but it is unclear whether the substrate analyzed 
was double-stranded in nature at 95°C. The addition of PBS1 Ugi in excess to 
the reaction resulted in only partial inhibition of the detected uracil-DNA 
glycosylase activity, suggesting that some of the cellular uracil-DNA 
glycosylase was inaccessible to Ugi or that a Ugi-insensitive uracil-DNA 
glycosylase exists in thermophilic organisms (59). 
Support for the latter hypothesis came with the identification of two 
enzymes with uracil-DNA glycosylase activity that displayed no significant 
homology to E. coli Ung. The first example was identified in the thermophilic 
archaebacteria Methanobacterium thermoautotrophicum THF. This organism 
contains a plasmid which encodes a restriction/modification system that 
recognizes GGCC sequences (51). Deamination of modified cytosine residues 
would therefore yield thymine bases. The plasmid also encodes an ORF 
(orf10) with significant sequence homology to E. coli MutY and endonuclease 
III (51). Expression of the orf10 gene and purification of the expressed protein 
product yielded a DNA glycosylase with no associated AP lyase activity which 
removed thymine from a TG mismatch in the GGTC context at 65°C (51). 
The substrate specificity of the enzyme was UG, TG > GG » AG, TC, UC. 
Single-stranded DNA and the mispairs TT and TU were not cleaved (51). The 
protein is also reported to remove EC residues paired with guanine (46). The 
enzyme was designated mismatch glycosylase (Mig.Mth) and orf10 was 
renamed mig (51). 
A second class of thermostable uracil-DNA glycosylase lacking 
homology to E. coli Ung was purified from the thermophilic microbe 15 
Thermotoga maritima. An ORF with low homology to E. coli MUG was 
predicted to encode a 185 amino acid protein with a predicted molecular 
weight of 20,578 Da (113). The ORF was cloned, overexpressed in ung E. coli, 
and the expressed protein was purified (113). The gene product released free 
uracil from UA, UG and single-stranded DNA at 75°C (113). TG mispairs 
were not excised (113). No associated AP lyase activity was detected (113). 
The enzyme was designated T. maritima UDG (TMUDG). Homo logs to 
TMUDG were identified in several strains of thermophilic eubacteria and 
archaebacteria, the human pathogens Rickettsia prowazekii and Treponema 
palladium, and the extremely radioresistant Deinococcus radiodurans (113). 
Except for D. radiodurans, all strains containing a putative TMUDG homolog 
lack amino acid sequences homologous to E. coli Ung (113), suggesting that 
this enzyme may be an evolutionarily divergent form of uracil-DNA 
glycosylase in microorganisms able to withstand extreme environments. 
Neither Mig.Mth nor TMUDG was analyzed for Ugi binding or 
inhibition. However based on their lack of sequence homology to Ung, one 
might not anticipate Ugi to inhibit either Mig.Mth or TMUDG. 
1.2.4  Structure of Uracil-DNA Glycosylase 
The tertiary protein structures have been determined for E. coli (110, 
111, 153), human (55, 79, 80, 103, 127), and HSV-1 (102, 116) uracil-DNA 
glycosylases by X-ray crystallography. The enzymes have been crystallized 
and analyzed in complex with a proteinaceous inhibitor, the PBS1/2 uracil-
DNA glycosylase inhibitor protein (Ugi). Comparisons between E. coli uracil-
DNA glycosylase in complex with Ugi with human UDGUgi complex and 
HSV-1 UDGUgi complex reveals that the human and E. coli proteins are 
more similar to each other than to the viral enzyme, although most key 
structural features are conserved in the HSV-1 enzyme (110, 111, 153). 
Uracil-DNA glycosylase contains a central, all parallel four-stranded 13-sheet 
flanked by a total of eight cc-helices (80, 110). The groove formed by 131 and 
r33 is approximately the width of a DNA double-stranded helix and is lined by 16 
positively charged, highly conserved residues (80, 127). The uracil 
recognition pocket is located deep within this groove and contains the active 
site (80). Structural analysis of human UDG indicated that amino acids Gln­
144, Asp-145, Tyr-147, and Asn-204 line one side of the uracil binding pocket 
(80). His-268, Ser-169, and Ser-270 line the other side of the active site, while 
Phe-158 lies along the bottom of the pocket and stacks with the uracil 
pyrimidine ring (80). The location of the Tyr-147 side chain allows 
discrimination against bases substituted at the 5 position, such as thymine or 
5-bromouracil (80). Evidence demonstrating the common role of these amino 
acids recently emerged from the crystallographic structures of E. coli Ung 
resolved to 3.2 A (111), 2.4 A (110), and 1.6 A (153) resolution. An overlay of 
the polypeptide Ca traces of human UDG and E. coli Ung showed 
conservation of both secondary-structural elements and tertiary conformation 
(110, 111, 153). Thus, these results indicate that E. coli Ung closely resembles 
its human enzyme counterpart and that Ung should be regarded as a 
prototypical enzyme. 
The position of the uracil binding pocket in the floor of the DNA 
binding groove necessitates that the enzyme bind uracil bases which have 
become extrahelical or "flipped out" of the DNA double helix (79, 80, 103, 
127). Nucleotide flipping is accompanied by the insertion of a conserved 
leucine (E. coli, Leu-190; human, Leu-272) into the DNA minor groove, 
followed by the rotation of the uracil nucleotide 180° about the 
phosphodiester backbone into the active site (127). 
Human UDG-DNA co-crystal structures suggest that a "Ser-Pro pinch" 
coupled with a "Leu push-pull" mechanism is utilized for uracil recognition 
(103). Electrostatic binding orients uracil-DNA glycosylase such that three 
conserved Ser-Pro loops bind and compress the DNA backbone at successive 
phosphate moieties (103). The DNA 5' and 3' of the extrahelical uracil is B-
form, but the distance between the phosphates on either side of the uracil 
residue is reduced from 12 to 8 A and the DNA is compressed at this position 
(103). Additionally, the conserved Leu loop contacts the minor groove purine 
N3 atoms through water-mediated interactions (103). Thus, the uracil 17 
nucleotide is extruded from the DNA base stack through the combined forces 
of enzyme-mediated DNA backbone compression, a concerted push via the 
leucine side chain, and the attractive pull of the uracil-binding pocket (103). 
Ung undergoes a "I3-zipper" conformational change during the DNA 
compression which extends the (3-sheet interactions between (31 and (33 by 
two additional residues, thus changing from an open conformation to a closed 
conformation (110). 
1.3  Uracil-Initiated Base Excision Repair 
The basic steps of uracil-initiated base excision repair are conserved 
between prokaryotic and eukaryotic cells, underscoring the importance of this 
pathway in maintaining the integrity of genomic DNA (62, 81). Uracil-
initiated base excision repair is a multistep pathway consisting of five steps: 
uracil removal, phosphodiester bond cleavage, sugar-phosphate removal, 
DNA synthesis, and phosphodiester bond ligation. The pathway is initiated 
by uracil-DNA glycosylase with the hydrolysis of the N-glycosyl bond of a 
uracil base, proceeds through a common DNA damage intermediate, and 
results primarily in single nucleotide repair patches (21, 38, 58). Repair by 
this mechanism is referred to as short patch base excision repair; however, 
repair patches of 2 nucleotides have also been recognized and referred to as 
long patch base excision repair (42, 76, 114). 
1.3.1  Prokaryotic Uracil-Initiated Base Excision Repair 
1.3.1.1  Removal of Uracil from DNA 
The first step of uracil-initiated BER in E. coli involves hydrolysis of the 
N-glycosyl bond of a uracil residue by uracil-DNA glycosylase, generating 
free uracil and an AP site (69). Several lines of evidence have implicated 
amino acids of E. coli Ung that are involved in DNA binding or catalysis. 
Photochemical cross-linking experiments using Ung and oligonucleotide dT20 
revealed four tryptic peptides (T6, T18, T19, T18/19) that adducted to the DNA 18 
(7). These peptides defined two primary sequences (amino acids 58-80 and 
185-213) that reside at or near the DNA-binding site. Amino acid sequence 
conservation between E. coli Ung and 9 other uracil-DNA glycosylases led to 
speculation that Asp-64 and His-187 serve as essential residues for activity (7). 
Additional insight into the structure and function relationship evolved 
following the solution of the X-ray crystal structure of HSV-1 and human A84 
uracil-DNA glycosylase bound to dT3 and duplex DNA, respectively (116, 
127). A84UDG is a recombinant protein generated for overexpression in E. 
coli which lacks the N-terminal 77 amino acid pre-sequence as well as the next 
7 nonconserved residues encoded by the  UNG gene (125). Additionally, three 
amino acid residues encoded by the vector (Met-Glu-Phe) were added to the 
N-terminus of the enzyme (125). Based on protein structural data, 
interactions between 13 amino acids and uracil-containing DNA were 
identified for the human enzyme (127). Table 1 summarizes the human UDG 
residues that interact with DNA and their homologous amino acids in E. coli 
and HSV-1 uracil-DNA glycosylases. Comparison of the amino acid sequence 
alignment between E. coli and human uracil-DNA glycosylase revealed that E. 
coli Ung possessed 12 (Gln-63, Asp-64, His-67, Phe-77, Ser-88, Asn-123, Ser-166, 
His-187, Ser-189, Leu-191, Ser-192, Arg-195) of the same 13 residues attributed 
to DNA interaction (103, 127). Recent protein structural results confirmed a 
common role for these amino acids in substrate binding (110, 111, 153). 
Uracil-DNA glycosylase activity requires enzyme-assisted nucleotide 
flipping to orient the uracil residue within the recognition pocket and to 
properly position the N1-C1' bond within the catalytic site (80, 110, 111, 116, 
127). Previously, three different catalytic mechanisms for glycosylic bond 
cleavage were proposed (80, 116). (i) The peptide carbonyl and side-chain 
carboxyl of Asp-178 (HSV-1) activate a water molecule that attacks a 
weakened glycosylic bond. Destabilization of the N1-C1' bond is brought 
about by distortion or protonation of the uracil 02 by His-210 NE2 (116). (ii) 
The imidazole group of His-268 (human) catalyzes a direct nucleophilic attack 
on the N1-C1' glycosylic bond of the uracil residue, and a second nucleophilic 19 
Table 1
 
DNA Interactions and Amino Acid Homology
 
of Human Uracil-DNA Glycosylase
 
DNA Interactions' 
Site of  Type of 
Human UDG  Contact  Interactionb  E. coli Ung  HSV-1 UDG 
Gln-144  Uracil (02)  H-bond (MC)  Gln-63  Gln-177 
Asn-145'  Uracil (02)  H-bond (MC)  Asp-64  Asp-178 
AP-sugar (C1)  H-bond (SC) 
His-148  (P+1) Phosphated  H-bond (SC)  His-67  His-181 
AP-sugar (04)  H-bond (SC) 
Phe-158  Uracil  Stacking  Phe-77  Phe-191 
Uracil (04)  H-bond (MC) 
Ser-169  (P0) Phosphate  H-bond (MC)  Ser-88  Ser-202 
(PO) Phosphate  H-bond (SC) 
Asn-204  Uracil (04)  H-bond (SC)  Asn-123  Asn-237 
Uracil (N3)  H-bond (SC) 
Ser-247  (P-2) Phosphate  H-bond (MC)  Ser-166  Thr-280 
(P-2) Phosphate  H-bond (SC) 
His-268  Uracil (02)  H-bond (SC)  His-187  His-300 
(P-1) Phosphate  H-bond (SC) 
(P-2) Phosphate  H-bond (MC) 
Ser-270  (P-1) Phosphate  H-bond (SC)  Ser-189  Ser-302 
Arg-272'  5' Guanine (N7)  H-bond (SC)  Leu-191  Leu-304 
(P+1) Phosphate  H-bond (SC) 
(P-1) Phosphate  H-bond (SC) 
Guanine' (N7)  H-bond (SC) 
Ser-273  3' Deoxyribose (04)  H-bond (SC)  Ser-192  Ser-305 
Tyr-275 
Arg-276 
Deoxyribosef (04) 
(P-3) Phosphate 
H-bond (SC) 
H-bond (SC) 
His-194 
Arg-195 
Lys-306 
Val-307 
a The locations and types of interactions by human UDG with DNA were summarized 
from (127). 
b Hydrogen bond interactions with amino acid main chain (MC) or side chain (SC) 
atoms are indicated. 
UDG-DNA co-crystal structure was determined by using a human A84UDG 
Asp145Asn/Leu272Arg double mutant (127). 
d Phosphate groups are numbered from PO at the uncleaved dUMP residue with 
phosphates of nucleotides 5' to the uracil base designated P+n and those 3' as P-n 
where n equals the number of phosphate groups removed from the dUMP site. 
This residue corresponds to the widowed guanine on the non-uracil containing DNA 
strand (127). 
f This deoxyribose moiety is located on the non-uracil containing DNA strand two 
nucleotides 3' of the widowed guanine residue (127). 20 
attack of a water molecule provides H- and OH-group addition to the N1 and 
C1' atoms, respectively (80). (iii) A single nucleophilic attack by His-268 
(human) on a water molecule abstracts a proton and creates an OH 
nucleophile that acts on the glycosylic bond (80). In each case, an absolutely 
conserved histidine residue (human, His-268; HSV-1, His-210) corresponding 
to E. coli Ung His-187 was proposed to play an essential role in catalysis. 
Recent kinetic studies examined the role of the conserved Asp-64 and His-187 
residues of E. coli Ung by generating D64N and H187Q mutants (153). The 
results implicated Asp-64 as a general base catalyst, while providing no 
evidence that His-187 is involved in general acid catalysis (153). However, 
common agreement on the reactive mechanism and the function of Ung His­
187 remained to be fully elucidated. 
1.3.1.2	  AP-Site Incision and Removal of 5'-Deoxyribose 
Phosphate 
DNA glycosylases hydrolyze the N-glycosylic bond linking damaged 
or inappropriate bases to the deoxyribose-phosphate backbone (29, 67). The 
resultant abasic sugar-phosphate is called an apurinic or apyrimidinic (AP) site. 
Removal of AP sites is initiated by the action of an AP endonuclease or AP 
lyase (25, 82, 146). AP lyases, formerly referred to as Class I AP 
endonucleases, catalyze a I3-elimination reaction to incise the phosphodiester 
bond 3' to the AP site (4, 57, 82). Alternatively, the DNA backbone is nicked 
when a Class II AP endonuclease cleaves the phosphodiester bond to the 5' 
side of an AP site, generating a 3'-terminal hydroxyl moiety and a 5'­
deoxyribose-phosphate residue (82). The 3'-OH group generated by the 
action of an AP endonuclease provides a substrate for DNA synthesis; 
however, the 5'-deoxyribose phosphate (dRp) group must be removed in 
order to complete the repair process (83). Some DNA glycosylases have an 
associated AP lyase activity, catalyzing sequential steps of the base excision 
repair pathway (2, 97, 135). Uracil-DNA glycosylase produces apyrimidinic 
sites and does not have an associated AP lyase activity (69). 21 
Although some studies suggest that in E. coli the 5'>3' exonuclease 
activity of DNA polymerase I may liberate the 5'-dRp moiety as a small 
oligonucleotide (3), a DNA deoxyribophosphodiesterase (dRpase) has been 
identified which acts on termini formed as the result of AP endonuclease 
activity (39). This 50,000 molecular weight protein does not display 
exonuclease, AP endonuclease, or DNA phosphatase activities (39). Rather, it 
generates a free sugar-phosphate and a single-nucleotide gap in the DNA 
backbone at a 5'-incised AP site (39). The identity of dRpase activity in E. coli 
was elucidated upon characterization of the recj gene product. Purified RecJ 
protein displayed dRpase activity (22) and the combined activities of Ung, AP 
endonuclease and RecJ/dRpase were capable of generating a BER 
intermediate containing a one-nucleotide gap with 3'-OH and 5'-phosphate 
termini (20). This reaction intermediate supported DNA synthesis and 
ligation (20). Together these results implicated RecJ in the elimination of 5'­
dRp residues during BER. 
In contrast, studies of the post-incision steps of bacterial BER using a 
closed circular DNA substrate containing a UG mispair demonstrated that cell 
extracts derived from E. coli strains deficient in reel were proficient in uracil-
DNA repair (114). Repair occurred with a patch size of 15 nucleotides, which 
was similar to the results observed with cell extracts of wild type E. coli (114). 
This suggests that other activities, for example the 5'>3' exonuclease of DNA 
polymerase I, may substitute for the dRpase activity of RecJ in BER in vivo. 
1.3.1.3  DNA Synthesis and Ligation 
Ung, DNA polymerase I, and DNA ligase were implicated in BER by 
studies of E. coli strains defective in dUTPase (138). E. coli dut strains have 
increased intracellular dUTP concentrations (147), which leads to increased 
incorporation of uracil during DNA synthesis (136). Mutants in dUTPase 
accumulate DNA fragments that resemble Okazaki fragments (138). These 
short Okazaki-like fragments appear transiently and are readily incorporated 
into higher molecular weight DNA (137, 138). The accumulation of short 22 
Okazaki-like fragments was suppressed in dut ung double mutants (137). 
Furthermore, dut polA and dut lig double mutations resulted in a decreased 
rate in rejoining of the fragments (137). Thus uracil-DNA glycosylase, DNA 
polymerase I and DNA ligase appeared to be necessary for uracil-initiated 
BER. 
The 3'-OH terminus generated by AP endonuclease is a substrate for 
DNA polymerase I (83, 146). Uracil-initiated BER of a double-stranded 
oligonucleotide substrate containing a single dUMP residue was examined in 
vitro using E. coli cell extracts. The primary product was a one-nucleotide 
repair patch and no significant DNA repair synthesis occurred 5' to the uracil 
residue (21). This suggested that the 5'3' exonuclease activity of DNA 
polymerase I was not involved in the hydrolysis of the 5'-dRp to a significant 
extent, although this process may be an alternative pathway which explains 
the low occurrence of larger repair patches (21). Additionally, the uracil-
initiated BER pathway was reconstituted using purified Ung, AP endonuclease, 
RecJ, DNA polymerase I, and DNA ligase III (20). The results were similar to 
those obtained using crude cell extracts, indicating that these species are 
sufficient to support repair (20). In contrast, when a closed circular DNA 
substrate containing a UG mispair was incubated with E. coli crude extracts, 
the predominant reaction product was not single-nucleotide repair patches 
(114). Rather, the results indicated that repair synthesis involved the 
incorporation of 11-19 nucleotides (-15 nt) 3' to the uracil residue (114). This 
suggests that repair patch size may be dependent on DNA substrate 
conformation. DNA synthesis was not detected in ung E. coli; thus, repair was 
absolutely dependent on hydrolysis of the uracil base by Ung (114). 
Additionally, similar repair patch sizes were observed with red and xon E. coli 
cell extracts, indicating that other cellular dRpase activities may function in 
BER in addition to RecJ (114). 23 
1.3.2  Eukaryotic Uracil-Initiated Base Excision Repair 
The overall process of uracil-initiated BER in eukaryotic cells is similar 
to that described for E. coli (62, 81). Repair involves hydrolysis of the N­
glycosyl bond to release uracil, phosphodiester bond cleavage at the resultant 
apyrimidinic site, deoxyribose phosphate removal, DNA synthesis and 
ligation. However, recent reports indicate that following removal of the uracil 
base by uracil-DNA glycosylase and AP site cleavage by a Class II AP 
endonuclease, the repair process may be completed by two alternative 
pathways (42, 77). Short patch BER involves the formation of a one-
nucleotide repair patch, while long patch BER results from the incorporation 
of 2-7 nucleotides during repair synthesis (20, 21, 42, 77, 123). The 
predominant mechanism observed in human cell extracts is short patch BER 
(21, 38, 58). 
Short patch BER has been reconstituted in vitro using purified human 
proteins. UDG, AP endonuclease (HAP1), DNA polymerase 13 (pol 13), and 
DNA ligase I have been implicated (94, 107). Similar reconstitution 
experiments indicated that pol 13, DNA ligase III and XRCC1 are involved in 
short patch BER, with XRCC1 acting to suppress the strand displacement 
activity of pol 13 (63). Long patch BER has also been reconstituted in vitro with 
AP endonuclease, pol (3, DNase IV, and DNA ligase I or III (58). The longer 
patch formation was due to the 5'-->3' exonuclease activity associated with 
DNase IV, which was stimulated by the proliferating cell nuclear antigen 
(PCNA) (58). 
DNA pol 13 appears to be the primary DNA polymerase involved in 
uracil-initiated BER in eukaryotic cells (21, 63, 90, 123, 129). Although the 
preferred substrate of pol 0 is a one-nucleotide gap, the enzyme is also 
capable of filling gaps consisting of 2-6 nucleotides (84, 124), suggesting it 
could function in both short and long patch BER. DNA pol 13 also has an 
intrinsic dRpase activity, which suggests that the enzyme may participate in 
sequential steps of the repair process (76, 104). The addition of purified pol 
f3 to human nuclear extracts increased uracil-initiated BER 10-fold, while DNA 24 
polymerases a, 8, and E had no significant effect (123). A multiprotein 
complex purified from bovine cell extracts which was capable of short patch 
BER in vitro consisted of UDG, AP endonuclease, pol (3, and DNA ligase I 
(123). Embryonic fibroblast Mi319tsA cells homozygous for a deletion 
mutation in the gene for pol 13 were unable to perform BER on a uracil-
containing linear substrate and the pathway was restored upon transfection of 
the cell line with a minigene expressing pol 0, providing evidence for the role 
of this polymerase in BER in vivo (129). 
However, pol f3 activity does not completely account for all BER DNA 
synthesis detected in eukaryotic cells. Studies with nuclear extracts 
demonstrated that the addition of ddNTPs, inhibitors of pol (3, to the base 
excision repair reaction resulted in only partial inhibition of DNA repair 
synthesis (21, 90). Similarly, the addition of aphidicolin in these reactions 
resulted in partial inhibition of DNA repair synthesis, suggesting the 
involvement of DNA polymerase 8 (pol 8) or E (pol c) (21). Similarly, a 
circular AP site-containing DNA substrate was repaired by extracts of the pol 
13-deficient M1319tsA fibroblast cell line previously described, indicating that 
other cellular DNA polymerases could replace pol (3 in the repair of a circular 
DNA (38). In this case both short and long patch repair were observed, 
although short patch repair was significantly slower than pol (3-containing 
extracts (38). Long patch repair was proliferating cell nuclear antigen 
(PCNA)-dependent, further implicating pol 8 or E in BER (38). 
Biade et al. (13) examined the effect of DNA substrate conformation on 
PCNA-dependent BER more carefully. They compared repair of covalently 
closed circular and linear DNA substrates containing a single AP site in pol 13­
proficient and pol (3- deficient cell extracts. Both linear and circular DNA 
substrates were repaired in wild type cell extracts (13) .  In the pol 13 mutant 
cell extracts, linear DNA was not efficiently repaired, but circular DNA was 
repaired in a PCNA-dependent fashion (13). DNA binding by PCNA is 
facilitated by replication factor C (RF-C), forming a PCNA/RF-C complex 
required for efficient DNA synthesis by pol 8 or pol E (56). Podust et al. (106) 25 
demonstrated that PCNA/RF-C complex pre-assembled on gapped circular 
DNA quickly dissociated when the DNA was linearized. Thus, the use of 
linear DNA substrate in BER assays may bias the reaction against pol 6, pol 
E, or other PCNA-dependent enzymes such as DNase IV. 
Dianov et al. (23) analyzed the products of long patch excision repair of 
circular DNA substrate in mammalian extracts, and the predominant product 
was a dRp-oligonucleotide which co-migrated with a trinucleotide marker 
during 20% polyacrylamide gel electrophoresis. Production of this product 
was reduced in pol 13- deficient cell extract and the size distribution of excision 
products was altered (23). The addition of purified pol (3 to the extract 
restored dRp-oligonucleotide release (23). The investigators concluded that 
pol 13 performs both the excision and repair synthesis steps in long patch BER. 
Alternatively, Stucki et al. (130) utilized fractionated cell extracts of pol 13­
deficient mouse fibroblast cells to examine the contributions of pol 8 and pol E 
to long and short patch BER. The substrate was a circular DNA template 
containing a single abasic site (130). Surprisingly, fractions containing pol 8 or 
pol e were capable of producing a one-nucleotide repair patch in the absence 
of PCNA (130). Completion of the repair process was slowed due to a 
reduced rate of 5'-dRp processing, which inhibited ligation (130). 
Additionally, both pol 8 and pol c were functional in long patch DNA repair 
synthesis, requiring PCNA and RF-C for nucleotide incorporation (130). 
Thus, it appears that DNA polymerases 13, 6, and e are each capable of 
functioning in the two alternative pathways utilized by mammalian cells to 
complete uracil-initiated BER. At the present time it is unclear which 
polymerase has a primary role in BER in vivo; however, it appears that pol (3 
may catalyze repair synthesis in both long patch and short patch BER with pol 
8 and/or E serving as a back-up system for repair synthesis. 
The fidelity of DNA synthesis associated with uracil-initiated BER in 
human glioblastoma cell extracts was examined recently by using a M13mp2 
lacZa DNA-based reversion assay (112). The assay was designed to detect 
misincorporations at a uracil target; thus, the study analyzed the error rates of 26 
short patch BER and the first nucleotide incorporation of long patch BER, but 
no attempt to determine patch size was made (112). The fidelity of DNA 
repair synthesis at a UT mispair was estimated to be -1 misincorporated 
nucleotide per 1900 repaired uracil residues (112). The majority (94%) of the 
base substitutions at the uracil lesion resulted in transversion mutations, which 
were approximately equally distributed between T- .G and T-->A 
transversions (112). 
Repair of abasic sites located in covalently closed circular DNA has also 
been studied by using purified mitochondrial enzymes from Xenopus laevis 
(105). Reconstitution of the reaction required a mitochondrial Class II AP 
endonuclease, DNA polymerase y (pol y), and mitochondrial DNA ligase 
(105). Repair was optimized when reaction conditions included high 
concentrations of MgC12 to minimize strand displacement synthesis, resulting 
primarily in a filled gap size of one nucleotide (105). In these studies, both 
DNA pol y and mtDNA ligase were shown to have AP lyase activity, which 
may fulfill the role of dRpase in the mitochondrial system (105). Long ley et al. 
(73) purified and characterized recombinant and native forms of the catalytic 
subunit of human pol y. Both forms exhibited DNA polymerase and 3'>5' 
exonuclease activities (73). Mutations in the exonuclease motif of the catalytic 
subunit abolished the 3'>5' exonucleolytic activity (73). Reconstitution of 
uracil-initiated BER with purified proteins revealed that the human pol y 
catalytic subunit was capable of filling a single nucleotide gap in the presence 
of a 5'-terminal dRp moiety (72). In addition, this peptide catalyzed the 
release of a dRp residue from incised AP sites, indicating that pol y contains an 
intrinsic dRpase activity (72). The mtDNA ligase cross-reacted with polyclonal 
antibody raised to a peptide fragment of DNA ligase III, suggesting that the 
mitochondrial ligase is related to nuclear DNA ligase III (105). 27 
1.4  Bacteriophage PBS2 Uracil-DNA Glycosylase Inhibitor Protein 
1.4.1  Bacteriophage PBS2 
The Bacillus subtilis bacteriophages PBS1 and PBS2 are unique because 
their double-stranded DNA genomes contain uracil in place of thymine (131). 
In addition, the overall base composition of their genomes is unusual in 
having a 72% A-U content (52, 131). In order for this AU-rich genome to be 
successfully replicated in a bacterial host which contains mechanisms for 
eliminating uracil-containing DNA, these bacteriophages have evolved 
strategies to increase the intracellular pool of dUTP for DNA replication and to 
inactivate uracil-DNA repair. Virally encoded dTMP 5'-phosphatase (108), 
dCTP deaminase (134), dUMP kinase (53), and dUTPase inhibitor (109) act to 
increase dUTP levels while depleting the dTTP pool. Similarly, production of 
uracil-DNA glycosylase inhibitor protein (Ugi) is induced upon infection to 
inactivate B. subtilis Ung, thus protecting the uracil-substituted genome from 
degradation by the host uracil-initiated BER enzymes (41). 
1.4.2  PBS2 Uracil-DNA Glycosylase Inhibitor 
The PBS2 uracil-DNA glycosylase inhibitor protein is a heat-stable, 
monomeric, 9,474 Dalton polypeptide (8). The deduced amino acid sequences 
of PBS1 and PBS2 Ugi are identical (74, 117, 143). Ugi is unusually acidic, with 
21% of its 84 amino acid residues being Glu or Asp (143). As a result, the 
protein has a pI of 4.2 and migrates anomalously during sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (8). Ugi is highly specific, 
inactivating uracil-DNA glycosylase from diverse biological sources but 
having no detectable effect on other classes of DNA glycosylases or other 
DNA repair enzymes that have been examined (54, 143, 152). 
Ugi inactivates uracil-DNA glycosylase by forming a noncovalent 
complex with 1:1 stoichiometry that is essentially irreversible under 
physiological conditions (8). Stopped-flow kinetic analysis indicated that the 
formation of UngUgi complex occurs via a two-step mechanism (10). The 28 
first step involves the formation of a reversible association between Ung and 
Ugi with a dissociation constant of 1.3 µM (10). The second step produces the 
UngUgi complex and is characterized by a rate constant of k=195 sec' (10). 
Thus complex formation proceeds through a "docking" and "locking" 
mechanism where the proteins become properly aligned and tightly 
bound (10). 
Several observations suggest that Ugi inhibits Ung by binding at the 
enzyme's DNA binding site:  (i) formation of Ung Ugi complex prevented 
enzyme binding to DNA (8); (ii) Ugi was capable of dissociating an UngDNA 
complex (8); (iii) UV cross-linking of oligonucleotide dT20 to Ung prevented 
association between Ung and Ugi (7); (iv) the addition of Ugi to UV cross-
linking reactions prevented the formation of cross-linked Ung x dT20 (7); and 
(v) X-ray crystallographic analysis of Ugi in complex with uracil-DNA 
glycosylase from human (79, 80), herpes simplex virus type-1 (117), and E. 
coli (110, 111) uracil-DNA glycosylases revealed that Ugi complexes with 
uracil-DNA glycosylase at the DNA binding domain by mimicking the 
structure of DNA. 
1.4.3  Structure of Uracil-DNA Glycosylase Inhibitor Protein 
The crystal structure of the PBS2 uracil-DNA glycosylase inhibitor 
protein has been reported in free form (110) and in complex with human 
[Mol, 1995 #169], HSV-1 [Savva, 1995 #243], and E. coli [Ravishankar, 1998 
#226; Putnam, 1999 #338] uracil-DNA glycosylases. The inhibitor displays 
charge, shape, and hydrophobic complementarity to the enzyme (79, 110). 
Crystal structures of free inhibitor indicated that Ugi complementarity with 
uracil-DNA glycosylase is pre-existing, although localized conformational 
changes around Ugi Glu-20 are observed following Ung Ugi complex 
formation (110). Ugi consists of a five-stranded antiparallel 13-sheet and two 
a-helices, which lie on opposite sides of the 13-strands (110). The protein has a 
compact, globular fold and displays extensive hydrophobic packing, 
observations which are consistent with its thermostability (110). 29 
Ugi forms a complex with the enzyme through two major interactions: 
(i) a hydrophobic cavity in Ugi between a2 and the 13-sheet envelops the 
leucine side chain in the conserved leucine loop (human Leu-272, E. coli Leu­
191) (110) and (ii) the Ugi 131 edge sequesters the DNA binding groove of the 
enzyme without contacting the uracil binding pocket (110). Upon binding 
Ung, Ugi undergoes a "I3-zipper" conformational change which extends the 
intramolecular interactions between the 131- and 132-strands (110). Rotation of 
the Gln-19 carbonyl by -180° positions Glu-20 to make important DNA-
phosphate-mimicking interactions with Ung (110). Alignment of E. coli Ung­
bound Ugi and human UDG-bound DNA reveals striking structural 
similarities between Ugi and DNA (110). Most carboxylate side chains in Ugi 
superimpose with the DNA phosphate backbone, including the DNA strand 
that is not contacted by UDG (110). Thus, irreversible inhibition of uracil-
DNA glycosylase by Ugi is a result of Ugi's mimicry of bound DNA. 
1.5  Research Objectives 
Several amino acid residues of E. coli Ung have been implicated in DNA 
binding or catalysis based on biochemical and structural data and amino acid 
sequence conservation between biologically distant species (7, 103, 116, 127). 
Several investigators have proposed catalytic mechanisms for uracil-DNA 
glycosylase and in each an absolutely conserved histidine residue 
corresponding to E. coli Ung His-187 was proposed to play an essential role in 
catalysis (80, 116); however, the function of Ung His-187 remains to be fully 
elucidated. Previously, an E. coli Ung H187D mutation was generated to 
examine the role of this absolutely conserved amino acid in substrate 
recognition, binding, and catalysis (6). As part of the research for this thesis 
the mutant protein was overproduced, purified to apparent homogeneity, and 
biochemically characterized. The mutation was anticipated to disrupt DNA 
binding or hydrolysis of the uracil N-glycosyl bond; thus, a comparison 
between wild type and H187D mutant proteins was expected to provide 
insight into the mechanism of uracil-DNA glycosylase catalysis. 30 
Additionally, techniques were developed to identify and purify uracil-
DNA glycosylases from biological samples by exploiting the high degree of 
homology displayed by this enzyme and the ability of the Ugi inhibitor 
protein to bind uracil-DNA glycosylase from sources other than B. subtilis. A 
Ugi-affinity resin and polyclonal antibody to E. colt Ung were used as probes 
to purify mitochondrial uracil-DNA glycosylases from partially purified 
extracts. The tools developed provide a rapid means for identifying and 
recovering uracil-DNA glycosylases from crude samples. 31 
2. MATERIALS AND EXPERIMENTAL PROCEDURES 
2.1  Materials 
2.1.1  Chemicals 
Trizma (Tris base), ethylenediaminetetraacetic acid (EDTA), MgSO4, 
HEPES, CAPS, MOPS, MES, 13-mercaptoethanol for buffers, bovine serum 
albumin, ATP, calf thymus DNA (type I), thiamine, tetracycline, ampicillin, 
streptomycin sulfate, alumina, phenylmethylsulfonyl fluoride (PMSF), 
tetrasodium pyrophosphate, uracil, 6-amino uracil, 5-fluorouracil, Freund's 
complete and incomplete adjuvants, Tween-80, and SDS-7L protein molecular 
weight markers were purchased from Sigma. Agarose, glycine, sodium 
dodecyl sulfate (SDS), isopropyl-P-D-thiogalactopyranoside (IPTG), 
dithiothreitol (DTT), ammonium sulfate, sucrose, urea, formamide, and 1 kb 
and 100 by DNA ladders were obtained from Life Technologies. J.T. Baker 
was the source of triethylamine, glycerol, NaOH, NaHCO3, glucose, isoamyl 
alcohol, perchloric acid, boric acid, mono- and dibasic potassium phosphate, 
dimethyl formamide (DMF), and lithium chloride. Potassium acetate, KC1, 
MgC12, methanol, ammonium hydroxide (50%), hydrochloric acid, acetic acid, 
trichloroacetic acid, and phenol were purchased from Fisher. 13­
mercaptoethanol for gel electrophoresis, protein assay (Bradford) dye 
reagent, bovine gamma globulin, bromophenol blue, xylene cyanol, 
prestained SDS-PAGE protein standards (Low Range), acrylamide, bis N,N'­
methylene-bis-acrylamide, ammonium persulfate, TEMED, Coomassie 
Brilliant Blue G250, bromochloroindolyl phosphate (BCIP) and nitro blue 
tetrazolium (NBT) were obtained from Bio-Rad. The source of horseradish 
peroxidase- and alkaline phosphatase-conjugated goat anti-rabbit antibodies, 
2, 2'- azino- di -[3- ethylbenzthiazoline sulfonate] (ABTS) and ABTS buffer was 
Boehringer Mannheim. Hydrogen peroxide and chloroform were purchased 
from Mallinckrodt. Pharmacia Biotech was the source of dATP, dCTP, dGTP, 
and dTTP. Formic acid was from EM Science. 32 
2.1.2  Radionucleotides 
[35S]methionine, [y- 32P]ATP, [3H]uracil, and [3H]leucine were purchased 
from DuPont-New England Nuclear. [3li]clUTP was obtained from 
Amersham Corp. 
2.1.3  Bacterial Growth Media 
2xYT medium was composed of 1% yeast extract (Difco), 2% tryptone 
(Difco). TYEN medium contained 1% tryptone, 1% yeast extract, and 0.5% 
NaC1, adjusted to pH 7.5 with 10 M NaOH. LB medium was comprised of 1% 
tryptone, 0.5% yeast extract, 1% NaCl, adjusted to pH 7.5 with 10 M NaOH. 
SOC medium contained 2% tryptone, 0.5% yeast extract, 0.05 % NaCl, 2.5 mM 
KC1, 10 mM MgC12, and 20 mM glucose, adjusted to pH 7.0 with 5 M NaOH. 
M9 medium contained 1.28% Na2HPO47H20, 0.3% KH2PO4, 0.05% NaC1, and 
0.1% NH4C1. Following sterilization, M9 medium was supplemented with 2 
mM MgSO4, 0.1 mM CaC12, 0.4% glucose, and 10 µg /ml thiamine from 
individual sterile stock solutions. 
Solid plates were prepared by the addition of 1.5% (w/v) bacto-agar 
(Difco) to liquid media. Where appropriate, liquid media or media plates were 
supplemented with 100 µg /ml ampicillin from a filter-sterilized stock solution 
(100 mg/ml) or with 15 µg /ml tetracycline from a 15 mg/ml stock (in 
ethanol). 
2.1.4  Bacterial Strains and Bacteriophage 
The genotypes of E. coli strains used in this research are listed in Table 2. 
E. coli strains JM105 and JC10289 and the Plvir lysate of JC10289 were 
provided by W. Ream (Oregon State University). 33 
Table 2 
E. coli Strains and Genotypes 
E. coli Strain  Genotype  Reference 
BD2314  thi-1 his-68 tyrA2 purC50 trp-45 
lacY1 gal-6 xyl -7 mtl -2 malA1 
rpsL125 tonA2 tsx-70 supE 
ung-152::Tn10  (30) 
BW310	  relA1 spoT1 thi-1 ung-1  (34) 
JC10289	  thr-1 leuB6 proA2 his-4 argE3 thi-1 
mtl -1 gatC? ara-14 lacY1 galK2 
xyl -5 rpsL3ltsx -33 supE44 
sr1R301::Tn10-84 4(recA-sr1)306  (19) 
JM105	  F' traD36 lad' 4(lacZ)M15 
proA+Bithi rpsL endA sbcB15 
sbcC? hsdR4 (rk-mk+),A(lac-proAB)  (154) 
MJ100a  BW310 sr1R301::Tn10-84 A(recA- srl)306 
' Strain constructed as described under "Experimental Procedures". 34 
2.1.5  Plasmids 
The overexpression vectors for producing Ung (pSB1051) (10), Ung 
H187D (pUngH187D) (6), and Ugi (pZWtacl) (144) were constructed as 
previously described. The plasmid pKK223-3 was purchased from Pharmacia 
Biotech. 
2.1.6  Chromatographic Resins 
DEAF- cellulose (DE52) anion exchange resin was obtained from 
Whatman. Sephadex G-25 and G-75, poly(U)-Sepharose, and activated 
Sepharose 4B were purchased from Pharmacia Biotech. Bio-Rad was the 
source of hydroxyapatite Bio-Gel HTP, Bio-Gel P-4, and Dowex 1-X8 ion 
exchange resins. 
2.1.7  Oligonucleotides 
The nucleotide sequences of the oligonucleotides used in the assays 
described in this thesis are listed below, where "B" indicates an abasic sugar 
and "P" indicates a 2-aminopurine residue. The dT20, U-25-mer, A-25-mer, and 
G-25-mer oligonucleotides were synthesized by the Center for Gene Research 
and Biotechnology (Oregon State University) on an Applied Biosystems Model 
380B DNA synthesizer. dT19 -U, 2AP-27-mer and U-27-mer oligonucleotides 
were supplied by Midland Certified Reagent Company. The dT19 -AP 
oligonucleotide was produced as described in this thesis. The following 
oligonucleotides were used in this research: 
1. Substrate Specificity Assays ("Section 2.2.22.5"): 
U-25-mer: 5'-GGG GCT CGT AUA AGG AAT TCG TAC C-3' 
A-25-mer: 5'-CCC CGG TAC GAA TTC CTT ATA CGA G-3' 
G-25-mer: 5'-CCC CGG TAC GAA TTC CTT GTA CGA G-3' 35 
2. UV-Crosslinking Assays ("Section 2.2.22.7"): 
dT20: 5'-TTT TIT TTT ITT 'fl 1 ITT TT-3' 
dT19-U:  TTT TTT TTU TTT TTT TT-3' 
dT19-AP: 5'-TTT TTT TTT TTB ITT TIT TT-3' 
3. Steady-State Fluorescence Assays ("Section 2.2.23"): 
2AP-27-mer: 5'-CCC CGG TAG ACG APT TCC TTG TAC GAG-3' 
U-27-mer: 5'-GGG GCT CGT ACA AGG AAU TCG TCT ACC-3' 
2.1.8  Enzymes 
BamHI, Pvu II, T4 polynucleotide kinase, and DNA polymerase I were 
obtained from New England Biolabs. The source of RNase H was GibcoBRL. 
2.2  Experimental Procedures 
2.2.1  Preparation of Chromatographic Resins 
2.2.1.1	  Preparation of DEAE-Cellulose, Sephadex G-25 and 
G-75, Bio-Gel P-4, and Poly(U) Sepharose 
DEAE-cellulose was prepared by using pre-swollen DE52 
diethylaminoethyl cellulose resin suspended at a 1:5 ratio (v/v) in TED buffer 
(10 mM Tris-HC1 (pH 8.0), 1 mM EDTA, 1 mM DTT). The resin was allowed to 
settle at room temperature, the buffer decanted to remove the fines, and fresh 
TED added with gentle agitation. The resin was defined 4-5 times in this 
manner and stored as a 50% (v/v) slurry in TED buffer containing 1 M NaC1 at 
4°C. 
Sephadex G-25 and G-75, Bio-Gel P-4, and poly(U) Sepharose resins 
were prepared as described above with various buffer conditions for 
hydration and storage. Sephadex G-25 was prepared in TEAB buffer (10 mM 
triethylammonium bicarbonate, pH 7.0). Sephadex G-75 was prepared in Ung 
Equilibration Buffer (UEB) (10 mM HEPES-KOH (pH 7.4), 10 mM 36 
13-mercaptoethanol, 1 mM EDTA, 5% (w/v) glycerol, 1 M NaC1) or Ugi 
Equilibration Buffer (IEB) (50 mM Tris-HC1 (pH 8.0), 1 mM EDTA, 1 mM DTT, 
100 mM NaC1, 10% (w/v) glycerol) for the purification of Ung and Ugi, 
respectively. Bio-Gel P-4 was prepared in TE (10 mM Tris-HC1 (pH 7.5), 1 mM 
EDTA) or DAB (30 mM Tris-HC1 (pH 7.4), 1 mM EDTA, 1 mM DTT, 5% (w/v) 
glycerol) buffers. Poly(U) Sepharose was hydrated in TMEG buffer (50 mM 
Tris-HC1 (pH 7.5), 10 mM13-mercaptoethanol, 1 mM EDTA, 10% (w/v) 
glycerol) and stored in TMEG buffer containing 1 M NaCl. 
2.2.1.2  Preparation of Hydroxylapatite 
Hydroxylapatite powder was suspended in 10 volumes of 0.5 M 
potassium phosphate (pH 7.5). After settling, the buffer was decanted and the 
resin suspended in 10 volumes of 20 mM potassium phosphate (pH 7.5). The 
resin was defined at least 5 times before storing as a 50% (v/v) slurry in 20 
mM potassium phosphate (pH 7.5) at 4°C. 
2.2.1.3  Preparation of Single-Stranded DNA-Agarose 
Calf thymus DNA (Type I, Sigma) was solubilized at 15 mg/ml in 250 
ml of 20 mM NaOH by gently stirring overnight at room temperature. The 
DNA solution was incubated at 95°C  for 15 min and mixed with an equal 
volume of molten 4% agarose equilibrated at 70°C. The mixture was poured 
into an ice cold Pyrex dish resting in an ice bath and allowed to solidify. The 
solid DNA/agarose mixture was passed twice through a stainless steel sieve 
(60 mesh) and the resultant gel particles were suspended in 150 ml of 
resuspension buffer (10 mM Tris-HC1 (pH 7.4), 1 mM EDTA, 100 mM NaC1). 
The gel was placed in a Buchner funnel (200 ml, 40-60 C) and washed with 
approximately 10 L of resuspension buffer until the A260  of the wash was 
below 0.02 absorbance units. The resin was stored at 4°C as a 50% (v/v) 
slurry in resuspension buffer. 37 
2.2.1.4  Preparation of Dowex 1-X8 
Dowex resin was converted from the chloride to the formate form for 
use in Ung and Ugi assays. A 1000 ml cylinder was filled with 800 ml of 1 M 
NaOH, and Dowex resin was added to bring the volume to 1000 ml. The 
mixture was inverted several times and allowed to settle 20 mM at room 
temperature. The NaOH was removed by aspiration and the cylinder refilled 
with 1 M NaOH to 1000 ml. This procedure was repeated until 4 L of 1 M 
NaOH was used. The resin was equally divided between three 200 ml glass 
filter funnels (40-60 C) and the residual NaOH allowed to drain by gravity. 
Each funnel was washed with 200 ml of 1 M ammonium formate buffer (1 M 
formic acid adjusted to pH 4.2 with concentrated ammonium hydroxide), 
followed by -667 ml of 10 mM ammonium formate buffer (pH 4.2). Dowex 
resin was stored as a 50% (v/v) slurry in 10 mM ammonium formate buffer at 
4°C. 
2.2.1.5  Preparation of Ung- and Ugi-Sepharose 
Ung- and Ugi-Sepharose were prepared by coupling purified Ung or 
Ugi to CNBr-activated Sepharose 4B. Activated Sepharose (6 g) was 
suspended in 40 ml of 1 mM HC1 at room temperature. The gel was washed 
with 1160 ml of 1 mM HC1 over 15 mM using a sintered glass filter (40-50 M), 
followed by a 50 ml wash with coupling buffer (0.1 M NaHCO3 (pH 8.3), 0.5 M 
NaC1). The gel was resuspended in 7 ml of coupling buffer and divided into 
two equal fractions based on settled gel volume. One portion was coupled to 
purified Ung or Ugi and the second was treated in a mock coupling reaction to 
produce control resin. In the mock reaction, an equal volume of coupling 
buffer (15 ml) was added to the gel. Purified Ung or Ugi (30 mg protein/g of 
dry Sepharose), diafiltered in coupling buffer, was diluted in coupling buffer 
such that the total volume addition of protein would equal the volume of gel. 
The coupling reaction was allowed to proceed for 2 h at room temperature 
with gentle rocking. The buffer was removed by filtration and the gel was 
washed with 5 volumes of coupling buffer. 38 
The unreacted active sites on the resin were blocked by incubating the 
gel with 35 ml of 0.1 M Tris-HC1 (pH 8.0) for 16 h at 4°C without agitation. 
The Tris buffer was decanted and fresh 0.1 M Tris-HC1 was added for an 
additional 1 h incubation at 4°C. The buffer was then removed by filtration. 
Uncoupled ligand was removed by washing the resin with three alternating 
cycles of low and high pH. For Ugi- and mock-treated Sepharose, washes 
consisted of 5 gel volumes of 100 mM glycine (pH 2.5) containing 1 M NaCl 
and 100 mM Tris-HC1 (pH 8.0) containing 1 M NaCl. For Ung-Sepharose, 100 
mM acetate (pH 4.0) containing 0.5 M NaC1 and 100 mM Tris-HC1 (pH 8.0) 
containing 0.5 M NaCl were used. The amount of ligand coupled was 
estimated by monitoring the coupling, blocking, and wash buffers for 
absorbance at 280 nm, determining their protein concentrations using the 
known extinction coefficient for each protein, and subtracting the total 
amount of recovered protein from the initial starting amount. 
The resin was washed with 5 gel volumes of 50 mM Tris-HC1 (pH 8.0), 1 
mM EDTA, 1 mM DTT, 100 mM NaC1 and stored as a 25% (v/v) slurry at 4°C 
in the same buffer. When used for affinity purification of antibody, DTT was 
omitted from the storage buffer. 
2.2.2  Preparation of Dialysis Tubing 
Dialysis tubing was cut into 25-30 cm lengths and soaked for 1 h in 1% 
acetic acid. The tubing was rinsed in distilled water then boiled in 1% (w/v) 
NaHCO3, 0.1% (w/v) EDTA with intermittent stirring. The solution was 
discarded upon turning a yellow color and replaced with fresh 
NaHCO3 /EDTA buffer. This procedure was repeated at least 3 times or until 
the solution no longer changed color with boiling. The tubing was rinsed with 
distilled water and boiled in fresh distilled water with one exchange. The 
prepared dialysis tubing was then stored in 10 mM EDTA at 4°C. 39 
2.2.3  Protein Concentration Measurements 
2.2.3.1  Concentration Determination by Bradford Assay 
The protein concentrations of crude extracts and sera were determined 
by the modified Bradford method (14) using the Bio-Rad Protein assay. For 
the standard procedure (20-140 lig protein, 200-1400n/m1), Bradford dye 
reagent was diluted 1:5 in distilled water and filtered through Whatman No. 1 
filter paper. Standards and diluted samples (100 ,1,1) were gently mixed with 5 
ml of dye diluted reagent. For the microscale procedure (1-20 mg protein, __25 
µg /ml), 0.8 ml of standards or diluted samples was mixed with 0.2 ml of 
Bradford dye reagent concentrate. After incubation at room temperature for 
5-60 min, absorbance at 595 nm was measured. BSA was used as a standard 
for crude extracts and bovine gamma globulin was used as a standard for 
sera. 
2.2.3.2	  Concentration Determination by Spectrophotometric 
Measurements 
The concentrations of purified E. coli Ung and Ugi were determined by 
absorbance spectroscopy using the molar extinction coefficients 6280 nm = 4.2 x 
104 liters/molcm and E280 nm = 1.2 x 104 liters/molcm for Ung and Ugi, 
respectively (8). 
2.2.4  Small-Scale Preparation of Plasmid DNA 
Minipreparation of plasmid DNA was performed by a modified 
alkaline lysis method (75). A single bacterial colony was transferred to 2 ml of 
2x YT medium (2% tryptone, 1% yeast extract) containing the appropriate 
antibiotic and the culture was incubated overnight at 37°C with shaking. The 
culture (1.5 ml) was transferred to a microfuge tube and centrifuged for 5 min 
at maximum speed in a microcentrifuge to pellet the bacteria. The medium 
was removed by using aspiration, leaving the pellet as dry as possible. The 
bacterial pellet was resuspended by vigorous vortexing in 100 ul of ice-cold 40 
buffer containing 50 mM glucose, 25 mM Tris-HC1 (pH 8.0), and 10 mM EDTA. 
A freshly prepared solution of 0.2 M NaOH containing 1% SDS (200 d) was 
added, the tube was gently inverted several times, and the mixture placed on 
ice for 5 min. Ice-cold potassium acetate buffer (1501,11; 3 M with respect to 
potassium, 5 M with respect to acetate) was added and the tube was gently 
vortexed in an inverted position. The mixture was stored on ice for 5 min 
then centrifuged at 12,000xg for 5 min at 4°C. The supernatant was 
transferred to a fresh tube. 
The DNA was extracted with an equal volume of phenol equilibrated in 
TE buffer by briefly vortexing, and centrifugation was conducted for 2 min in 
a microcentrifuge. The aqueous layer was transferred to a fresh tube and 
extracted with an equal volume of chloroform:isoamyl alcohol (24:1). After 
centrifugation as before, the aqueous layer was transferred to a fresh tube and 
the DNA was precipitated with the addition of 2.5 volumes of ice-cold absolute 
ethanol. After incubating 2 min at room temperature, the DNA was 
recovered by centrifugation in a microcentrifuge for 5 min at maximum 
speed. The supernatant was removed by aspiration, the pellet washed with 
ice-cold 70% ethanol, and the tube centrifuged as described previously. 
After removing the ethanol by aspiration, the pellet was dried under 
vacuum, then resuspended in 20 d of TE buffer. The DNA was stored at 
20 °C and used for restriction enzyme digestion or electroporation. 
2.2.5  Restriction Enzyme Digestion of Plasmid DNA 
Plasmid DNA from minipreps (1-2 lig) was incubated in a 201./1 reaction 
mixture for 1 h at 37°C with 10 units of BamHI or Pvull restriction 
endonuclease in reaction buffer containing 10 mM Tris-HC1 (pH 7.9), 150 mM 
NaCl, 10 mM MgC12, 1 mM DTT. BamH I digestion mixtures were 
supplemented with 100 µg /ml BSA. Loading dye (10 mM EDTA, 0.1% SDS, 
0.001% bromophenol blue, 5% (w/v) glycerol) was added to each sample for 
analysis by 2% agarose gel electrophoresis. 41 
2.2.6  Oligonucleotide Purification 
Synthetic oligonucleotides were supplied from either the Center for 
Gene Research and Biotechnology or Midland Certified Reagent Company as 
a lyophilized powder. The powder was resuspended in 1 ml of TEAB buffer 
(10 mM triethylamine-bicarbonate adjusted to pH 7.0 by bubbling CO2 gas 
through the solution). The sample was loaded onto a Sephadex G-25 column 
(1.5 cm2 x 7 cm) equilibrated in TEAB at room temperature and eluted with 
equilibration buffer. Fractions (1 ml) were collected at a flow rate of -15 ml/h 
and oligonucleotide-containing fractions were identified by absorbance at 260 
nm. Peak fractions were pooled and evaporated to dryness by using a Speed-
Vac Concentrator. When ready for use, each oligonucleotide preparation was 
resuspended in a total of 100-150 Al of distilled H2O. The concentration of 
resuspended oligonucleotide was determined by absorbance spectroscopy (1 
A260 nm = 20 µg /ml) and the purity was determined by the OD280  / OD260 
ratio. The expected 
°D280 nm / °D260 nm value for pure preparations of DNA is 1.8. 
2.2.7  5'-end 32P-Phosphorylation of Oligonucleotides 
For oligonucleotides used in substrate specificity assays, 
phosphorylation reactions (1380 consisting of 4 nmol of U-25-mer, 50 units 
of T4 polynucleotide kinase, and 0.3 µM of [y32P]ATP in kinase reaction buffer 
(50 mM Tris-HC1 (pH 7.6), 10 mM MgC12, 5 mM DTT, 0.1 mM EDTA) were 
incubated for 15 mM at 37°C then supplemented with 200 IIM of ATP. The 
reaction was continued for 45 mM at 37°C and terminated by the addition of 
EDTA to a final concentration of 10.7 mM plus heating at 70°C for 10 mM. 
Complementary oligonucleotides were phosphorylated in a similar fashion 
using nonradioactive ATP in place of [y32P]ATP. 
To radiolabel oligonucleotide for UV crosslinking experiments, reaction 
mixtures (200 Ill) typically contained -300 nmol of oligonucleotide, 100 units of 
T4 polynucleotide kinase, 0.2 tiM of [y32P]ATP, and a 2-fold molar excess of 
nonradioactive ATP relative to oligonucleotide in kinase reaction buffer. The 42 
samples were incubated for 60 mM at 37°C and reactions were terminated by 
the addition of EDTA to a final concentration of 10.7 mM and heating at 70°C 
for 5 min 
Phosphorylated oligonucleotide was purified from free ATP by using P­
4 spun columns equilibrated in TE or DAB buffer for specificity or crosslinking 
studies, respectively. The sample was typically split into two equal volumes 
and each diluted to 250 ill with the appropriate equilibration buffer. The 
samples were applied to two consecutive P-4 columns (1.5 ml resin, each) and 
centrifuged for 2.5 mM in an IEC clinical centrifuge (setting #4) at room 
temperature. 
2.2.8  Generation of Abasic Site-Containing Oligonucleotide 
Oligonucleotide dT19-U (5'-TTT TTT TTT TTU TTT TTT TT-3') was 
treated with E. coli Ung (Fraction IV) to generate an apyrimidinic site 
containing DNA substrate. After 5'-end 32P-labeling of dT19-U as described 
above, 110 nmol of [32P]dT19-U (4600 cpm/pmol) was incubated with -7.5 x 105 
units of Ung for 30 mM at 37°C in a total reaction volume of 315 pl. 
The DNA-enzyme mixture was then incubated with 575 jil of Ugi-Sepharose 
resin for 45 mM at 4°C, with inversion of the reaction tube several times 
during the incubation period. The reaction tube was centrifuged for 2.5 mM in 
an IEC clinical tabletop centrifuge (setting #4) to separate the resin from the 
DNA-containing supernatant. The resin was washed once with 250 ul of 
distilled water to recover any residual DNA, and the wash was pooled with 
the supernatant buffer. The recovered oligonucleotide was concentrated to 
100 jil in a Centricon-3 (Amicon) concentrator. The substrate was verified by 
subjecting the abasic site to alkaline lysis and analyzing the cleavage product 
by 12% polyacrylamide gel electrophoresis. 
2.2.9  Hybridization of Oligonucleotides 
Double-stranded DNA was formed by annealing 750 pmol of [32P]U-25­
mer to 1,500 pmol of A-25-mer or G-25-mer to construct duplex [321-Ili/A- and 43 
[32P]U /G -25 -mer DNA substrates. Annealing reaction mixtures (186 i,d) 
contained SSC buffer (20 mM Tris-HC1 (pH 7.4), 2 mM MgC12, and 50 mM 
NaC1). Reaction mixtures were placed in a 500 ml beaker containing 70°C 
distilled H2O and allowed to cool to room temperature (-4 h). 
Uracil-containing 27-mer was annealed in excess of complementary 2­
aminopurine-containing 27-mer oligonucleotide to generate substrate for 
steady-state fluorescence experiments. U-27-mer (74 nmol) and (2AP)-27-mer 
(59.2 nmol) were combined in an annealing reaction mixture (470 ul) 
containing SSC buffer and treated as described above. 
2.2.10 Electroporation of E. coli with Plasmid DNA 
E. coli strains were transformed by electroporation. Cells were 
prepared for electroporation by growing in 1 L of TYEN broth (1% tryptone, 
1% yeast extract, 0.5% NaC1, adjusted to pH 7.5 with 10 M NaOH) at 37°C to 
mid-log phase (0.5-1.0 OD,00.). The culture was chilled on ice for 5 min 
before centrifugation at 4,000xg for 15 mM at 4°C. All subsequent 
centrifugations were performed in an identical manner. The bacterial pellets 
were resuspended in an equal volume of ice-cold distilled water, centrifuged, 
resuspended in 0.5 volume of ice-cold distilled water, centrifuged, 
resuspended in 0.02 volume of ice-cold 10% glycerol (w/v), centrifuged, and 
finally resuspended in 2-3 ml of ice-cold 10% glycerol (w/v). Cells were 
frozen at -80°C in 50 ul aliquots until ready for use. 
For electroporation, 4-8 ng of plasmid DNA was mixed with 50 Ill of 
prepared cells. The cell/DNA mixture was transferred to a cold 
electroporation cuvette (0.2 cm electrode gap) and incubated on ice for 1 mM. 
The cells were exposed to a pulse of 2.5 kV, 25 µF, and 200 Q with a time 
constant of -5-7 msec (Gene Pulser II, BioRad). Immediately after the pulse, 1 
ml of SOC medium was added to the cuvette, then the culture was transferred 
to a culture tube and incubated for 1 h at 37°C with shaking. Aliquots of cells 
were then plated on the appropriate selective media. 44 
2.2.11 Transduction of E. coli BW310 by P1vir 
A saturated culture of E. coli BW310 was diluted (1:100) with 10 ml of 
fresh TYEN broth and grown to early mid-log stage (0D600  0.4-0.5) at 37°C 
with shaking. The cells were pelleted at room temperature in an IEC clinical 
centrifuge (setting #5) for 20 min and then resuspended in 1 ml of LB broth 
(1% tryptone, 0.5% yeast extract, 1% NaC1, adjusted to pH 7.5 with 10 M 
NaOH). The bacterial suspension (0.5 ml; -1 x 109 cells /ml) was mixed with an 
equal volume of 15 mM CaC12 containing 30 mM MgSO4 and one half volume 
of a P1 lysate (-1 x 108 pfu/ml in LB). The multiplicity of infection was -0.05. 
The mixture was incubated for 20 min at 37°C, centrifugation was conducted 
as described, and the cell pellet was washed with an equal volume (1.25 ml) of 
TYEN broth. The cells were pelleted again and resuspended in 0.1 ml of LB. 
The entire volume was plated on LB agar containing 15 pig/m1 tetracycline and 
incubated overnight at 37°C. Approximately 300 tetracycline resistant 
colonies appeared. Sixteen colonies were purified on LB-tet plates and one 
was screened for sensitivity to UV-irradiation. 
Overnight cultures (5 ml) of the transductant, E. coli BW310, and 
JC10289 were grown in the appropriate media. The cultures were streaked 
across LB agar in parallel lines. While working in the dark, the lids of the Petri 
plates were removed and the plates were placed -75 cm from a UV source 
(,max = 254 nm) with a dose rate of 2.4 J/m2/sec. Sections of the plates were 
UV-irradiated for increasing intervals of time, resulting in exposures of 4.8­
57.6 J/m2. The lids were replaced and the plates were wrapped in aluminum 
foil before incubating overnight at 37°C. 
2.2.12 Preparation of Crude Cell Extracts 
E. coli JM105 containing pUngH187D, pSB1051, or pKK223 -3 was 
streaked onto fresh LB agar plates containing 100 µg /ml ampicillin (Amp) and 
grown at 37°C overnight. An isolated colony was used to inoculate TYEN-
Amp broth and the culture was incubated overnight with shaking at 37°C. 
The overnight culture was diluted (1:100) into 10 ml of fresh TYEN-Amp and 45 
grown with shaking at 37°C to an optical density of 0.6-0.8 at 600 nm. Gene 
expression was induced with 1 mM IPTG and the culture incubated an 
additional 3 h. Uninduced cultures were grown to 0.6-0.8 OD600. and allowed 
to grow an additional 3 h without addition of IPTG. The cultures were then 
chilled and the cells harvested by centrifugation at 3500xg at 4°C for 15 min. 
Cell pellets were stored at -80°C until ready to use. 
Thawed pellets were resuspended in 4 ml of 10 mM Tris-HC1 (pH 8) 
and lysed by sonication using 8-12 pulses (30 s on/30 s off). Intact cells and 
cellular debris were removed from the suspension by centrifugation at 7500 
rpm (SA600) for 20 min at 4°C. The supernatant was designated cell-free 
extract (CFE). CFE (25 tig) was mixed with cracking buffer (50 mM Tris-HC1 
(pH 6.8), 1% SDS, 143 mM (3-mercaptoethanol, 10% (w/v) glycerol, 0.04% 
bromophenol blue), placed in a boiling water bath for 10 min, and then 
analyzed by 12.5% SDS-PAGE. 
2.2.13 Purification of E. coli Uracil DNA Glycosylase 
2.2.13.1  Large Scale Purification of ling 
A saturated culture (25 ml) of E. coli JM105 containing pSB1051 was 
diluted (1:100) into 2 L of LB broth supplemented with 0.01% ampicillin. The 
culture was grown at 37°C until the OD600. reached 0.8. IPTG was added to 
a final concentration of 1 mM and the culture incubated an additional 3 h to 
induce expression of the ung gene. The culture was then chilled on ice and 
centrifuged at 3,500xg for 15 min at 4°C. The supernatant was discarded and 
the pellets were stored at -80°C until ready for use. 
Cell pellets were thawed and resuspended in TED buffer (40 ml/L 
culture) using a Dounce homogenizer to disrupt aggregates. The cells were 
lysed either in 40 ml aliquots by using a French pressure cell at 15,000 psi or by 
sonication using 10-12 pulses of 30 sec each. All subsequent procedures were 
performed at 4°C. Cellular debris was removed by centrifugation at 6,500xg 
for 20 min. An equal volume of 1.6% (w/v) streptomycin sulfate in TED 46 
buffer was added to the supernatant (Fraction I) dropwise with stirring. After 
the entire volume of streptomycin sulfate had been added, the solution was 
stirred for an additional 30 mM then centrifuged for 20 mM at 6,500 x g. Finely 
ground ammonium sulfate was slowly added to the supernatant with stirring 
to a final concentration of 70% (saturation). After stirring for 30 mM, the 
precipitate was collected by centrifugation at 10,000xg for 15 mM. The pellet 
was resuspended in 5 ml of UEB buffer (10 mM HEPES-KOH (pH 7.4), 10 mM 
(3-mercaptoethanol, 1 mM EDTA, 5% (w/v) glycerol, 1 M NaCl). The solution 
was dialyzed in 12-14,000 MWCO tubing overnight against UEB (2 L) with 2-3 
changes of buffer. The solution (Fraction II) expanded to -25 ml during 
dialysis. 
The sample was applied to a Sephadex G-75 column (6 cm2 x 88 cm) 
equilibrated in UEB buffer and eluted at a rate of 20 ml/h with the 
equilibration buffer. Fractions (5 ml) containing Ung activity were pooled and 
concentrated 2-fold using an Amicon stirred cell (YM10 membrane) under N2 
gas (55 psi). After diafiltration against HAB buffer (10 mM potassium 
phosphate (pH 7.4), 1 mM DTT, 200 mM KC1), the sample (Fraction III) was 
loaded onto a hydroxylapatite column (2 cm2 x 10 cm) equilibrated in the same 
buffer. Fractions (5 ml) were collected and Ung activity was recovered in the 
flow through. The peak fractions were pooled (Fraction IV) and dialyzed 
against DAB buffer (30 mM Tris-HC1 (pH 7.4), 1 mM EDTA, 1 mM DTT, 5% 
(w/v) glycerol). The sample was applied to a DNA agarose column (19.6 cm2 
x 42 cm) equilibrated in DAB and fractions (6.5 ml) were collected. The column 
was washed with - 750 ml of equilibration buffer before performing a step­
wise elution with DAB containing 150 mM NaCl. Fractions containing Ung 
activity were pooled, concentrated 40-fold, and diafiltered into DAB by using 
an Amicon stirred cell (YM10 membrane) as described above. The purified 
protein (Fraction V) was stored in aliquots at -80°C. 47 
2.2.13.2  Purification of [3H-Leu]Ung 
Radioactively labeled Ung was purified as described above with the 
following modifications: Cells were grown in M9 minimal salts medium 
supplemented with 10 lag/m1 thiamine and 0.01% ampicillin. A 1 L culture was 
grown to 0.625 °Dna°  (5 x 108 cells/m1) before adding 1.0 mCi (180 
Ci/mmol) [3,4,5- 3H(N)]- leucine. The cells were grown for 35 min before 
inducing with IPTG. Cells were lysed by sonication as described previously. 
2.2.13.3  Purification of Ung H187D 
Ung H187D was purified from E. coli JM105 harboring pUngH187D by 
essentially the same protocol as the wild-type enzyme through Fraction IV. 
Subsequently, Fraction IV (26 ml) was dialyzed against DAB buffer and one 
half the preparation was applied to a single-stranded DNA agarose column 
(5.3 cm2 x 28 cm) equilibrated in DAB. The column was washed with 150 ml of 
equilibration buffer and then eluted with a 400 ml linear gradient from 0 to 
150 mM NaC1 in DAB. Fractions (2.5 ml) were analyzed for Ung activity, the 
absorbance at 280 nm was measured, and the salt concentration was 
determined by measuring the conductivity of the fractions. The flow through 
fractions containing Ung H187D were pooled, dialyzed into in TMEG buffer 
(50 mM Tris-HC1 (pH 7.5), 10 mM 13-mercaptoethanol, 1 mM EDTA, 10% 
(w/v) glycerol) and designated Fraction V. Ung H187D (-8 mg) was applied 
to a poly(U) Sepharose column (2 cm2 x 12 cm) equilibrated in TMEG. The 
column was washed with 24 ml of equilibration buffer and eluted with 30 ml 
of TMEG containing 500 mM NaCl. Fractions containing Ung H187D were 
pooled, concentrated, dialyzed into DAB buffer and designated Fraction VI. 
2.2.13.4  Rechromatography of Ung and Ung H187D 
Purified Ung H187D (4.53 mg, 167 units) or a mixture of Ung H187D 
(4.53 mg, 167 units) and purified wild-type E. coli Ung (8.35 x 10 mg, 167 
units) were applied to separate single-stranded DNA agarose columns (1.8 cm2 
x 5.6 cm), washed, and step eluted with DAB buffer containing 150 mM NaCl. 48 
Fractions (1m1) were assayed for Ung activity and protein concentration was 
determined by absorbance at 280 nm. 
2.2.14 Purification of PBS2 Uracil-DNA Glycosylase Inhibitor Protein 
2.2.14.1  Large Scale Purification of Ugi 
A saturated culture (25 ml) of E. coli JM105/pZWtac1 was diluted (1:100) 
into 2 L of TYEN medium containing 0.01% ampicillin. Cells were grown to 
0.6-0.8 OD600,,, and IPTG added to 1 mM to induce expression of the ugi gene. 
Growth was continued for an additional 3 h then the culture was chilled and 
the cells harvested by centrifugation at 3,500xg for 15 min at 4°C. The 
supernatant was decanted and the pellets stored at -80°C. Pellets were thawed 
and resuspended in 80 ml of 10 mM Tris-HC1 (pH 8.0) with a Dounce 
homogenizer. Cells were disrupted by sonication using 10-12 pulses of 30 sec 
each. The sonicated solution was centrifuged at 11,500xg for 15 min at 4°C. 
The cell extract (Fraction I) was heated at 100°C for 10 min then allowed to 
cool to room temperature. The precipitates were removed by centrifugation 
at 11,500xg for 20 min at 4°C. The supernatant was dialyzed against TED 
buffer (10 mM Tris-HC1 (pH 8.0), 1 mM EDTA, 1 mM DTT) using 6-8,000 
MWCO tubing. 
After dialysis, the sample was centrifuged at 11,500xg for 20 min at 4°C 
to remove remaining precipitates and the supernatant was designated 
Fraction II. Fraction II (48 ml) was loaded onto a DEAE-cellulose column (4.9 
cm2 x 10 cm) equilibrated in TED buffer. Fractions (4.5 ml) were collected as 
the column was washed with 112 ml of equilibration buffer at a flow rate of 40 
ml/h. Ugi was eluted with a 200 ml linear gradient from 0 to 650 mM NaC1 in 
TED buffer. Fractions were assayed for NaC1 concentration, inhibitor activity, 
and protein concentration by absorbance spectroscopy. Peak fractions were 
pooled and designated Fraction III. Fraction III was concentrated with a 
Centriprep 10 concentrator to approximately one half the initial volume. The 
concentrated sample was loaded onto a Sephadex G-75 column (5.3 cm2 x 70 49 
cm) equilibrated in IEB buffer (50 mM Tris-HC1 (pH 8.0), 1 mM EDTA, 1 mM 
DTT, 100 mM NaC1, 10% (w/v) glycerol). The protein was eluted from the 
column with equilibration buffer at a rate of -15 ml/h. Fractions (4.2 ml) 
containing inhibitor activity were analyzed for purity by using 20% SDS­
polyacrylamide gel electrophoresis and peak fractions were pooled. The 
purified protein was designated Fraction IV, concentrated under N2 gas (55 
psi) by using an Amicon stirred cell (YM3 membrane) to obtain a 
concentration of 2-5 mg/ml, and stored in aliquots at -80°C. 
2.2.14.2  Purification of [35S-Met]Ugi 
Radioactively labeled Ugi was purified as described above with the 
following modifications: Cells were grown in M9 minimal salts medium 
supplemented with 10 fig/m1 thiamine and 0.01% ampicillin. A 1.5 L culture 
was grown to 0.625 OD600n,, (5 x 108 cells/ml) before addition of 5.0 mCi (1175 
Ci/mmol) [35S]- methionine. The cells were grown for 35 min before inducing 
with IPTG. 
2.2.15 Ung- and Ugi- Sepharose Chromatography 
Ung- or Ugi-Sepharose affinity chromatography was performed by 
incubating samples (100 W) with an equal volume of the resin slurry in DAB 
buffer for 10 min at 25°C. Micro-purification columns were designed by 
plugging gel-loading micropipet tips with Sigma-coat-treated glass wool. The 
plugged tips were incubated 10 min at 25°C with 100111 of 10 mM potassium 
phosphate buffer containing 100 µg /ml BSA to block nonspecific protein 
binding. The buffer was removed by brief centrifugation in an IEC clinical 
centrifuge (setting #4) at room temperature and the resin-enzyme slurry was 
transferred to the micro-columns. The buffer was removed from the resin by 
centrifugation as described. The resin was washed three times with 200111 of 
DAB buffer applied in two equal aliquots, while centrifuging between buffer 
additions. The columns were sealed by heating and 100 ill of SDS gel loading 
dye (50 mM Tris-HC1 (pH 6.8), 1% SDS, 143 mM13-mercaptoethanol, 10% 50 
(w/v) glycerol, and 0.04% bromophenol blue) was added to the resin. The 
columns were incubated at 100°C for 10 min to remove bound protein. The 
columns were then unsealed and centrifuged to dryness. Aliquots (25 ul) of 
flow through and wash fractions and 50 IA of each SDS elution fraction were 
analyzed by 12.5% SDS polyacrylimide gel electrophoresis. When applicable, 
aliquots of flow through (100 0, wash (100 pa), and SDS elution (25 pil) 
fractions and the resin were quantitated for radioactivity by liquid scintillation 
counting in 0.5 ml of water by using 5 ml of Formula 989 fluor. 
2.2.16 Isolation of Liver Mitochondria 
A fresh pig liver (Clark Meat Laboratory, Oregon State University) was 
obtained and the gall bladder removed. The tissue was lacerated several times 
and placed in 500 ml of 0.25 M sucrose on ice. The liver was sliced into -2 cm3 
pieces and soaked in 0.25 M sucrose. The tissue slices were pulverized with a 
meat grinder and 1200 g of ground liver was mixed with 2.5 L of 0.25 M 
sucrose. The tissue was homogenized two times through a Zeigler 
homogenizer, 200 ml of 1 M potassium phosphate (pH 7.5) was added, and 
the total volume was brought to 4 L with 0.25 M sucrose. The liver 
homogenate was centrifuged at 2,750 rpm for 10 min in a GSA rotor at 4°C to 
remove whole cells and nuclei. The supernatant was filtered through two 
layers of cheesecloth and the filtrate centrifuged at 9,000 rpm in an SA-600 
rotor for 30 min at 4°C to remove lysosomes. The mitochondrial pellets were 
resuspended in 800 ml of homogenization buffer (0.25 M sucrose, 50 mM Tris­
HC1 (pH 8.0), 25 mM KC1, 5 mM (3-mercaptoethanol, 1 mM EDTA, 5 mM 
MgC12) with a Dounce homogenizer. The resuspended mitochondria were 
further centrifuged at 2,750 rpm for 10 min at 4°C in a GSA rotor. The 
supernatant fraction was centrifuged in an SA-600 rotor at 9,000 rpm for 10 
min at 4°C. The mitochondrial pellet was resuspended in an equal volume of 
homogenization buffer then centrifuged as described above. This process was 
repeated 3 times, reducing the volume of homogenization buffer by 50% with 51 
each resuspension. The final mitochondrial pellets were pooled, frozen in 
liquid nitrogen, and stored at -80°C. 
Rat liver mitochondria were prepared by Dr. John Domena by the 
previously described procedure (27). 
2.2.17 Purification of Mitochondrial Ung 
Approximately 200 g of frozen rat or pig liver mitochondrial pellets 
was ground to a paste with 125 g alumina powder in a chilled mortar, 500 ml 
of extraction buffer (50 mM Tris-HC1 (pH 8.0), 5 mM 13-mercaptoethanol, 1 
mM EDTA, 1 M NaC1, 1 mM PMSF) was slowly added, and the slurry was 
further ground until smooth. The slurry was centrifuged at 470xg for 10 min 
at 4°C. The supernatant was centrifuged at 10,000xg for 10 mM at 4°C. The 
final supernatant was subjected to ultracentrifugation at 100,000xg for 1 h at 
4°C. The supernatant was recovered (the pellets and lipids being discarded), 
and dialyzed into TMEG buffer (20 mM Tris-HC1 (pH 8.0), 5 mM (3­
mercaptoethanol, 1 mM EDTA, 10% (w/v) glycerol) containing 150 mM NaC1, 
and designated Fraction I. Ammonium sulfate precipitations at 0-35% and 35­
65% of saturation were performed on the sample and the resultant pellet was 
resuspended in 30 ml of TEDG buffer (20 mM Tris-HC1 (pH 8.0), 1 mM DTT, 1 
mM EDTA, 10% (w/v) glycerol). The solution was dialyzed extensively 
against TEDG then centrifuged in an SA-600 rotor at 10,000 rpm for 15 mM at 
4°C to remove precipitates. The supernatant, designated Fraction II, was 
allowed to flow over a Ugi-Sepharose column (1000. The column was 
washed with 100 ptl of 10 mM potassium phosphate (pH 7.2). Nonspecifically 
bound proteins were removed with three 100 i.il washes of 0.5 M NaC1 
followed by 100 jil of 10 mM potassium phosphate (pH 7.2). The bound Ung 
was eluted with three 50 ill washes of 10 mM potassium phosphate (pH 7.2) 
containing 5 M MgCl2. 52 
2.2.18 Polyacrylamide Gel Electrophoresis 
2.2.18.1	  Sodium Dodecyl Sulfate Polyacrylamide Gel 
Electrophoresis 
Denaturing polyacrylamide gel electrophoresis was performed 
essentially as described by Laemmeli (64). The stacking gel (1 cm) contained 
3% acrylamide, 0.08% N,N'-methylenebis(acrylamide), 0.125 M Tris-HC1 (pH 
6.8), and 0.1% SDS. The resolving gel (13 cm) contained 12.5% acrylamide, 
0.33% N,N'-methylenebis(acrylamide), 0.375 M Tris-HC1 (pH 8.8), and 0.1% 
SDS. Protein samples were mixed with an equal volume of loading dye 
containing 50 mM Tris-HC1 (pH 6.8), 1% SDS, 143 mM 13-mercaptoethanol, 
10% (w/v) glycerol, and 0.04% bromophenol blue and heated for 10 min at 
90°C. Electrophoresis was performed for 1 h at 100 V, at which time the 
voltage was increased to 200 V until the tracking dye had migrated 
approximately 2 cm from the bottom of the gel. The running buffer contained 
25 mM Trizma base, 192 mM glycine, and 0.1% SDS. 
Protein bands were detected by staining overnight with 0.05% 
Coomassie Brilliant Blue G-250 in 50% methanol and 10% acetic acid. The gels 
were washed with destain solution (7% acetic acid and 5% methanol) to reduce 
background staining. When more sensitive detection was required, protein 
bands were visualized by silver staining using the ICN Rapid Ag-Stain kit with 
minor modifications to the manufacturer's directions. The gels were first fixed 
for 12-24 h in a solution of 40% methanol and 10% acetic acid, followed by a 30 
min wash with 10% ethanol and 5% acetic acid. The gel was then soaked in 
distilled water for 30 min before proceeding with the kit instructions. In 
addition, following incubation with the silver staining solution, the gel was 
washed extensively with distilled water to reduce background staining. The 
staining reaction was stopped by washing the gel with 5% acetic acid. 53 
2.2.18.2  Nondenaturing Polyacrylamide Gel Electrophoresis 
Nondenaturing polyacrylamide gel electrophoresis was performed 
with slab gels containing a stacking gel (1 cm) composed as described above 
but without the 0.1% SDS. The resolving gel (13 cm) contained 18% 
acrylamide, 0.48% N,N'-methylenebis(acrylamide), and 0.375 M Tris-HC1 (pH 
8.8). Protein samples (115 IA) were combined with 23 ill of loading dye 
containing 300 mM Tris-HC1 (pH 6.8), 60% (w/v) glycerol, and 0.12% 
bromophenol blue before loading samples onto the gel. The running buffer 
consisted of 90 mM Trizma base, 90 mM boric acid, and 2 mM EDTA. 
Electrophoresis was performed as described but at 4°C. 
Proteins were visualized by rapid staining with a solution of 0.04% 
Coomassie Brilliant Blue G-250 in 3.5% perchloric acid. The gel was destained 
as described above to eliminate background. 
2.2.18.3  Polyacrylamide Sequencing-Gel Electrophoresis 
Analysis of uracil-DNA glycosylase reaction products produced from 
5'-end 32P- labeled oligonucleotide substrates was performed using denaturing 
polyacrylamide gels composed of 12% acrylamide, 0.41% N,1\11­
methylenebis(acrylamide), 8.3 M urea, and TBE buffer (90 mM Tris base, 90 
mM boric acid, 2 mM EDTA). Samples were mixed with an equal volume of 
dye buffer (95% formamide, 10 mM EDTA, 0.1% (w/v) bromophenol blue, 
and 0.1% xylene cyanol) and heated for 3 mM at 95°C before loading on the 
gel. Electrophoresis was performed in TBE buffer at 1200 V until the 
bromophenol blue had migrated approximately 20 cm. Gels were soaked 
briefly in water to remove urea and dried for 2 h at 80°C, followed by 
autoradiography. 
2.2.19 Agarose Gel Electrophoresis 
Plasmid DNA and restriction digest products were analyzed on 2% 
(w/v) agarose gels. Mini-gels (7 cm x 8 cm x 1 cm) and standard gels (13 cm x 
14 cm x 1 cm) were prepared by melting agarose (electrophoresis grade) in 54 
TAE buffer (40 mM Trizma-acetate, 1 mM EDTA). After the mixture had 
cooled to -60 °C, ethidium bromide was added to 0.5 µg /ml. The mixture 
was poured into a gel-casting tray and allowed to polymerize for -30 min 
DNA samples were combined with dye buffer (10 mM EDTA, 0.1% SDS, 0.01% 
bromophenol blue, 5% (w/v) glycerol) and loaded into the sample wells. 
Electrophoresis was performed in TAE buffer at 70 V until the tracking dye 
had migrated approximately 75% of the length of the gel. DNA bands were 
visualized by 300 nm UV-light. 
2.2.20 Quantitation of Radio labeled Proteins and DNA from 
Polyacrylamide Gels 
Radioactive products resolved by polyacrylamide gel electrophoresis 
were quantitated using a "cutting and counting" method. Native or 
denaturing polyacrylamide gels were dried under vacuum for 2 h at 80°C then 
exposed to Kodak X-OMAT AR X-ray film for autoradiography. The gels 
were overlaid with the films to visualize the location of the radioactive bands, 
and the positions of the products of interest were marked on the gel. The 
areas containing the radioactivity were excised as dried gel slices. A gel slice 
was placed in a liquid scintillation vial (7 ml) and 30% hydrogen peroxide (500 
itl) was added. The vials were tightly capped and incubated at 55°C for 24 h to 
solubilize the gel slice. After cooling to room temperature, 10 ml of 
scintillation fluor (Formula 989, DuPont NEN) was added to each vial and the 
samples were mixed by shaking. The vials were then counted for 
radioactivity to detect the appropriate isotope (35S or 32P) in a liquid 
scintillation counter. 
2.2.21 Synthesis of [uracil-3H] DNA 
Activated calf thymus DNA was incubated with E. coli DNA polymerase 
I and [3H]dUTP in a nick translation DNA synthesis reaction to produce 
substrate for uracil-DNA glycosylase and uracil-DNA glycosylase inhibitor 
assays. The reaction mixture (50 ml) consisted of 70 mM potassium phosphate 55 
(pH 7.5), 1 mMI3-mercaptoethanol, 10 mM MgC12, 90 AM each of dATP, dGTP, 
dCTP and dUTP, 450 µg /ml of activated calf-thymus DNA, 2.0 units/ml, E. coli 
DNA polymerase I, and 1 mCi of [3H]dUTP (specific activity = 15 Ci/mmol). 
The buffer components and DNA were pre-warmed at 37°C before initiating 
the reaction with the addition of DNA polymerase and radioisotope. 
Incorporation of [3H]dUTP was monitored by removing 50 IA aliquots at 30 
mM intervals; these were mixed with 100 til of 1 mg/ml bovine serum 
albumin containing 0.1 M sodium pyrophosphate followed by 5001.11 of cold 
10% (saturation) trichloroacetic acid. The mixtures were then applied to #30 
glass fiber filters and washed 6 times with 3 ml each of 1 M HC1 containing 0.1 
M sodium pyrophosphate to recover acid-insoluble precipitates. The filters 
were washed with 95% ethanol and dried under a heat lamp for 5 mM. The 
amount of radioactivity incorporated into the activated DNA was determined 
by analyzing the dried filters in 10 ml of 0.4 % 2,5-bis-2-(5­
tertbutylbenzoxazoly1)-thiophene in a liquid scintillation counter. 
When incorporation of [3H]dUMP had plateaued, typically after 2 h, the 
reaction was terminated by the addition of NaCl to a final concentration of 500 
mM and heating for 5 mM at 70°C. The DNA was then extracted with an 
equal volume of phenol equilibrated in 10 mM Tris-HC1 (pH 7.5), 1 mM EDTA, 
and 500 mM NaCl. The aqueous phase was sequentially dialyzed against: (i) 
3.0 L of 10 mM Tris-HC1 (pH 7.5), 1 mM EDTA, 500 mM NaC1, (ii) 2.0 L of 10 
mM Tris-HC1 (pH 7.5), 1 mM EDTA, and (iii) 2.0 L of 10 mM Tris-HC1 (pH 7.5). 
The specific radioactivity of the resultant substrate was typically 180-190 
cpm/pmol [3H]dUMP. 
2.2.22 Enzyme Assays 
2.2.22.1  Ugi Assay 
Uracil-DNA glycosylase inhibitor activity was measured in reaction 
mixtures (100 Ill) containing 70 mM HEPES-KOH (pH 8.0), 1 mM EDTA, 1 mM 
DTT, 1.5 pig of [uracil-31-1]DNA (180 cpm/pmol, 435 pmol [3H]uracil/assay), 56 
0.03-0.13 units of E. coli uracil-DNA glycosylase (fraction V) and serial dilutions 
of uracil-DNA glycosylase inhibitor protein in Ugi dilution buffer (50 mM Tris­
HC1 (pH 8.0), 1 mM EDTA, 1 mM DTT, 100 mM NaC1) introduced as 25 Al 
additions. Reactions were allowed to proceed for 30 min at 37°C then 
terminated with the addition of 250 iil of formate buffer (10 mM ammonium 
formate (pH 4.2)). To resolve free [3I-I]uracil from [uracil- 3H]DNA, 300 IA of 
the terminated reaction mixture was applied to a 1 ml Dowex 1X-8 column. 
The column was washed with 700 p1 of formate buffer. The flow through and 
wash were collected in a 7 ml liquid scintillation vial. In a second vial, an 
additional 1 ml of wash buffer was collected. Formula 989 fluor (5 ml) was 
added to each vial and radioactivity was measured by liquid scintillation 
counting. One unit of uracil-DNA glycosylase inhibitor is defined as the 
amount that inactivates 1 unit of uracil-DNA glycosylase under standard 
reaction conditions. 
2.2.22.2  Ling Assay 
E. coli uracil-DNA glycosylase (fraction V), uracil-DNA glycosylase 
H187D (fraction VI), and E. coli and mitochondrial crude extracts were assayed 
for Ung activity in reactions (100 IA) containing 70 mM HEPES-KOH (pH 8.0), 
1 mM EDTA, 1 mM DTT and 1.5 lig of [uracil- 3H]DNA (180 cpm/pmol, 435 
pmol rHiuracil/assay). Samples of interest were serially diluted in UDB (Ung 
dilution buffer: 50 mM HEPES-KOH (pH 7.4), 1 mM EDTA, 1 mM DTT, 100 
itg/m1 BSA) and introduced into the assay as 25 pl additions. Reactions were 
conducted for 30 min at 37°C, then terminated and processed using Dowex 1­
X8 columns as described for Ugi assays above. One unit of uracil-DNA 
glycosylase is defined as the amount that releases 1 nmol of uracil/h under 
standard conditions. 
2.2.22.3  Assay for pH Optima 
To determine pH optima of uracil-DNA glycosylase, standard Ung 
assays were performed with modifications. The following buffers were 57 
substituted for HEPES-KOH (pH 8.0) in the reaction mixture: HEPES-KOH 
(pH 6.5-8.5), Tris-HC1 (pH 7.0-9.5), CAPS-KOH (pH 9.6-11.5), MES-KOH (pH 
5.0-7.0), MOPS-KOH (pH 6.0-8.0). Ung or Ung H187D were diluted to 0.03­
0.13 units in UDB made with the same buffering component used for the 
reaction mixture as indicated above substituted for HEPES-KOH (pH 7.4). 
2.2.22.4  Substrate Titration and Uracil Inhibition Assays 
Standard Ung assays were modified to determine the effect of varying 
substrate concentration and free uracil on enzyme activity. Ung or Ung 
H187D were diluted to -0.13 units in UDB made with HEPES-KOH (pH 7.0 or 
8.0). Diluted Ung was added as 25% of the final reaction volume to a mixture 
containing 70 mM HEPES-KOH (pH 7.0 or 8.0 to match UDB), 1 mM EDTA, 
and 1 mM DTT. For uracil inhibition assays, 0-1.0 mM uracil was included in 
the reaction mix. This reaction mixture (751.11) was added to 25 pa of [uracil-
3I-1]DNA diluted in 10 mM Tris-HC1 (pH 7.5). The final substrate concentration 
was 0-3.7 i.ig of [uracil-3H]DNA (180 cpm/pmol), 0-10 JIM with respect to 
[3H]uracil. The volume of Dowex 1-X8 columns was increased to 1.5 ml to 
avoid exceeding the resin's binding capacity. 
2.2.22.5  Assay for Substrate Specificity 
Ung activity was measured on single- or double-stranded [321W-25­
mer oligonucleotides in reaction mixtures (12.5 IA containing 70 mM HEPES­
KOH (pH 7.0 or 8.0), 1 mM EDTA, 1 mM DTT, 4 pmol [32P]U -25 -mer, 
[32P]U/A-25 -mer, or [32P]U/G -25 -mer (15,500-22,000 cpm/pmol), and varying 
amounts of Ung or Ung H187D diluted in UDB (pH 7.0 or 8.0). After 
incubating for 30 min at 37°C, the reactions were terminated on ice by the 
addition of 0.8 lig of Ugi protein. Alkaline lysis of apyrimidinic sites was 
performed by adding 3 M K2HPO4 (pH 13.7) to 10% (v/v) and heating for 3 h 
at 55°C. Samples were then neutralized with the addition of 3µl of 1.5 M 
KH2PO4, and mixed with 17.5 pi of formamide dye (95% formamide, 10 mM 
EDTA, 0.1% bromophenol blue, 0.1% xylene cyanol). After heating at 95°C for 58 
3 min, 10 ill of each sample was analyzed by 12% denaturing polyacrylamide 
sequencing gel. Gels were dried and substrate and product bands were 
quantitated by "cutting and counting" as described above (Section 2.2.20). 
2.2.22.6	  Ung/Ugi Binding Assay 
Ung/Ugi binding reactions (100 til) were prepared by mixing 300 pmol 
of [35S]Ugi (151.11) with varying amounts of Ung or Ung H187D in DAB buffer. 
Samples were incubated for 10 min at 25°C, then 20 min at 4°C. Following 
complex formation, each sample was mixed with native gel loading dye and 
analyzed by 18% native polyacrylamide gel electrophoresis as described. Free 
and complexed [35S]Ugi were detected by the previously described "cutting 
and counting" method (Section 2.2.20). 
2.2.22.7	  Assay of DNA Binding by Ung Using UV-Catalyzed 
Crosslinking Reactions 
Time course reactions were performed in microcentrifuge tube or 
liquid scintillation vial caps. Caps were pre-irradiated for 45 min in the 
presence of DAB buffer. Reaction mixtures (135-150111) consisted of 3.8 nmol 
of Ung or Ung H187D plus a 2-fold molar excess of 5'-end 32P- labeled dT20 
oligonucleotide (1000 cpm/pmol). When indicated, uracil was included in the 
reaction at a 2 mM final concentration. Reaction mixtures were incubated on 
ice for 15 mM then UV-irradiated (,max = 254 nm) in a Stratalinker 1800 
(Stratagene Cloning Systems) with 15111 aliquots removed at various time 
points. Samples were mixed with an equal volume of SDS-PAGE loading dye, 
heated for 20 min at 42°C, and 251.11 were analyzed by 12.5% SDS-PAGE. 
Ung and Ung H187D binding to oligonucleotide containing uracil or 
apyrimidinic sites were measured in 15 W reactions containing dilutions of 
wild-type or mutant enzyme and various 5'-end 3213-labeled oligonucleotides 
(0.028-2.28 nmol). Samples were incubated on ice for 15 min in a 96-well 
microtiter plate (Corning round-bottom well, low protein binding), pre-
irradiated as described above, then UV-irradiated for 30 min. Following 59 
crosslinking, 15 µl of SDS-PAGE loading buffer was added to each well, the 
plate was incubated at 42°C for 20 min, and 25 ill of each sample was analyzed 
by 12.5% SDS-PAGE. 
After electrophoresis, the bottom portion of each gel was removed to 
eliminate uncrosslinked [32P]oligonucleotide and reduce background 
radioactivity. Gels were stained with Coomassie Brilliant Blue to visualize free 
protein, then dried and processed as described above to quantitate the 
amount of radioactivity in Ung x [32P]DNA crosslinked product. 
2.2.23 Steady-State Fluorometry 
Steady-state fluorescence measurements were performed with a Perkin 
Elmer Luminescence Spectrometer LS50 using an excitation wavelength of 310 
nm and detecting emission at 370 nm. Double-stranded 2AP-27-mer 
oligonucleotide containing a 2-aminopurine:uracil basepair was diluted to 
various concentrations (20-4000 nM) in TE buffer and a 20 til aliquot was 
allowed to equilibrate with 400R1 DAB (pH 7.4) for 60 sec while monitoring 
emission to establish a baseline. After 60 sec, 20 ill of Ung or Ung H187D in 
DAB (pH 7.4) at 25°C was then added to a final concentration of 2 nM or 250 
nM, respectively. Fluorescence was monitored for an additional 2 min for 
Ung or an additional 4 min for Ung H187D. The initial velocity of Ung was 
determined by calculating the slope of the line determined by linear 
regression from 70-90 sec reaction time. The initial velocity of Ung H187D 
was calculated in a similar manner, using the data from 70-300 sec reaction 
time. 
2.2.24 Polyclonal Antiserum Production 
After a 5-day quarantine, pre-immune serum was collected by 
performing test bleeds (3-5 ml) via cardiac puncture on female New Zealand 
White rabbits (2.1-2.5 kg). The blood was clotted by incubating for 1 h at 
37°C, followed by 8-12 h at 4°C. The sample was centrifuged in an IEC clinical 60 
centrifuge (setting #4) at room temperature for 20 min and the serum (2-2.5 
ml) removed from the clot. Serum was stored at -20°C in 0.5 ml aliquots. 
By using a Virtis "23" mixer, complete Freund's adjuvant was 
emulsified with an equal volume of purified E. coli Ung (0.3 mg in 0.5 ml DAB 
buffer) or Ugi inhibitor protein (0.38 mg in 0.5 ml DAB buffer). 
Approximately 1.0 ml of antigen/adjuvant was injected subcutaneously into 
each rabbit at five separate sites. 
Boost injections of Ung or Ugi plus incomplete adjuvant were 
performed every 5-6 weeks as described above. Test bleeds were taken 
approximately 10 days after each boost and serum was processed as 
described. After 4-6 boosts a terminal bleed was performed by cardiac 
puncture, yielding approximately 150 ml of blood. After clotting, the samples 
were centrifuged at 10,000xg for 10 min at 4°C to recover the serum (-75 ml). 
Serum was assayed for Ung activity and the ability to inhibit Ung or 
Ugi activity in functional assays. The titer of anti-Ung or anti-Ugi antibody 
was determined by ELISA using the appropriate antigen. 
2.2.25 Functional Assay of Serum 
Pre-immune and polyclonal antisera were assayed for endogenous Ung 
activity and the ability to inhibit purified Ung or Ugi. Standard Ung and Ugi 
assays were performed with modifications. Sample additions consisted of 15 
til of serum serially diluted in UDB and 10 til of Ugi dilution buffer or 0.1 units 
of Ugi. When assaying for serum inhibition of Ung or Ugi, -0.12 units of 
enzyme per reaction was included in the reaction mixture. For detection of 
serum inhibition of Ugi, inhibitor was preincubated on ice for 5 min with 
diluted serum before adding 75 ill of reaction mix. Reactions were then 
incubated and processed as described for the standard Ung assays. 
2.2.26 Immunoassay of Serum and Affinity-Purified Antibody 
ELISA was performed to determine the titer of anti-Ung or anti-Ugi 
IgG as well as total IgG present in polyclonal antisera and affinity-purified 61 
antibody preparations. When testing for antigen-specific IgG, Ung or Ugi was 
diluted in HN buffer (10 mM HEPES-KOH (pH 7.6), 150 mM NaC1) to 5 
µg /ml. Wells of a microtiter plate were coated with 50 p,1 of antigen for 30 
min to overnight. The antigen was removed and the plate washed with 200 ,t1. 
of HN. Wells were then blocked with 100 ul of HNA buffer (10 mM HEPES­
KOH (pH 7.6), 150 mM NaCl, 1% BSA) for 30 min. The plate was washed 
twice with 200 ttl of HNAT buffer (10 mM HEPES-KOH (pH 7.6), 150 mM 
NaC1, 0.2% BSA, 0.02% Tween 80). Polyclonal antiserum or purified antibody 
was serially diluted in HNAT and 50 ptl was incubated in the wells for 30 min. 
The plate was washed twice with 200 pil of HNAT and 50 ttl of a 1:2000 dilution 
(in HNAT) of horseradish peroxidase-conjugated secondary antibody (goat 
anti-rabbit IgG, Boehringer Mannheim) was incubated in each well for 30 min. 
After extensive washing with HNAT, 100 ml of reaction mix (1 mM 2,2-azino­
di-[3-ethylbenzthiazoline sulfonate] in ABTS buffer (3.25 mM sodium 
perborate, 39.8 mM citric acid, 60 mM disodium hydrogen phosphate, pH 4.5)) 
was added to each well and the reaction was allowed to develop for 20-40 min 
before reading absorbance at 405 nm with a microplate reader. 
The protocol for surveying samples for total IgG was essentially the 
same as described above; however, dilutions of serum or antibody in HNAT 
were added directly to the wells of the microtiter plate without any 
preliminary binding of antigen. 
2.2.27 Western Blot Analysis of Ung-Containing Samples 
Following electrophoresis, proteins were transferred to nitrocellulose 
from the 12.5% SDS-polyacrylamide gel for Western blot analysis using a 
semi-dry transfer method. Ten sheets of Whatman (3MM CHR) 
chromatography filter paper and a 0.45 Am nitrocellulose membrane were cut 
to the dimensions of the resolving gel. Milli Blot-Graphite Electroblotter 
graphite plates were wet with Transblot buffer (48 mM Tris, 39 mM glycine, 
1.3 mM SDS, 20% methanol) and the transfer apparatus was assembled by 
positioning on the anode plate 5 sheets of filter paper presoaked in Transblot 62 
buffer followed by the nitrocellulose membrane presoaked in distilled water, 
the resolving gel, and 5 sheets of presoaked filter paper. A test tube was 
rolled across the top of the filter paper to remove air bubbles and the cathode 
plate was set in position to complete the apparatus. The gel was transblotted 
at 0.8 mA/cm2 for 1 h. 
All subsequent incubations were performed by shaking at room 
temperature. The nitrocellulose sheet was blocked overnight in 20-30 ml of 
HNAT (10 mM HEPES-KOH (pH 7.6), 150 mM NaC1, 0.2% BSA, 0.02% Tween­
80). Anti-Ung serum or affinity-purified antibody was diluted (1:5000 and 
1:200, respectively) in 10 ml of HNAT and incubated with the membrane for 1 
h. The membrane was washed three times by incubating with 20 ml of HNAT 
for 5 min each wash. Alkaline phosphatase secondary antibody (goat anti-
rabbit IgG, Boehringer Mannheim) was diluted 1:2000 in 10 ml of HNAT and 
incubated with the membrane for 1 h. The membrane was washed as 
described and then reacted with 10 ml of 100 mM NaHCO3 (pH 9.8), 10 mM 
MgC12 containing 100 iAl each of 30 mg/ml nitroblue tetrazolium in 70% DMF 
and 15 mg/ml 5- bromo -4- chloro- 3- indolyl phosphate in 100% DMF for 15-30 
min to develop a purple precipitate at sites of the alkaline phosphatase 
reaction. The reaction was terminated by washing the membrane with 
distilled H2O. The membrane was air-dried and protected from light. 
2.2.28 Antibody Purification 
Conditions for the affinity purification of anti-Ung polyclonal IgG were 
optimized by suspending Ung-Sepharose resin in 10 mM phosphate buffer 
(pH 7.5). Polyclonal antiserum from a terminal bleed (50 IA) was mixed with 
100 jAl of Ung-Sepharose and incubated for 10 min at 25°C. Micro-purification 
columns were poured and washed as described in Section 2.2.15. Bound 
antibody was eluted as described in Table 3. The eluted antibody was assayed 
by ELISA for the presence of total and anti-Ung IgG as previously described. 
Aliquots (1.250 were also analyzed by 12.5% SDS-polyacrylamide gel 
electrophoresis followed by silver staining. Table 3
 
Buffer Conditions for Ung-Sepharose Affinity Chromatography
 
Wash Buffer'  Elution Bufferb  Neutralizing Buffer` 
10 mM potassium phosphate (pH 6.8)  100 mM glycine (pH 2.0)  10 mM potassium phosphate (pH 8.0) 
10 mM potassium phosphate (pH 6.8)  100 mM glycine (pH 1.8)  10 mM potassium phosphate (pH 8.0) 
10 mM potassium phosphate (pH 8.0)  100 mM TEA (pH 11.5)  10 mM potassium phosphate (pH 6.8) 
10 mM potassium phosphate (pH 7.2)  3.5 M MgC12, 10 mM potassium 
phosphate (pH 7.2) 
10 mM potassium phosphate (pH 7.2)  5 M LiC1, 10 mM potassium 
phosphate (pH 7.2) 
a After incubation with sample as described under "Experimental Procedures", the affinity resin was washed 3 times with 200 p,1 of wash
buffer applied in 100 [1.1 aliquots. 
b Bound protein was eluted from the affinity resin with 100 ill of elution buffer. 
' When necessary, the eluted fraction was collected into 10 [1.1 of neutralization buffer. 64 
Once optimal purification conditions were determine, a large scale 
purification was performed by mixing 25 ml of Ung-Sepharose with 12.5 ml of 
serum. The slurry was mixed on a rocking table for 30 min at 25°C then 
transferred to a 1.5 cm diameter BioRad column. Fractions (1 ml) were 
collected at a rate of 15 ml/h at 4°C. The resin was washed with 
approximately 25 ml of 10 mM potassium phosphate buffer (pH 7.2) and 
bound antibody eluted with 3.5 M MgC12 in 10 mM potassium phosphate 
buffer (pH 7.2). Fractions were assayed for total protein by absorbance 
spectroscopy at 280 nm and for total and anti-Ung IgG by ELISA as described. 
Aliquots of a 1:50 dilution of flow through fractions (6.25 Ill) and wash and 
elution fractions (1.25 111) were analyzed by SDS-polyacrylamide gel 
electrophoresis and silver staining as previously described. Fractions 
containing the peak anti-Ung IgG were pooled and stored at -20°C. 65 
3. RESULTS
 
3.1	  Overproduction and Characterization of Uracil-DNA
 
Glycosylase H187D
 
3.1.1	  Verification of Ung and Ung H187D Overexpression Vectors 
The plasmids used for overexpressing the ung and ungH187D genes are 
shown in Figure 1. They are based on the overexpression vector pKK223-3 
(Figure 1A). The construction of pSB1051 and pUngH187D was performed by 
Dr. Sam Bennett as described previously (6, 10) and the vectors were 
provided as a gift by Dr. Bennett. pSB1051 consists of the E. coli ung gene 
cloned behind the IPTG-inducible tac promoter of pKK223-3 (Figure 1B). Site-
directed mutagenesis of pSB1051 produced pUngH187D (Figure 1C), which 
carries a His to Asp mutation at codon 187 in the Ung protein. 
These three vectors were electroporated into E. coli JM105, ampicillin-
resistant bacteria were cultured, plasmid DNA was isolated, restriction 
enzyme digests performed and the restriction fragments were analyzed by 
2% agarose gel electrophoresis (Figure 2). Plasmid DNA was also run on the 
same gel without subjecting it to restriction enzyme digestion to verify DNA 
recovery by minipreparation. A mixture of supercoiled and nicked circular 
plasmid was observed in lanes containing unrestricted DNA (Figure 2, lanes 1, 
4, and 7). As expected, digestion of all three plasmids by Pvu II resulted in 
single linear fragments (Figure 2, lanes 2, 5, and 8). BamH I digested pKK223-3 
into two fragments that corresponded to the expected sizes of 4316 by and 268 
by (Figure 2, lane 3). The banding pattern observed subsequent to digestion 
of pSB1051 by BamH I corresponded to the expected three fragments of 4316, 
811, and 486 by (Figure 2, lane 6). The H187D mutation in the ung gene 
introduced a new BamH I site in the BamH I 811 by fragment of pSB1051 
(Figure 1B); thus, digestion of pUngH187D by BamH I should result in 
fragments of 4316, 486, 442, and 369 by (Figure 1C). The estimated size of the 66 
Figure 1. Restriction maps of pSB1051 and pUngH187D overexpression 
vectors. The ung and ungH187D genes were cloned into the overexpression 
plasmid pKK223-3 as described in (6, 10). The restriction sites pertinent to the 
cloning are indicated for pKK223-3 (A), pSB1051 (B), and pUngH187D (C). 67 
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Figure 2. Restriction site analysis of overexpression vectors isolated from E. 
coli strain JM105. Isolates of pKK223-3 (lanes 1-3), pSB1051 (lanes 4-6), or 
pUngH187D (lanes 7-9) were recovered from E. coli strain JM105, treated with 
10 units Pvu II or BamH I restriction endonuclease as indicated, and analyzed 
by 2% agarose gel electrophoresis as described under "Experimental 
Procedures". Locations of DNA fragments have been highlighted by white 
squares. 69 
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four fragments resulting from BamH I digestion was in agreement with the
 
expected sizes (Figure 2, lane 9).
 
3.1.2	  Transformation of E. coil BD2314 (ung-152::Tn10) and BW310 
(ung-1) with pKK223 -3, pSB1051 and pUngH187D 
Plasmid DNA from minipreparations of E. coli JM105 was introduced 
into E. coli strains BD2314 (ung-152::Tn10) and BW310 (ung-1) by 
electroporation in order to express ungH187D in an ung background. The 
plasmid DNA was isolated from ampicillin resistant colonies. The resultant 
DNA was analyzed following digestion with BamH I restriction endonuclease 
by 2% agarose gel electrophoresis. While pKK223-3 vector recovered from 
ung strains produced fragments consistent with the expected sizes (4316 and 
268 bp) upon BamH I digestion (Figure 3A and B, lanes 1-3), the wild type and 
mutant Ung-containing vectors resulted in unexpected BamH I restriction 
patterns. Two E. coli BD2314/pSB1051 clones yielded vector DNA that 
produced bands approximately 4100 and 800 by long (Figure 3A, lanes 4 and 
6), while a third produced a single restriction fragment of -4100 by (Figure 3A, 
lane 5). Digestion of one pUngH187D isolate from E. coil BD2314 also yielded 
-4100 and -800 by fragments (Figure 3A, lane 7); in addition to these bands, a 
second isolate produced an additional -250 by fragment (Figure 3A, lane 8). 
A third pUngH187D sample yielded three bands approximately 4100, 450, and 
350 by in length (Figure 3A, lane 9). Similarly, one sample of pSB1051 
recovered from E. coli BW310 produced -4100, -450, and -350 by fragments 
while a second was restricted into fragments of -4100 and -800 by (Figure 3B, 
lanes 4 and 6, respectively). The third sample was not cleavable by BamH I 
(Figure 3B, lane 5). Plasmid pUngH187D recovered from E. coli BW310 
likewise produced unanticipated restriction patterns. In addition to an isolate 
which could not be digested by BamH I (Figure 3B, lane 7), the pUngH187D 
recovered from E. coil BW310 resulted in the previously observed -4100 and 
-800 by digestion pattern (Figure 3A, lanes 8 and 9). 71 
Figure 3. BamH I restriction site analysis of overexpression vectors from E. 
coli strains BD2314 and BW310. The Dung strain BD2314 (A) and the ung-1 
strain BW310 (B) were transformed with the overexpression vectors. Three 
isolates each of pKK223-3 (lanes 1-3), pSB1051 (lanes 4-5), and pUngH187D 
(lanes 7-9) were isolated by minipreparation, subjected to digestion with 10 
units of BamH I, and analyzed by 2% agarose gel electrophoresis as described 
under "Experimental Procedures". Location of DNA fragment has been 
highlighted by white square (lane 7). 72 
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3.1.3	  Construction of E. coli recA ung Strains for Overexpression of 
the ungH187D Gene 
It was hypothesized that the pSB1051 and pUngH187D vectors were 
unstable or lethal to the E. coli ung strains. As a result pSB1051 and 
pUngH187D may have undergone rearrangements or deletions upon 
electroporation into strains BW310 and BD2314. In order to prevent this 
instability, E. coli BW310 was made recA-defective by P1vir transduction. A 
P1vir lysate of the E. coli JC10289 strain containing a Tn10 disruption of recA 
was incubated with a mid-log culture of E. coli BW310 at a multiplicity of 
infection of -0.05. Transductants were selected for tetracycline resistance and 
one clone, designated MJS100, was isolated and screened for sensitivity to UV-
irradiation. Saturated cultures of E. coli BW310, JC10289, and MJS100 were 
streaked onto LB agar then irradiated with UV light for various time intervals. 
Figure 4 shows that although E. coli BW310 was resistant to UV doses up to 
57.6 J/m2, JC10289 and the transductant MJS100 were equally sensitive to UV-
irradiation, exhibiting inhibition of growth with UV doses of 9.6 J/m2 and 
higher. 
3.1.4	  Transformation of E. coli MJS100 with pSB1051 and pUngH187D 
pSB1051 and pUngH187D recovered from E. coli JM105 were 
transformed into E. coli MJS100 by electroporation. Tetracycline- and 
ampicillin-resistant clones were selected for minipreparation of plasmid DNA. 
The recovered vectors were analyzed by BamH I digestion and 2% agarose gel 
electrophoresis. Samples of pSB1051 isolated from E. coli MJS100 displayed the 
expected BamH I restriction fragments (4316, 811, and 486 bp) (Figure 5, lanes 
1-3). Unexpectedly, digestion of pUngH187D recovered from E. coli MJS100 
with BamH I resulted in DNA fragments -2200 and -800 by in length (Figure 
5, lanes 5-7). Although it was preferable to express the ungH187D gene in an 
ung background, these efforts did not resolve the problem of plasmid 
instability in an E. coli ung strain; thus, Ung H187D was overproduced in E. coli 
JM105 in order to purify the mutant form of the enzyme. 74 
Figure 4. UV light sensitivity of E. coli BW310, JC10289, and MJS100. 
Saturated cultures of E. coli BW310 (A), MJS100 (B), and JC10289 (C) were 
streaked onto LB agar, exposed to various doses of UV-irradiation, and 
incubated at 37°C in the dark. Columns 1-6 correspond to UV doses of 4.8, 
9.6, 14, 19, 38, and 58 J/m2, respectively. The unirradiated controls are 
designated Column C. 75 
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Figure 5. BamH I restriction site analysis of ung overexpression vectors 
isolated from E. coli MJS100. Plasmids pSB1051 (lanes 1-3) and pUngH187D 
(lanes 5-6) were transformed into the Aung ArecA strain MJS100. Plasmid 
DNA was isolated by minipreparation and three isolates of each plasmid were 
subjected to BamH I digestion and analyzed by 2% agarose gel electrophoresis 
as described under "Experimental Procedures". Lane 4 contains a 1 kb DNA 
ladder (Life Technologies). 77 
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3.1.5  Overproduction of the Ung H187D Protein 
To assess the level of Ung H187D overproduction, three mid-log 
cultures of E. coli JM105 cells transformed with either pKK223-3, pSB1051, or 
pUngH187D were each divided in half and grown in the presence or absence 
of 1 mM IPTG to induce ung gene expression. Cell-free extracts were 
analyzed by 12.5% SDS-polyacrylamide gel electrophoresis as shown in Figure 
6. A Coomassie Brilliant Blue stainable protein band corresponding to the 
approximate molecular weight of Ung (Mr = 25,000) was observed to be IPTG-
induced in E. coil containing pSB1051 (Figure 6, lane 4) and pUngH187D 
(Figure 6, lane 6). 
The specific activity of uracil-DNA glycosylase was determined for each 
cell-free extract (Figure 6). As expected, E. coli JM105 cells transformed with 
pSB1051 displayed an IPTG-inducible Ung activity. Overproduction of Ung in 
E. coil JM105/pSB1051 cells produced 130,000 units/mg of cellular protein, 
which was 11-fold higher than that of uninduced cells (Figure 6, lanes 3 and 
4) and 930-fold higher than cells containing the vector control (Figure 6, lanes 
2 and 4). In contrast, E. coil JM105/pUngH187D cells treated with or without 
IPTG did not show significantly increased specific activity of uracil-DNA 
glycosylase relative to the cells containing the vector control (Figure 6, lanes 2 
and 6, 1 and 5, respectively). In each case, the specific activity was 
approximately 1.5 times the corresponding vector control, though the Ung 
H187D protein was overproduced to a much greater extent. These results 
implied that the UngH187D protein was defective in uracil-DNA glycosylase 
activity. 
3.1.6  Purification of the Ung H187D Protein 
To facilitate characterization of Ung H187D, the protein was 
overproduced in E. coli JM105/pUngH187D and purified as outlined in Figure 
7. Typically, a mid-log culture of E. coil JM105/pUngH187D was incubated 3 h 
at 37°C in the presence of 1 mM IPTG to induce ungH187D gene expression. 
Cells were harvested by centrifugation and lysed by sonication. The cell 79 
Figure 6. Overproduction of Ung and Ung H187D. E. coli JM105 
transformed with pKK223-3 (lanes 1 and 2), pSB1051 (lanes 3 and 4), or 
pUngH187D (lanes 5 and 6) were grown in the presence (+) or absence (-) of 1 
mM IPTG as indicated. Cell-free extracts were prepared, samples (501.tg total 
protein) were analyzed on a 12.5% SDS-polyacrylamide gel, and protein bands 
were visualized by Coomassie Brilliant Blue staining as described under 
"Experimental Procedures". The molecular weight standards for bovine serum 
albumin, ovalbumin, glyceraldehyde-3-phosphate dehydrogenase, carbonic 
anhydrase, trypsinogen, and a-lactalbumin are indicated by arrows from top to 
bottom. The positions of Ung and the tracking dye (TD) are indicated by 
arrows. The specific activity of uracil-DNA glycosylase in each cell-free extract 
was determined by using standard assay conditions and the results are 
indicated. 80 
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Figure 7. Scheme for purification of Ung and Ung H187D from E. coli 
JM105. Ung and Ung H187D were purified from E. coli JM105 containing 
pSB1051 or pUngH187D, respectively, according to the protocol outlined here 
and described under "Experimental Procedures". 82 
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extract was treated with an equal volume of 1.6% streptomycin sulfate and the 
precipitate removed by centrifugation at 20,000xg for 15 min. The 
supernatant was adjusted to 70% (saturation) ammonium sulfate. Precipitated 
proteins were recovered by centrifugation at 10,000xg for 15 min then 
resuspended and dialyzed in UEB buffer. UngH187D was subjected to size 
exclusion chromatography using Sephadex G-75 resin. This resulted in a 
single activity peak at fraction 58 (Figure 8), which is characteristic of wild type 
Ung. Presumably, a large portion of the activity detected in the peak fractions 
was due to the wild type Ung endogenous to E. coli JM105. Analysis of 
fractions across the peak by 12.5% SDS polyacrylamide gel electrophoresis 
revealed that the activity peak was coincident with the overproduced Ung 
H187D protein of -25,000 molecular weight (data not shown). Peak fractions 
(53-63) were pooled and applied to a hydroxyapatite column. After washing 
the column, uracil-DNA glycosylase activity eluted as a peak at fraction 6 
(Figure 9). Fractions (5-9) containing overproduced UngH187D were pooled 
and applied to a single-stranded DNA agarose column, where two peaks of 
Ung activity were detected (Figure 10A). The major activity peak containing a 
relatively small amount of protein eluted from the column at a NaC1 
concentration (-100 mM) characteristic of wild type Ung. The minor activity 
peak found in the flow through fractions constituted -9% of the recovered 
activity but contained a relatively large amount of protein. Analysis of the 
flow through fractions using 12.5% SDS-polyacrylamide gel electrophoresis 
revealed a large protein band (Mr -25,000) corresponding to the 
overproduced Ung H187D protein. Additionally, several minor contaminants 
were observed corresponding to -26,000 and -22,000 molecular weight 
species, plus a low molecular weight species which migrated on the dye front 
(data not shown). 
It was predicted that although Ung H187D had reduced affinity for 
single-stranded DNA, it might retain the ability to bind uracil. Thus, additional 
purification of Ung H187D was carried out using poly(U) Sepharose. Flow 
through fractions (62-102) from single-stranded DNA agarose 
chromatography containing the overproduced Ung H187D were pooled and 84 
Figure 8. Sephadex G-75 chromatography of Ung H187D. A culture (2 L) of 
E. coli JM105 containing pUngH187D was grown, induced with IPTG, and the 
cells harvested and sonicated as outlined in Figure 7 and described under 
"Experimental Procedures". After streptomycin sulfate and ammonium sulfate 
precipitations, Fraction II (-25 ml) was applied to a Sephadex G-75 column (6 
cm2 x 88 cm) equilibrated in UEB buffer. Fractions (5 ml) were collected and 
25 til aliquots (1/50 dilution in UDB buffer) were assayed for uracil-DNA 
glycosylase activity by using standard reaction conditions. Peak fractions were 
pooled, concentrated (-2-fold), and diafiltered against HAB buffer to obtain 
Fraction III. 85 
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Figure 9. Hydroxylapatite chromatography of Ung H187D. Fraction III (-25 
ml) was applied to a hydroxylapatite column (2 cm x 10 cm) equilibrated with 
HAB buffer. Fractions (5 ml) were collected and 25 µl aliquots (1/50 dilution) 
were assayed for uracil-DNA glycosylase activity using standard reaction 
conditions as described under "Experimental Procedures". Peak fractions 
were pooled and designated Fraction IV. 87 
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Figure 10. Single-stranded DNA agarose and Poly(U) Sepharose 
chromatography of Ung H187D. (A) Fraction IV (17 mg) was dialyzed against 
DAB buffer and applied to a single-stranded DNA agarose column (19.6 cm2 x 
42 cm) equilibrated in DAB buffer. The column was then washed and eluted 
with a linear gradient of 0-150 mM NaC1 in DAB buffer. Fractions (2.5 ml) 
were collected, 25 ul aliquots were assayed for Ung activity (), and 
absorbance (0D280,,m) was measured (0). NaC1 concentration () was 
determined by measuring the conductivity of fractions (100 u.1) diluted 1/10 in 
distilled water at room temperature. Flow through fractions (62-102) were 
pooled and dialyzed against TMEG buffer, which constituted Fraction V.  (B) 
Fraction V (8 mg) was loaded onto a poly(U) Sepharose column equilibrated 
in TMEG buffer. The column was washed and eluted step-wise with 500 mM 
NaC1 in TMEG buffer. Fractions (2 ml) were collected and the absorbance at 
280 nm measured (0). NaC1 concentration () was determined by measuring 
conductivity as described in (A). Peak fractions (35-38) were analyzed on a 
12.5% SDS-polyacrylamide gel (insert) as described under "Experimental 
Procedures". The location of Ung H187D is indicated by an arrow. 89 
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designated Fraction V. An aliquot of Fraction V (8 mg) was applied to a 
poly(U) Sepharose column. After washing the column, protein which bound 
to the matrix was eluted stepwise by using 500 mM NaCl. Fractions were 
analyzed for the presence of protein by absorbance spectroscopy at 280 nm. 
A broad protein peak was observed in the wash fractions while a sharp, 
relatively concentrated protein peak was detected at fraction 36 subsequent to 
the step elution (Figure 10B). Analysis of peak fractions by SDS­
polyacrylamide gel electrophoresis revealed that the protein contained in the 
elution fractions was the overproduced Ung H187D, yielding an apparently 
homogeneous preparation of the mutant enzyme (Figure 10B, insert). After 
pooling the peak fractions, the specific activity of Ung H187D was determined 
to be 37 units/mg, whereas wild type Ung was determined to have a specific 
activity of 2.1 x 106 units/mg under standard reaction conditions. 
3.1.7	  Rechromatography of Ung H187D on Single-Stranded DNA 
Agarose 
Although single-stranded DNA agarose chromatography appeared to 
separate Ung H187D from wild type Ung (Figure 10A), this observation alone 
did not eliminate the possibility that the activity detected in the Ung H187D 
preparation was due to a trace contaminant of Ung. To determine whether 
residual Ung was present in Ung H187D (Fraction VI), a sample (167 units) of 
Ung H187D was rechromatographed on a single-stranded DNA agarose 
column (Figure 11A). A single peak of activity was detected in the flow 
through fractions and no significant activity was observed binding to the 
matrix with characteristics of wild type Ung. In order to verify that this 
chromatographic system would have resolved an Ung contaminant, if 
present, the experiment was repeated using an identical sample of Ung H187D 
to which 167 units of Ung was added. Following chromatography, two peaks 
of activity corresponding to Ung H187D and Ung were resolved (Figure 11B). 
The specific activity of the flow through fractions shown in Figure 11A was 
calculated to be 49 units/mg of protein. Likewise, the flow through fractions 
shown in Figure 11B had a specific activity of 49 units/mg of protein despite 91 
Figure 11. Rechromatography of Ung H187D on single-stranded DNA 
agarose. (A) Ung H187D (Fraction VI, 167 units) was applied to a single-
stranded DNA agarose column (5.7 cm x 1.8 cm2) equilibrated in DAB buffer. 
The column was washed and then step-eluted with DAB buffer containing 150 
mM NaC1 as described under "Experimental Procedures".  (B) A sample 
containing Ung H187D (Fraction VI, 167 units) and wild type Ung (Fraction V, 
167 units) in DAB buffer was prepared and single-stranded agarose 
chromatography performed as described in (A). Fractions (1 ml) were 
collected, assayed under standard reaction conditions for uracil-DNA 
glycosylase activity (), measured for absorbance at 280 nm (0), and 
monitored for conductivity (). 92 
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being mixed with wild type Ung. Together these observations suggest that 
the activity detected in the Ung H187D preparation was inherent to the 
mutant enzyme. 
3.1.8	  Ability of Ung and Ung H187D to Bind the Uracil-DNA 
Glycosylase Inhibitor 
To determine whether the Ugi inhibitor protein was able to bind Ung 
H187D, band shift assays were performed using radioactively labeled Ugi. 
[35S]Ugi (300 pmol) was incubated with increasing molar amounts of Ung or 
Ung H187D (75-1,500 pmol). Enzyme-inhibitor complex was resolved from 
the individual components by native polyacrylamide gel electrophoresis. 
[35S]Ugi was included as a control to indicate the location of uncomplexed 
inhibitor (Figure 12A and C, lane C). Autoradioagraphy was performed to 
determine the location of free and complexed [35S]Ugi (Figure 12A and C). At 
a molar ratio of Ung to Ugi of 1:1, 66% of the [35S]Ugi was detected in complex 
(Figure 12B). In contrast, 87% of the [35S]Ugi complexed with Ung H187D at 
the same molar ratio (Figure 12D). Wild type Ung complex formation reaches 
a plateau at ratios higher than 2:1 while Ung H187D complex formation 
plateaus at a 0.75 ratio with [35S]Ugi. In both cases, a small fraction of the 
[35S]Ugi preparation appears to be incapable of forming complex with enzyme 
(Figure 12B and D). 
3.1.9 pH Optimum of Ung H187D Activity 
The specific activity of Ung H187D and Ung was determined in Tris­
HC1 and HEPES-KOH buffers over a pH range of 6.5-9.5 (Figure 13). Maximal 
activity of Ung H187D was observed with HEPES-KOH at pH 7.0 which was 
one pH unit lower than the pH optimum for Ung (pH 8.0). 
3.1.10 Substrate Specificity of Ung and Ung H187D 
The relative ability of Ung and Ung H187D to remove uracil from 
either a single-stranded or double-stranded oligonucleotide containing a U/A 94 
Figure 12. Binding of Ung and Ung H187D by uracil-DNA glycosylase 
inhibitor protein. (A) UngUgi complex formation was studied in binding 
reaction mixtures (1001.11) containing 300 pmol of [35S]Ugi and 0, 75, 150, 225, 
300, 375, 450, 600, or 1,500 pmol of Ung (lanes C, 1-8, respectively). Samples 
were incubated at 25°C for 10 min and 4°C for 20 min, then analyzed by 18% 
nondenaturing polyacrylamide gel electrophoresis and autoradiography. 
Arrows indicate the location of [3 S]Ugi and Ung[35S]Ugi. (B) Following 
electrophoresis the _gel was dried, autoradiography performed, radioactive 
bands containing [35S]Ugi and Ung[35S]Ugi were detected and excised from 
the gel. The 35S radioactivity was measured in each gel slice as described 
under "Experimental Procedures". The amount of unbound [35S]Ugi () and 
Ung[35S]Ugi complex () was measured as the percentage of the total 
amount of 35S radioactivity detected. (C) Complex formation between Ung 
H187D and Ugi was similarly examined in identical reaction mixtures 
containing 300 pmol of [35S]Ugi and 0, 75, 150, 225, 300, 375, 450, 600, or 1,500 
pmol of Ung H187D (lanes C, 1-8, respectively). (D) The amount of unbound 
[35S]Ugi and Ung H187D[35S]Ugi complex was determined as described 
above. C
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Figure 13. Comparison of pH optima of wild type Ung and Ung H187D 
activity. Four sets of standard uracil-DNA glycosylase reaction mixtures 
containing Ung () or Ung H187D (0) were prepared except that either (A) 70 
mM Tris-HC1 (pH 7.0-9.5) or (B) 70 mM HEPES-KOH (pH 6.5-8.5) was used as 
a buffer as indicated. Three concentrations (0.03-0.13 units) of enzyme were 
assayed at each pH and were used to determine the specific activity for each 
reaction condition. U
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base pair or U/G mispair was examined. A 5'-end 32P-labeled oligonucleotide 
([32P]U -25 -mer) with a site-specific uracil residue at position 11 was annealed to 
one of two complementary oligonucleotides producing either a [32M/A-25­
mer or [32M/G-25-mer DNA substrate. Each of the three substrates (U, 
U/A, U/G) was incubated with Ung at pH 8.0 to catalyze uracil excisions, 
producing apyrimidinic sites. After alkali-induced cleavage of the 
deoxyribose-phosphate bond, an AP site-containing [32P]11 -mer was resolved 
by denaturing polyacrylamide gel electrophoresis as the reaction product 
(Figure 14A-C). The rate of uracil excision was determined for each DNA 
substrate, and the wild type Ung was found to hydrolyze the single-stranded 
U-25-mer about 3- and 5-fold faster than the U/G- and U/A-25-mer, 
respectively (Figure 14D). Interestingly, when Ung H187D was examined 
under the same reaction conditions, the U/G-25-mer was found to be the 
preferred substrate. Activity on the single-stranded U-25-mer and the U/A­
25-mer was reduced by -1.5- and 2.3-fold, respectively, compared to the U/G­
25-mer substrate (Figure 14E-H). When wild type Ung was assayed at the 
suboptimal pH of 7.0, its activity on U-25-mer was reduced -2.6-fold relative 
to standard assay conditions (pH 8.0) and activity on double-stranded 
substrate was not detected (Figure 15A-D). When Ung H187D was assayed at 
its optimal pH of 7.0, all three substrates were processed with similar 
efficiencies (Figure 15E-H). Activity on the U/G- and U/A-25-mer was 
determined to be 75% and 86% of the rate of activity on the U-25-mer which 
was increased -3-fold relative to the assay at pH 8.0. 
3.1.11 Effect of Uracil on Ung and Ung H187D Activity 
Inhibition studies were conducted to determine whether the H187D 
mutation of Ung affected the binding of uracil to the enzyme. Standard assays 
were conducted using Ung or Ung H187D in the presence of various amounts 
of free uracil, 6-amino uracil or 5-fluorouracil and the percent of activity 
relative to the control was determined as shown in Figure 16. At pH 8.0, Ung 
activity appeared to be 50% inhibited by -0.15 mM uracil. In contrast, Ung 99 
Figure 14. Substrate specificity of Ung and Ung H187D at pH 8.0. Three sets 
of standard uracil-DNA glycosylase reaction mixtures (125 1.,11) each containing 
0.3 units of Ung and either [32P]U -25 -mer (A), [32P]U/A -25 -mer (B), or
[32P]U/G-25 -mer (C) were incubated at 37°C for 0, 10, 20, 30, 40, 50, or 60 min 
(lanes 1-7, respectively). Reactions were conducted using 70 mM HEPES-KOH 
(pH 8.0) as a buffer. A control reaction (lane C) was prepared which was 
incubated without Ung on ice for 60 min. After incubation, each reaction was 
terminated, AP-sites were hydrolyzed by alkaline treatment, and samples 
were analyzed by denaturing 12% urea-polyacrylamide gel electrophoresis. 
Arrows indicate the locations of 25-mer substrate (S) and 11-mer product (P) 
on the autoradiogram. (D) Radioactive bands were excised from the dried gel, 
the amount of 32P radioactivity was measured for bands S and P, and the 
percent of 25-mer hydrolyzed for the U (), U/A (A), and U/G () containing 
oligonucleotide was calculated. Three similar sets of reaction mixtures each 
containing Ung H187D and either [32P]U -25 -mer (E), [32M/A-25-mer (F), or
[32P]U/G-25 -mer (G) were incubated. (H) The percent of 25-mer hydrolyzed 
for each substrate was determined as described above. 100 
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Figure 14 (Continued) 
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Figure 15. Substrate specificity of Ung and Ung H187D at pH 7.0. Three sets 
of standard uracil-DNA glycosylase reaction mixtures (125 pl) each containing 
0.3 units of Ung and either [32P]U -25 -mer (A), [32P]U/A -25 -mer (B), or 
[32P]U/G -25 -mer (C) were incubated at 37°C for 0, 10, 20, 30, 40, 50, or 60 min 
(lanes 1-7, respectively). Reactions were conducted using 70 mM HEPES-KOH 
(pH 7.0) as a buffer. A control reaction (lane C) was prepared which was 
incubated without Ung on ice for 60 min. After incubation, each reaction was 
terminated, AP-sites were hydrolyzed by alkaline treatment, and samples 
were analyzed by denaturing 12% urea-polyacrylamide gel electrophoresis. 
Arrows indicate the locations of 25-mer substrate (S) and 11-mer product (P) 
on the autoradiogram. (D) Radioactive bands were excised from the dried gel, 
the amount of 32P radioactivity was measured for bands S and P, and the 
percent of 25-mer hydrolyzed for the U (), U/A (A), and U/G () containing 
oligonucleotide was calculated. Three similar sets of reaction mixtures each 
containing Ung H187D and either [32P]U -25 -mer (E), [32P]U/A -25 -mer (F), or
[32P]U/G-25 -mer (G) were incubated. (H) The percent of 25-mer hydrolyzed 
for each substrate was determined as described above. 103 
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Figure 15 (Continued) 
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Figure 16. Effect of uracil on wild type Ung and Ung H187D activity. (A) 
Four sets of standard uracil-DNA glycosylase reaction mixtures (100 ml) were 
prepared containing either 1.3 units of Ung (,) or 0.6 units of Ung H187D 
(0,). Reactions were conducted using 70 mM HEPES-KOH (pH 8.0) (AD) or 
70 mM HEPES-KOH (pH 7.0) (,0) and each reaction was supplemented with 
various amounts of uracil as indicated. (B) Similarly, four sets of reaction 
mixtures were prepared and supplemented with different amounts of 6-amino 
uracil or (C) 5-fluorouracil as indicated. After incubation at 37°C for 30 min, 
the amount of [3H]uracil released from the DNA substrate was measured. 
The percent of Ung activity inhibited was determined relative to the control 
lacking uracil. 106 
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H187D was much more resistant and showed about 7.5% inhibition at the 
same uracil concentration (Figure 16A). Similar results for inhibition by uracil 
were observed for reactions conducted at pH 7.0 (Figure 16A). Substitution of 
6-amino uracil in place of uracil also demonstrated that Ung was more 
sensitive to the inhibitor than Ung H187D, and that the observed level of 
inhibition was not significantly affected by the change of pH (Figure 16B). 
Inhibition of Ung by 5-fluorouracil (Figure 16C) was least pronounced, 
regardless of pH: -20% at 1 mM 5-fluorouracil. Moreover, inhibition of Ung 
H187D was not observed at any of the 5-fluorouracil concentrations tested 
(Figure 16C). 
3.1.12 Ability of Ung and Ung H187D to Bind DNA 
To assess the relative affinity of Ung and Ung H187D for DNA, UV-
catalyzed cross-linking experiments were conducted using three different 
oligonucleotides. Nonspecific DNA interactions were analyzed after mixing 
[32P]dT20 with either Ung or Ung H187D, irradiating with UV light for various 
times, and resolving the reaction products using SDS-polyacrylamide gel 
electrophoresis. Autoradiography was used to detect the enzyme x [32P]dT20 
bands as shown in Figure 17A. The rate of cross-linking was determined by 
measuring the amount of 32P radioactivity contained in the enzyme x dT20 
bands as a function of UV irradiation time (Figure 17B). A comparison of the 
cross-linking rates indicated that Ung (0.36 pmol/min) was -2.2-fold more 
efficient than Ung H187D (0.16 pmol/min) at forming a protein x dT20 
complex. Enzyme saturation experiments using various concentrations of 
oligonucleotide to perform UV-catalyzed cross-linking revealed the extent of 
Ung and Ung H187D x dT20 product formation (Figure 18A). In both cases, 
cross-linking increased with increasing dT20 concentration until reaching a 
plateau where -1.5-fold more Ung x dT20 than Ung H187D x dT20 was 
produced. The experiment was also conducted using [32P]cIT1-U, a uracil-
containing oligonucleotide (20-mer) possessing a uracil residue 12 nucleotides 
from the 5'-end (Figure 18B). With this DNA substrate, the ability of Ung 108 
Figure 17. Relative ability of Ung and Ung H187D to form UV-catalyzed 
cross-links with dT20. (A) Two reaction mixtures (150111) containing DAB 
buffer, 3.8 nmol of either Ung or Ung H187D were UV-irradiated on ice as 
described under "Experimental Procedures". At the times indicated, 15 ul 
samples were removed and analyzed by 12.5% SDS-polyacrylamide gel 
electrophoresis. The protein bands were visualized by Coomassie Brilliant 
Blue staining and the enzyme x [32P]dT20 (arrow) was detected by 
autoradiography. Lanes 1-7 correspond to UV-light exposure times of 0, 2.5, 
5, 10, 20, 30, and 45 min, respectively. (B) The amount of [3211dT20cross-linked 
to Ung () and Ung H187D (0) was quantitated by excising the radioactive 
bands from the dried gel, solubilizing the gel with 30% H202 at 55°C, and 
measuring the 32P radioactivity in a liquid scintillation counter using 5 ml of 
Formula 989 fluor. 109 
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Figure 18. Effect of uracil- and AP-sites on UV-catalyzed cross-linking of 
Ung and Ung H187D to dT20. (A) Samples (15111) containing 0.38 nmol of Ung 
() or Ung H187D (0) and 0.028, 0.084, 0.25, 0.76, or 2.28 nmol of [32P]dT20 
were UV-irradiated for 30 min as described under "Experimental Procedures". 
Identical UV-catalyzed cross-linking reactions were carried out except that 
[32P[cITI9-U (B) or [32P[c1T19-AP (C) was substituted as the oligonucleotide. 
After UV irradiation, samples were analyzed by 12.5% SDS-polyacrylamide 
gel electrophoresis and the amount of enzyme cross-linked to 
[ 2P[oligonucleotide was determined by liquid scintillation counting as 
described in Figure 17. 1
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H187D, relative to Ung, to form a cross-linked complex was nearly identical. 
In addition, the cross-linking efficiency was measured by using [32P]dT19-AP, 
which contained an apyrimidinic site in place of the site-specific uracil residue 
of dT19-U (Figure 18C). Recognition of dT19-AP by Ung was 2-fold greater 
than by Ung H187D, due primarily to the decreased ability of Ung H187D to 
cross-link to this oligonucleotide relative to either dT20 or dT19 U. 
3.1.13 Effect of Uracil on DNA Binding 
To determine the effect of free uracil on the DNA affinity of Ung and 
Ung H187D, UV-catalyzed cross-linking experiments were carried out in the 
presence of [32P]dT20 and 2 mM uracil (Figure 19). Inspection of the respective 
autoradiographs (Figure 19A and B) and cross-linking rates (Figure 19C) 
shows that, in the absence of uracil, the extent of UV-catalyzed oligonucleotide 
cross-linking to Ung was approximately twice that of Ung H187D. However, 
in the presence of the highly inhibitory concentration of free uracil, the extent 
of Ung cross-linking remained unaffected, whereas Ung H187D cross-linking 
was reduced more than two-fold. 
3.1.14 Enzyme Kinetics of Ung and Ung H187D 
The effect of substrate concentration on enzyme activity was examined 
by titrating various amounts of calf thymus [uracil-3H] DNA substrate into the 
standard uracil-DNA glycosylase assay. Vmax and Km values were calculated 
from the double reciprocal plot shown in Figure 20 and are summarized in 
Table 4. The Ung H187D mutation increased Vmax and Km at standard 
conditions by 1.9- and 4.3-fold, respectively. The reaction pH affected these 
values, with larger Vmax corresponding to pH 8.0. Similarly the Km was 
increased for wild type Ung from 0.32 pLIVI at pH 7.0 to 0.88 µM at pH 8.0. The 
Ung H187D Km increased from 1.7 W to 3.8 pt,M at pH 7.0 and pH 8.0, 
respectively. The values for kcat were compared and the substitution of Asp­
187 for His-187 led to a reduction of approximately five orders of magnitude, 113 
Figure 19. Effect of free uracil on UV-catalyzed cross-linking of Ung and 
Ung H187D to dT20. (A) Two reaction mixtures (1351,a) containing 3.4 nmol of 
Ung and 6.8 nmol of [32P]dT20 were UV-irradiated with UV-light in the 
presence or absence of 2 mM uracil. Samples (15 ill) were removed after the 
irradiation times indicated and subsequently analyzed by 12.5% SDS­
polyacrylamide gel electrophoresis. (B) An identical set of reaction mixtures 
was prepared except that 3.4 nmol of Ung H187D was substituted as the 
enzyme. Autoradiogray was conducted to locate the cross-linked enzyme x
[32P]dT20 species. Lanes 1-7 correspond to irradiation times of 0, 2.5, 5, 10, 20, 
30, and 45 min, respectively. (C) The amount of enzyme x [32P]dT20 produced 
was quantitated by liquid scintillation counting as previously described for 
Ung () and Ung H187D (R) in the presence and Ung (0) and Ung H187D () 
in the absence of uracil. 114 
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Figure 20. Effect of substrate concentration on Ung and Ung H187D activity. 
Modified uracil-DNA glycosylase reaction mixtures containing Ung (,11) or 
Ung H187D (0,6) were diluted in UDB buffers by using 70 mM HEPES-KOH 
(pH 8.0) (Ik) or 70 mM HEPES-KOH (pH 7.0) (,0) and calf thymus [uracil­
3H] DNA concentrations of 0-10 ,tN4 with respect to Muracil as described 
under "Experimental Procedures, Section 2.2.22.4". After incubation at 37°C 
for 30 min, the reaction was stopped with 10 mM ammonium formate buffer 
(pH 4.2), free [3H]uracil was recovered by Dowex chromatography and the 
amount of [3H]uracil released from the DNA substrate was determined by 
liquid scintillation counting. 116 
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Kinetic Parameters for Wild Type and H187D Mutant Uracil-DNA Glycosylases on
 
Calf Thymus [uracil-31-11 DNA Substrate'
 
kcat/Km  Vmax/Km
Enzyme  Vmax  Km  kcal 
(M-lsec-1 x 103)  (sec-1 x 10')
(pH)''  (M/sec x 1010)  (M x 10')  (sec-1) 
1.3  0.32  1.3  4100  4.1
Ung (7.0) 
12  14000  4.4
Ung (8.0)  3.9  0.88 
3.0 0.0023  1.4 Ung H187D (7.0)  5.1  1.7 
3.8  0.00025  0.066  1.9
Ung H187D (8.0)  7.3 
a The reaction mixture (75 Al) was added to 25 1.(1 of [uracil-3H] DNA diluted in 10 mM Tris-HC1 (pH 7.5). The 
final substrate concentration was 0-3.71.1g of furacil-31-11 DNA (180 cpm/pmol), 0-10 ,(1\/1 with respect to 
[3H] uracil. 
b Ung or Ung H187D (-0.13 units in UDB with HEPES-KOH (pH 7.0 or 8.0, as indicated)) was included in a 
modified reaction mixture as described under "Experimental Procedures". 118 
from 12 sec' to 0.00025 sec", under standard conditions. In contrast, pH and 
the H187D mutation had relatively minor effects on Vmax/Km. The values of 
Vmax /Km for Ung at pH 7.0 and pH 8.0 were nearly identical at 4.1 x 10-4 and 4.4 
x 10-4 sec-1, respectively. The Ung H187D mutant Vmax /Km at pH 8.0 was 
reduced 2.3-fold to 1.9 x 10-4 sec-1. At the mutant's pH optimum, Vmax/Km was 
calculated to be 3.0 x 10-4 sec', which is only 1.4-fold less than that of the wild 
type enzyme at the same pH. 
The kinetics of the wild type and mutant enzymes on double stranded 
oligonucleotide containing a 2-aminopurinedU basepair were also studied 
using steady-state fluorometry. 2-Aminopurine (2-APu) is an adenine isomer 
which is fluorescent but exhibits quenching within duplex DNA (145). Thus, 
upon excision of uracil by the action of Ung or Ung H187D, the 2-APu residue 
becomes unpaired and fluorescent with an emission wavelength of 370 nm. 
Various amounts of double-stranded 2AP-27-mer substrate were equilibrated 
in DAB buffer (pH 7.4) for 60 sec and emission was monitored to establish a 
baseline. After 60 sec, Ung or Ung H187D was added to the reaction chamber 
at a final concentration of 2 nM or 250 nM, respectively. A large spike in 
fluorescence was detected due to sample addition and mixing from -60-70 sec. 
After enzyme addition, the fluorescence was monitored for an additional 2 
min for wild type Ung and an additional 4 min for Ung H187D. The initial 
reaction velocity for Ung was determined from the slope of the line (AI/At) 
from 70-90 sec at each oligonucleotide concentration (Figure 21). The initial 
velocity for Ung H187D was determined from the slope of the line from 70­
300 sec at each oligonucleotide concentration (Figure 22). Double reciprocal 
plots were produced by using these calculated values. Representative double 
reciprocal plots are shown in Figure 23. Four trials were performed with wild 
type Ung, and the average value of Km was determined to be 55 (± 3) nM 
(Figure 23A). The Km of Ung H187D was calculated to be 1700 (± 300) nM, 
which is the average of three trials (Figure 23B). These values are 
considerably lower than those determined using calf thymus [uracil -3H] DNA. 
The kcat of Ung and Ung H187D were calculated as 0.59 sec' and 0.68 x 10-3 
sec', respectively. 119 
Figure 21. Steady state kinetics of Ung with a 2-aminopurine-containing 
double-stranded oligonucleotide. Steady-state fluorescence measurements 
were performed using double-stranded 2AP-27-mer oligonucleotide 
containing a 2-aminopurine:uracil basepair with an excitation wavelength of 
310 nm and emission wavelength of 370 nm. An aliquot (20 IA of the 
oligonucleotide was mixed with 4001.11 of DAB buffer (pH 7.4) and 
fluorescence was monitored for 60 sec to establish a baseline. Oligonucleotide 
concentrations were 20, 40, 50, 60, 80, 100, 120, 150, 200, 250, 300, 400, 500, 800, 
or 1000 nM (A -O, respectively). After 60 sec, 20 j.il of Ung (2 nM) was added to 
the reaction cuvette (arrows indicate Ung addition). Fluorescence was 
monitored for an additional 2 min and the intensity of fluoresence was plotted 
versus time. The initial velocity (AI/At) of the reaction was determined from 
the slope of the line calculated by linear regression from the data points 
encompassing 70-90 sec incubation time. 1
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Figure 21 (Continued) 
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Figure 22. Steady state kinetics of Ung H187D with a 2-aminopurine­
containing double-stranded oligonucleotide. Steady-state fluorescence 
measurements were performed using double-stranded 2AP-27-mer 
oligonucleotide containing a 2-aminopurine:uracil basepair with an excitation 
wavelength of 310 nm and emission wavelength of 370 nm. An aliquot (200 
of the oligonucleotide was mixed with 400 ill of DAB buffer (pH 7.4) and 
fluorescence was monitored for 60 sec to establish a baseline. Oligonucleotide 
concentrations were 500, 1000, 1500, 2000, 2500, 3000, or 3500 nM (A-G, 
respectively). After 60 sec, 20 [1,1 of Ung H187D (250 nM) was added to the 
reaction cuvette (arrows indicate Ung addition). Fluorescence was monitored 
for an additional 4 min and the intensity of fluoresence was plotted versus 
time. The initial velocity (AI/At) of the reaction was determined from the 
slope of the line calculated by linear regression from the data points 
encompassing 70-300 sec incubation time. 123 
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Figure 23. Double reciprocal plots of Ung and Ung H187D hydrolysis of a 
2-aminopurine-containing double-stranded oligonucleotide. Steady-state 
fluorescence measurements were performed using double-stranded 
oligonucleotide containing a 2-aminopurine:uracil basepair incubated with (A) 
Ung or (B) Ung H187D as described in "Figures 21 and 22". Reaction velocity 
was calculated from the data in "Figures 21 and 22" and double reciprocal 
plots were produced. 126 
3.2	  Ugi-Affinity Purification of Mitochondrial Uracil-DNA Glycosylases 
3.2.1	  Production of Polyclonal Antisera to Uracil-DNA Glycosylase 
and Uracil-DNA Glycosylase Inhibitor 
Polyclonal antibody was raised to E. coli uracil-DNA glycosylase and 
PBS2 uracil-DNA glycosylase inhibitor by injecting rabbits with 0.30 mg of 
purified Ung (Fraction V) or 0.38 mg of purified Ugi (Fraction IV), 
respectively. Boost injections were performed every 5-6 weeks and blood 
samples were taken 10 days subsequently to assay for the presence of 
inhibiting antibody. Tables 5 and 6 summarize the results of these assays. 
After 2-3 injections, sera immunized to Ung typically inhibited 60-70% of the 
Ung activity in a standard uracil-DNA glycosylase assay. When the antigen 
was Ugi, one animal produced a relatively weak immune response, resulting 
in serum that was capable of inhibiting only 16% of the Ugi activity relative to 
the control after 6 injections (Table 6, Rabbit #77). In contrast, a second animal 
produced a very strong response (Table 6, Rabbit #76), inhibiting greater than 
98% of the Ugi activity after only 2 injections. Subsequent boosts resulted in a 
decrease in Ugi inhibition to 56-59%. A 1:100 dilution of serum from Rabbit 
#78 also inhibited 52% of human A84UDG uracil-DNA glycosylase activity 
(data not shown). 
3.2.2	  Preparation of Ugi- and Ung-Sepharose 
Ugi was coupled to Sepharose 4B to make affinity resin for purification 
of polyclonal antibody raised to Ugi and uracil-DNA glycosylases from varied 
biological sources. Additionally, Ung was coupled to Sepharose 4B to produce 
affinity resin to be used in the affinity purification of anti-Ung polyclonal 
antibody. CNBr-activated Sepharose 4B was incubated with purified Ung or 
Ugi (30 mg protein/g of Sepharose) for 2 h at room temperature. Unreacted 
active sites on the resin were then blocked by incubating with 0.1 M Tris-HC1 
(pH 8.0) and uncoupled ligand was removed by extensive washing with 
alternating cycles of low and high pH buffer. The amounts of Ugi and Ung Table 5 
Inhibition of Uracil-DNA Glycosylase by Polyclonal Antisera to E. coli
 
Uracil-DNA Glycosylase
 
Rabbit #78  Rabbit #79 
Boost 
Uracil Released (pmol)a 
Ungb  Ung + Serum`  % Controld  Boost 
Uracil Released (pmol)a 
Ungb  Ung + Serum`  Control" 
0" 
1 
2 
3 
41 
31 
63 
93 
66 
70 
35 
58 
29 
21 
28 
>100 
92 
31 
32 
40 
0' 
1 
2 
3 
4 
5 
6f 
23 
73 
90 
64 
72 
60 
57 
33 
32 
36 
17 
25 
22 
21 
>100 
46 
40 
27 
35 
37 
37 
a E. coli Ung activity was determined by quantitating the release of [31-1]uracil (180 cpm/pmol) from uracil-
containing calf thymus DNA in modified Ung assays as described under "Experimental Procedures, Section 2.2.25". 
b The activity of E. coli Ung (-0.12 units) was determined in the absence of serum with the addition of UDB buffer. 
`The activity of E. coli Ung (-0.12 units) was determined in the presence of polyclonal antiserum (10' dilution) in 
UDB buffer. 
Percent control was calculated by dividing pmol of uracil released with samples containing Ung + Serum by pmol 
uracil released with samples containing Ung. Stimulation of Ung activity was seen in the presence of serum. 
`Pre-immune sera were sampled and assayed prior to immunizations with E. coli Ung. 
f Terminal bleeds were performed subsequent to the final injection. Table 6 
Inhibition of Uracil-DNA Glycosylase Inhibitor by Polyclonal Antisera to PBS2
 
Uracil-DNA Glycosylase Inhibitor
 
Rabbit #76  Rabbit #77 
Boost 
Uracil Released (pmol)' 
Ugib  Ugi + Serum`  % Controld  Boost 
Uracil Released (pmol)a 
% Controld Ugib  Ugi + Serum' 
0' 
1 
2 
3 
4g 
77 
74 
62 
56 
71 
82 
9 
<1.2f 
23 
31 
>100 
12 
<2 
41 
44 
0' 
1 
2 
3 
4 
5 
6g 
77 
72 
57 
47 
73 
55 
56 
73 
59 
37 
45 
71 
53 
47 
95 
82 
65 
96 
97 
96 
84 
a Ugi activity was determined by quantitating the inhibition of [3H]uracil (180 cpm/pmol) release from uracil-
containing calf thymus DNA by E. coli Ung (-0.12 units) in assays modified as described under "Experimental 
Procedures, Section 2.2.25". 
"The activity of Ugi ( -.0.1 units) was determined in the absence of serum with the addition of UDB buffer. 
The activity of Ugi (-0.1 units) was determined in the presence of polyclonal antiserum (10-3 dilution) in UDB 
buffer. 
d Percent control was calculated by dividing pmol of uracil released by Ung in samples containing Ugi + Serum by 
pmol uracil released by Ung in samples containing Ugi. Stimulation of Ung activity was seen in the presence of 
serum. 
e Pre-immune sera were sampled and assayed prior to immunizations with E. coli Ung. 
f This value represents the assay's lower limit of detection. 
8 Terminal bleeds were performed subsequent to the final injection. 129 
coupled to Sepharose 4B resin were estimated to be 220 nmol/ml and 97 
nmol/ml of packed resin, respectively, based on the amount of uncoupled 
ligand recovered during the coupling process. The binding capacity of Ugi-
Sepharose was determined by incubating 100 d of resin (25% (v/v) slurry) 
with varying amounts of [3H]Ung (13.5 cpm/pmol). The resin was washed 
and bound protein removed with gel loading dye containing 1% SDS and 
boiling for 10 min. Flow through, wash, and elution fractions were analyzed 
by 12.5% SDS-polyacrylamide gel electrophoresis as described (Figure 24). 
The amount of [3H]Ung in the flow through (Figure 24A-E, lane 1) increased 
with increasing Ung concentrations. In contrast, the size of the protein band 
in the elution fractions increased with increasing Ung addition up to 3900 
pmol, where it appeared to plateau (Figure 24D, lanes 4-6). Quantitation of 
3H-radioactivity recovered by SDS elution via liquid scintillation counting 
revealed that protein binding increased with increasing Ung addition until the 
capacity of the resin was reached at -90 nmol of Ung per ml of Ugi-Sepharose 
resin (Figure 24F). Binding capacity was similarly estimated for Ung-
Sepharose by incubating coupled resin with [35S]Ugi. The binding capacity of 
Ung-Sepharose was determined to be -40 nmol of Ugi per ml of Ung-
Sepharose resin (Figure 25). In both cases, a small fraction (<1%) of 
radioactive protein remained bound to the resin after SDS elution. The 
amount of [3H]Ung which could not be eluted from the Ugi-Sepharose resin 
was 19 pmol, while the amount of unrecovered [35S]Ugi was 36 pmol (data not 
shown). 
3.2.3  Affinity Chromatography of Uracil-DNA Glycosylase 
In order to determine whether Ung could be detected at physiological 
concentrations in whole cell extracts by Ugi-Sepharose, E. coli JM105 crude cell 
extract was incubated with Ugi-Sepharose beads. In addition, cell extract 
mixed with 5 or 50 lig of purified E. coli Ung (Fraction V) was incubated with 
Ugi-Sepharose resin in case the endogenous levels of Ung were below the 
limits of detection for the purification system. The resin was washed and 130 
Figure 24. Binding capacity of Ugi-Sepharose. The binding capacity of Ugi-
Sepharose was determined by incubating 975 (A), 1950 (B), 2930 (C), 3900 (D), 
or 4870 (E) pmol of [3H]Ung (13.5 cpm/pmol) with 100 til of a 25% (v/v) resin 
slurry in DAB buffer for 10 min at 25°C as described under "Experimental 
Procedures". The resin was washed three times with 200 iil of DAB buffer and 
the bound Ung was eluted by the addition of 100 Ill of SDS sample buffer (50 
mM Tris-HC1 (pH 6.8), 1% SDS, 143 mM(3-mercaptoethanol, 10% (w/v) 
glycerol, and 0.04% bromophenol blue) and incubating at 100°C for 10 min. 
Aliquots (25 IAD of flow through (lane 1) and wash (lanes 2 and 3) were 
analyzed by 12.5% SDS polyacrylamide gel electrophoresis along with 50 ml of 
elution fractions (lanes 4-6). The molecular weight standards for bovine 
serum albumin, ovalbumin, glyceraldehyde-3-phosphate dehydrogenase, 
carbonic anhydrase, trypsinogen, trypsin inhibitor and a-lactalbumin are 
indicated by arrows from top to bottom. (F) Flow through (100 IA), wash (100 
p.1), and SDS sample buffer eluted fractions (251.11) and the resin were 
quantitated for 3H-radioactivity by liquid scintillation counting using Formula 
989 fluor. The total amount of bound [3H]Ung was calculated by summing the 
amount of radioactivity detected in SDS sample buffer eluted fractions and 
resin. A
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Figure 25. Binding capacity of Ung-Sepharose. The binding capacity of Ung-
Sepharose was determined as described in Figure 23 by incubating 390 (A), 
780 (B), 1170 (C), 1560 (D), 1950 (E), or 3900 (F) pmol of [35S]Ugi (28 
cpm/pmol) with 100111 of a 25% (v/v) resin slurry in DAB buffer for 10 min at 
25°C as described under "Experimental Procedures". The resin was washed 
three times with 200 IA of DAB buffer and the [35S]Ugi was eluted by the 
addition of SDS sample buffer (50 ml) and incubating at 100°C for 10 min. 
Aliquots of flow through (100 Ill), wash (100 pl), and SDS sample buffer eluted 
fractions (25 Ill) and the resin were quantitated for [35S] radioactivity by liquid 
scintillation counting using Formula 989 fluor. The total amount of bound
[35S]Ugi was determined by summing the amount of radioactivity detected in 
SDS sample buffer eluted fractions and resin. 133 
Figure 25 
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bound proteins were eluted with gel loading dye containing SDS. Aliquots of 
flow through, wash, and elution fractions were analyzed by SDS­
polyacrylamide gel electrophoresis. Although no detectable Ung was 
recovered when Ugi-Sepharose was incubated with cell extract alone (Figure 
26, lane 14), protein bands corresponding to Ung were visualized when the 
extract was supplemented with purified E. coli Ung (Figure 26, lanes 15 
and 16). 
In order to optimize elution conditions, Ugi-Sepharose resin was 
incubated with 1950 pmol of [3H]Ung and washed. Buffers of varying pH and 
ionic strengths were tested as elutants. In some cases, the elutant was 
collected into 10111 of neutralizing buffer as described in Table 3. The 
efficiency of elution was determined by quantitating the amount of recovered 
[3H]Ung by liquid scintillation counting. Buffers composed of 100 mM TEA 
(pH 11.5), 10 mM potassium phosphate buffer (pH 7.2) and 5 M LiC1 (pH 7.2), 
and 2 M guanidine-HC1 eluted  5`)/0 of the bound ['Fi]ling (Figure 27A). The 
100 mM glycine buffers (pH 1.8 and 2.5) removed -20-25% of the bound 
[3H]Ung. In contrast, buffer containing 10 mM potassium phosphate buffer 
(pH 7.2) and 3.5 M MgC12 eluted -43% of the bound Ung. The concentration 
of MgC12 and pH of the potassium phosphate buffer were then varied as 
described in Figure 27B in an attempt to increase total recovery of bound Ung. 
The amount of [3H]Ung eluted increased with increasing MgC12; 5 M MgC12 
recovered nearly twice as much Ung versus 2 M MgC12 and 34 times more 
Ung than 0.5 M MgC12 (Figure 27B). While the recovery of bound Ung was 
enhanced -8-fold by increasing the buffer pH from 6.2 to 6.8, there was no 
significant change in recovery when the pH was increased to 7.2 (Figure 27B). 
Consequently, 10 mM potassium phosphate buffer (pH 7.2) and 5 M MgC12 
was adopted as the standard elution conditions for recovery of Ung utilizing 
Ugi-Sepharose chromatography. 135 
Figure 26. Recovery of Ung from E. coli cell extracts by Ugi-Sepharose 
chromatography. Cell-free extract (95 lig) was prepared, mixed with 0-50 idg 
of purified E. coli Ung, then incubated with 100 pi of Ugi-Sepharose or 
Sepharose 4B resin (25% (v/v) slurries) for 10 min at 25°C. The extract was 
removed by centrifugation as described under "Experimental Procedures". 
The resin was washed three times with 200 d of DAB buffer and bound 
proteins were removed with 100 Ill of SDS sample buffer and heating at 100°C 
for 10 min. Aliquots (50 iAl) of each flow through, wash and elution fraction 
were prepared for 12.5% SDS polyacrylamide gel electrophoresis. Lanes 1-3 
contain flow through fractions of Ugi-Sepharose incubated with cell-free 
extract containing 0, 5, or 50 lig of Ung, respectively. Lane 4 contains flow 
through of cell-free extract incubated with Sepharose 4B control resin. Wash 
fractions of Ugi-Sepharose plus cell-free extract supplemented with 0, 5, or 50 
lig Ung are shown in lanes 5-7, respectively. The second and third washes of 
Ugi-Sepharose plus cell-free extract supplemented with Ung are likewise 
shown in lanes 8-10 and 11-13. Lanes 14-16 contain fractions eluted with SDS 
sample buffer from Ugi-Sepharose incubated with cell-free extract containing 
0, 5, or 50 idg of Ung, respectively, and lane 17 contains cell-free extract 
incubated with Sepharose 4B control resin and eluted with SDS sample buffer. 
The locations of Ung and tracking dye (TD) are indicated by arrows. The 
molecular weight standards for bovine serum albumin, ovalbumin, 
glyceraldehyde-3-phosphate dehydrogenase, carbonic anhydrase, 
trypsinogen, and trypsin inhibitor are indicated by arrows from top to bottom. 136 
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Figure 27. Elution of E. coli Ung from Ugi-Sepharose. [3H]Ung (1950 pmol, 
13.5 cpm/pmol) was incubated with 100 ul of Ugi-Sepharose slurry (25% v/v) 
at 25°C for 10 min. The resin was washed as described under "Experimental 
Procedures" then bound [3H]Ung was eluted with various buffer conditions 
(A) or varying concentrations of MgC12 and pH (B) as indicated. The total 
amount of [3H]Ung recovered in each elution fraction was quantitated by 
liquid scintillation counting as described under "Experimental Procedures". 138 
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Elution conditions 139 
3.2.4	  Affinity Purification of Polyclonal Antibody to Uracil-DNA 
Glycosylase 
Antiserum was incubated with Ung-Sepharose to determine optimum 
elution conditions for the affinity purification of polyclonal antibody to Ung. 
The resin was washed and eluted with various buffer conditions as previously 
described for the affinity purification of Ung ("Section 2.2.15", Table 3). Eluted 
antibody was detected by 12.5% SDS-polyacrylamide gel electrophoresis and 
silver staining (Figure 28). The amount of purified IgG recovered was 
estimated by comparing the relative intensity of the bands corresponding to 
heavy chain (-55 kDa) and light chain (-25 kDa) polypeptides with other 
serum proteins detected in the elution fractions. Although 100 mM glycine 
(pH 2.0) and 100 mM TEA (pH 11.5) appeared to recover the greatest quantity 
of bound antibody (Figure 28, samples 1 and 3, respectively), buffer 
containing a 3.5 M MgC12 concentration also eluted a reasonable amount of 
antibody from the resin (Figure 28, sample 4). Thus, 3.5 M MgC12 in 10 mM 
potassium phosphate buffer (pH 7.2) was selected for the elution buffer 
because it dissociated a large quantity of bound antibody yet did not require 
additional steps to neutralize extremes of pH. 
Large-scale purification of anti-Ung antibody was performed by 
incubating 12.5 ml of serum with 25 ml of Ung-Sepharose slurry (25% (v/v)). 
After washing the resin with potassium phosphate buffer (pH 7.2), Ung 
antibody was eluted with 3.5 M MgC12 in 10 mM potassium phosphate (pH 
7.2). The purification profile is shown in Figure 29. The flow through fractions 
contained large amounts of serum protein which were not immunoreactive to 
Ung in ELISA. The minor protein peak at fraction 70 produced a strong 
reaction against Ung in ELISA and was enriched for the 55 kDa and 25 kDa 
protein species corresponding to the heavy and light IgG polypeptides. In 
addition, ELISA for total IgG produced a strong response across fractions 68­
80. 140 
Figure 28. Determining elution conditions for affinity purification of 
polyclonal antibody to Ung using Ung-Sepharose. Optimum conditions for 
the elution of anti-Ung antibody from Ung-Sepharose resin were identified by 
incubating polyclonal antiserum (50 I.11) immunized to E. coli Ung with 100 IA of 
Ung-Sepharose for 10 min at 25°C. The resin was washed and eluted with (1) 
100 mM glycine (pH 2.0), (2) 100 mM glycine (pH 1.8), (3) 100 mM TEA (pH 
11.5), (4) 3.5 M MgC12 and 10 mM potassium phosphate (pH 7.2), or (5) 5 M 
LiC1 and 10 mM potassium phosphate (pH 7.2) as described under 
"Experimental Procedures". Aliquots (1.25 Ill) of the two elution fractions (A 
and B) from each sample were analyzed by 12.5% SDS-polyacrylamide gel 
electrophoresis followed by silver staining. The location of IgG heavy and 
light chains are denoted by H and L, respectively. The molecular weight 
standards for bovine serum albumin, ovalbumin, glyceraldehyde-3-phosphate 
dehydrogenase, carbonic anhydrase, trypsinogen, and trypsin inhibitor are 
indicated by arrows from top to bottom. 141 
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Figure 29. Affinity purification of anti-Ung polyclonal antibody. 
Purification of anti-Ung polyclonal antibody was performed by mixing 25 ml 
Ung-Sepharose with 12.5 ml of immunized rabbit serum for 30 min at 25°C. 
The slurry was transferred to a 1.5 cm diameter BioRad column, the resin was 
washed with 10 mM potassium phosphate buffer (pH 7.2), and eluted with 3.5 
M MgC12 in 10 mM potassium phosphate buffer (pH 7.2). (A) Fractions (1 ml) 
were collected and selected fractions were analyzed by 12.5% SDS 
polyacrylamide gel electrophoresis and silver staining as described under 
"Experimental Procedures". The molecular weight standards for bovine 
serum albumin, ovalbumin, glyceraldehyde-3-phosphate dehydrogenase, 
carbonic anhydrase, trypsinogen, and trypsin inhibitor are indicated by arrows 
from top to bottom. (B) Fractions were assayed for total protein () by 
absorbance spectroscopy at 280 nm and for total () and anti-Ung () IgG by 
detecting the product of the horseradish peroxidase reaction with ABTS in an 
ELISA at 405 nm as described under "Experimental Procedures". 143 
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3.2.5  Purification of Ung from Mitochondrial Extracts 
In order to determine whether polyclonal antiserum to E. coli Ung was 
capable of cross-reacting with mitochondrial uracil-DNA glycosylase, Western 
blot analysis was performed on samples containing mitochondrial crude 
extract or purified E. coli Ung. Additionally, mixtures of mitochondrial extract 
and E. coli Ung were analyzed to determine whether mitochondrial proteins 
interfered with the detection of Ung in the event that immunoreactive bands 
were not visualized in mitochondrial samples. No immunoreactive bands 
were detected in the mitochondrial crude extract (Figure 30A), although the 
specific uracil-DNA glycosylase activity of the extract was determined to be 
-6.4 units/mg protein. E. coli Ung was detected by Western blot analysis to 
6.25 ng, in purified form and when mixed with mitochondrial extract (Figure 
30B and C, respectively). A protein species that migrated faster than E. coli 
Ung was also observed (Figure 30B and C, lanes 6 and 7). The smaller 
apparent molecular weight, cross-reactivity with Ung specific antibody, and 
the increasing intensity of the band with increasing concentrations of Ung, 
suggests a degradation product in the purified Ung preparation. 
The process of base excision repair in mitochondria has not been 
extensively studied. Although reconstitution of mitochondrial BER has been 
attempted, these studies utilized AP site containing DNA (105) or a truncated 
form of human UDG (72) rather than purified mitochondrial uracil-DNA 
glycosylase to catalyze the first step of the repair reaction. In order to fully 
understand this pathway in mitochondria, a source of mitochondrial uracil-
DNA glycosylase free of contaminating nuclear activity would be desirable. 
Thus, a protocol was devised for purifying Ung activity from mitochondrial 
extracts (Figure 31). Rat or pig liver mitochondria were disrupted by grinding 
with alumina powder and the crude extract was recovered by centrifugation 
as described previously. The proteins that precipitated between 35% and 65% 
(saturation) ammonium sulfate were recovered, resuspended, and subjected 
to Ugi-Sepharose affinity chromatography. Fractions from each step of the 
purification were analyzed by SDS-polyacrylamide gel electrophoresis and 145 
Figure 30. Detection of Ung in mitochondrial extracts using Western blot 
analysis. Samples containing (A) 10, 20, 30, 40, 60, 80 or 100 jig of rat liver 
mitochondrial extract (lanes 1-7), (B) 0.05, 0.25, 1.25, 6.25, 31, 156 or 781 ng of 
E. coli Ung (lanes 1-7), or (C) a mixture of -30 jig of mitochondrial extract with 
0.05, 0.25, 1.25, 6.25, 31, 156 or 781 ng of E. coli Ung (lanes 1-7) were prepared 
for 12.5% SDS polyacrylamide gel electrophoresis. Western blot analysis was 
performed as described under "Experimental Procedures". The proteins were 
transferred to nitrocellulose and probed with anti-Ung antiserum (1:5000 
dilution). After the addition of alkaline phosphatase-conjugated secondary 
antibody (1:2000 dilution) the Western blot was developed with 100 mM 
NaHCO3 (pH 9.8), 10 mM MgC12, 3 mg nitro blue tetrazolium in 70% dimethyl 
formamide, and 15 mg bromochloroindolyl phosphate in 100% dimethyl 
formamide. The prestained molecular weight standards for phosphorylase B, 
bovine serum albumin, carbonic anhydrase, soybean trypsin inhibitor, and 
lysozyme are indicated by arrows from top to bottom. A
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Figure 31. Scheme for purification of rat or pig liver mitochondrial Ung. 
Uracil-DNA glycosylase was purified from rat or pig liver mitochondria by 
grinding mitochondria frozen in liquid N, with alumina powder and 
extraction buffer (50 mM Tris -HCJ (pH 8.0), 5 mM (3-mercaptoethanol, 1 mM 
EDTA, 1 M NaC1, 1 mM PMSF). The sample was centrifuged at 5,000 x g for 10 
min to remove the alumina, followed by centrifugation at 10,000 x g for 10 
min to remove unbroken mitochondria. The mitochondrial membranes were 
removed by ultracentrifugation at 100,000 x g for 1 h and the supernatant 
(Fraction I) was recovered. Ammonium sulfate precipitations were 
performed as described under "Experimental Procedures". The ammonium 
sulfate-insoluble fraction was resuspended in TDEG buffer and designated 
Fraction II after dialysis into the same buffer. Fraction II was applied to a Ugi-
Sepharose column (100 Ill) and serial washes (100 p1,1) of 10 mM potassium 
phosphate (pH 7.2), 0.5 M NaC1, and 10 mM potassium phosphate (pH 7.2) 
were performed as described under "Experimental Procedures". The column 
was eluted step-wise with three 50 p1 washes of 10 mM potassium phosphate 
(pH 7.2) containing 5 M MgC12. 148 
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silver staining. From the rat source, the final purification step yielded a 
sample greatly enriched for a single protein slightly smaller than E. coli Ung 
(Figure 32A). When the proteins contained within the polyacrylamide gel 
were transferred to nitrocellulose and Western blot analysis was performed, 
elution fractions produced anti-Ung antibody immunoreactive bands which 
stained with an intensity similar to that of a sample containing 6 ng (0.2 pmol) 
of purified E. coli Ung (Figure 32B). Purification of porcine mitochondrial Ung 
resulted in two major protein bands, one similar in size to E. coli Ung, which 
had an apparent molecular weight of -29,000, and a second of -48,000 (Figure 
33A). The 28,000 molecular weight species was immunoreactive to affinity-
purified anti-Ung antibody while the 48,000 molecular weight species was 
relatively unreactive (Figure 33B). 150 
Figure 32. Purification of uracil-DNA glycosylase from rat liver 
mitochondrial extracts. Aliquots of fraction I (1 ill), II (1 0, and wash and 
elution fractions (2 !al each) from Ugi-Sepharose chromatography were 
prepared for 12.5% SDS polyacrylamide gel electrophoresis as described under 
"Experimental Procedures". After electrophoresis, protein bands were 
visualized by silver staining (A) or Western blotting (B) using anti-Ung 
antibody as described under "Experimental Procedures". Lane 1, Fraction I; 
lane 2, Fraction II; lane 3, 10 mM potassium phosphate buffer (pH 7.2) wash; 
lanes 4-6, 0.5 M NaC1 washes; lane 7, 10 mM phosphate buffer (pH 7.2) wash; 
lanes 8-10, 10 mM potassium phosphate (pH 7.2) and 5 M MgC12 elution 
fractions. A titration series of 0.01, 0.05, 0.23, 1.2, 5.8, and 29 pmol of E. coli 
Ung is shown in lanes 11-17, respectively. The location of E. coli Ung is 
indicated by arrows. 151 
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Figure 33. Purification of uracil-DNA glycosylase from pig liver 
mitochondrial extracts. Aliquots of Fraction II (1 ii1), and wash and elution 
fractions (2 iAl each) from Ugi-Sepharose chromatography were prepared for 
12.5% SDS polyacrylamide gel electrophoresis as described under 
"Experimental Procedures". After electrophoresis, protein bands were 
visualized by silver staining (A) or Western blot analysis (B) using anti-Ung 
antibody as described under "Experimental Procedures". Lane 1, Fraction II; 
lane 2, 10 mM potassium phosphate buffer (pH 7.2) wash; lanes 3-5, 10 mM 
potassium phosphate (pH 7.2) and 5 M MgC12 elution fractions. The 
prestained molecular weight standards for phosphorylase B, bovine serum 
albumin, ovalbumin, carbonic anhydrase, soybean trypsin inhibitor, and 
lysozyme are indicated by arrows from top to bottom. The locations of E. coli 
Ung and tracking dye (TD) are indicated by arrows. 153 
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4. DISCUSSION
 
4.1	  Overproduction and Characterization of Uracil-DNA Glycosylase 
H187D 
Site-directed mutagenesis was performed to examine the role of an 
active site amino acid residue (His-187) in uracil-DNA recognition and excision 
by E. coli uracil-DNA glycosylase. After verifying the construction of the 
overexpression vectors containing the ung and ungH187D genes by BamH I 
digestion of plasmid DNA recovered from E. coli JM105, transformation of 
pSB1051 and pUngH187D into an E. coli ung background was attempted. 
However, neither E. coli strains BW310 (ung-1) nor BD2314 (ung-152::Tn10) 
stably maintained the overexpression vectors. None of the pSB1051 or 
pUngH187D isolates from E. coli BD2314 or BW310 displayed the expected 
restriction fragments upon digestion with BamH I restriction endonuclease. 
Some isolates appeared to have lost their BamH I recognition sites as they 
were incapable of being cleaved by the restriction enzyme. The remaining 
isolates produced restriction fragments that could not be identified relative to 
the known plasmid maps of pSB1051 and pUngH187D. Thus, the restriction 
patterns observed suggested that deletions and/or rearrangements occurred 
on the plasmids. 
The reason for the instability was not determined, although it was 
hypothesized that the ung and ungH187D gene products may be toxic to E. coli 
ung strains. The E. coli ung strains transformed with pSB1051 or pUngH187D 
formed smaller colonies and grew more slowly when compared to the same 
strains transformed with the control vector that lacked an insert. The Ung and 
Ung H187D proteins themselves did not appear to cause toxicity as both 
plasmids were stable in E. coli JM105. Thus, the instability appeared to arise 
from the ung genotype in concert with the ung- or ungH187D-containing 
vector. It is likely the BW310 and BD2314 genomes had higher concentrations 
of uracil residues in DNA than wild type E. coli due to the absence of Ung 
activity in these strains. Thus, some of the uracil may have been incorporated 155 
in close proximity to uracil residues on the opposite DNA strand. This 
phenomenon might offer a possible explanation for the genetic instability. 
The presence of closely spaced uracil residues on opposing DNA strands has 
been demonstrated to increase the rate of double-strand breaks and deletion 
formation in ung+ E. coli (24). Expression of ung after transformation of E. coli 
BW310 and BD2314 with pSB1051 would make these strains ung+ and capable 
of excising uracil residues from their genomes. Transformants harboring 
pUngH187D would also be capable of uracil excision if the ungH187D gene 
product retained some catalytic activity despite the mutation. Thus plasmid 
rearrangements may have resulted from the introduction of uracil-DNA 
glycosylase activity in these strains as a mechanism to prevent potentially 
lethal double-strand breaks or deletion mutations resulting from the excision 
of numerous uracil residues. Recombination may have occurred between 
copies of the plasmid or between plasmid and homologous regions of the 
chromosomal ung sequences. 
To address the potential problem of gene rearrangement and 
recombination, E. coli BW310 was made recA defective by P1vir transduction. 
The resulting transductant was designated E. coli MJS100. E. coli MJS100 
appeared to be defective in recA by virtue of its sensitivity to UV radiation, 
which was phenotypically equivalent to the parent strain E. coli JC10289 from 
which the transducing phage was created. Although the recA mutation 
allowed pSB1051 to be stably maintained in E. coli MJS100 cells, pUngH187D 
remained unstable. It is not clear why the plasmid containing the mutant 
ungH187D gene would be less stable than wild type ung. Rather than attempt 
to further address this instability, the Ung H187D protein was overproduced 
in wild type E. coli and purification was undertaken to isolate the Ung H187D 
protein and to resolve it from wild type Ung. 
The activity of crude cell extracts containing overproduced Ung H187D 
suggested that the H187D mutation compromised the enzyme's catalytic 
activity. While pSB1051 containing crude extracts demonstrated a 930-fold 
increase in Ung activity with IPTG-induction, extracts containing 
overproduced Ung H187D had only 1.5 times more uracil-DNA glycosylase 156 
activity relative to cell extracts containing the pKK223-3 control vector. Thus it 
appeared that the H187D mutation reduced the enzyme's activity by at least 
620-fold. 
During the purification of Ung H187D, it was observed that, unlike the 
endogenous wild type enzyme, the H187D mutant failed to bind single-
stranded DNA agarose under conditions conducive to stable binding by wild 
type Ung. In contrast, Ung H187D was observed to stably bind to poly(U) 
Sepharose. These findings suggested that the His to Asp substitution 
interfered with the ability of the mutant enzyme to form a persistent complex 
with single-stranded DNA. However, one may infer both from the low, but 
detectable, catalytic activity and from the observed inhibition by free uracil 
that Ung H187D conserved, to some extent, the native uracil nucleotide 
interaction. A structural comparison of the active sites by Tainer and 
coworkers (110) implies that steric constraints should not dramatically affect 
uracil binding by Ung H187D (Figure 34). Furthermore, the experimental 
findings indicating altered DNA substrate specificity of Ung H187D suggested 
that the negative charge of the Asp-187 side chain may repel the phosphate 
backbone of the single-stranded DNA, which is less constrained than in 
double-stranded DNA. This interpretation was consistent with the close 
proximity of the Asp-187 carboxyl group to the 3'- and 5'-phosphates of the 
target uracil nucleotide in DNA (Figure 34B). In addition, when the equivalent 
histidine residue in human uracil-DNA glycosylase (His-268) was mutated to 
Leu, significantly lowered affinity to DNA was not observed (80), presumably 
because the Leu side chain lacked the long range interactions of the Ung Asp­
187 carboxylate. In the case of binding to poly(U)-Sepharose, perhaps the 
negative Asp-187 carboxylate:phosphate interaction in DNA is mitigated in 
part by hydrogen bonding between the ribose 2' hydroxyl and the Asp side 
chain. 
E. coli Ung was purified to apparent homogeneity, as evidenced by the 
presence of a single protein band coincident with the Ung H187D activity 
eluted from poly(U)-Sepharose when fractions were analyzed by SDS­
polyacrylamide gel electrophoresis. A low level of uracil-DNA glycosylase 157 
Figure 34. Model of E. coli Ung binding to uracil-containing DNA. The 
location of Ung (A) and Ung H187D (B) active site amino acid residues are 
shown as determined by Tainer and coworkers using high resolution X-ray 
crystallography (110). The position of the cleaved uracil nucleotide was 
modeled into the uracil recognition pocket by superimposing the Ung 
structure onto the human uracil-DNA glycosylase:U/G-DNA co-crystal 
structure (103). Alignment was performed by the program CKWHENCE 
(110). The active site residues portrayed are absolutely conserved between E. 
coli and human uracil-DNA glycosylase. The proposed interactions between 
various residues, uracil, deoxyribose phosphates, and water are indicated. 
Protein is shaded in light gray, DNA in dark gray; heteroatoms are nitrogen 
(gray), oxygen (black), and phosphorus (white). 3
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activity was detected in the Ung H187D preparation. This activity was 
reduced approximately 55,000-fold relative to that of wild type Ung as 
indicated by a specific activity of 37 units/mg. Based on this observation, Ung 
H187D was calculated to have a turnover rate of 0.95 uracil/h. Several 
observations indicated that the activity of the Ung H187D preparation was 
inherent to the mutant protein and not the result of very low-level 
contamination by wild type Ung: 1) a preparation of Ung H187D deliberately 
contaminated with Ung was effectively resolved into two distinct peaks 
(mutant and wild type Ung) using DNA-agarose affinity chromatography, 
which was applied to the separation procedure during the final step in the 
purification protocol; 2) the pH optimum of Ung H187D (pH 7.0) was distinct 
from that of Ung (pH 8.0); and 3) the substrate specificity of Ung H187D 
differed from that of Ung. From these observations it was concluded that the 
Ung H187D mutant enzyme preparation was sufficiently pure to warrant 
further characterization. 
Recently, the structures of both Ung and Ung H187D in complex with 
the uracil-DNA glycosylase inhibitor protein were determined by X-ray 
crystallography at 2.4 A and 2.6 A resolution, respectively (110). Ung is the 
first full-length uracil-DNA glycosylase for which crystal structure information 
is available (110, 111, 153). Overlay of the Ung and Ung H187D structures 
indicated that the mutant protein is properly folded with respect to the wild 
type enzyme, and the principal amino acid residues that form the uracil 
binding pocket and active site (Asp-64, Pro-65, Tyr-66, Phe-77, Asn-123, 
His/Asp-187) of Ung and Ung H187D are nearly superimposable when the 
two structures are compared (110). Moreover, structural comparison of E. coli 
Ung with both the human (79) and HSV-1 (117) uracil-DNA glycosylase 
homologs has indicated that the major structural motifs implicated in enzyme 
function and specificity have been conserved, specifically the Leu intercalation 
loop (E. coli residues 187-HPSPLSAHR-195), the Pro-rich loop (84-AIPPS-88), 
the Gly-Ser loop (165-GS-166), the uracil specificity region (120-LLLN-123), and 
the catalytic water-activating loop (63-QDPYH-67) (103, 110). Thus, 
conclusions concerning the catalytic role of Ung His-187 are most likely 160 
applicable to the various members of the uracil-DNA glycosylase protein 
family for which this amino acid is an absolutely conserved residue. 
In addition to structural analysis, the Ung H187D enzyme was 
subjected to biochemical characterization. As previously shown, uracil-DNA 
glycosylases display a marked preference for single-stranded uracil-containing 
DNA, and favor U/G mispairs over U/A basepairs in double-stranded DNA 
(9, 102). Under conditions optimal for wild type Ung (pH 8.0), the substrate 
preference of Ung H187D was U/G-25-mer > single-stranded U-25-mer > 
U/A-25-mer. However, Ung H187D processed these same DNA substrates at 
pH 7.0 with comparable rates, although single-stranded U-25-mer was slightly 
preferred. Furthermore, activity on the single-stranded uracil-DNA substrate 
increased about three-fold at pH 7.0 compared to that at pH 8.0. That the 
substrate specificity and specific activity of Ung H187D were pH-dependent 
suggested that the protonation state of the Asp-187 y-carboxylate may affect 
various aspects of the uracil-excision reaction including: the extent and 
duration of DNA-binding, uracil nucleotide flipping, and stabilization of the 
uracil/deoxyribose transition state. In this regard it was interesting that the 
effect of pH on uracil inhibition of both Ung and Ung H187D was small, and 
that Ung H187D was less susceptible than Ung to uracil inhibition. In addition, 
the mutant enzyme was not inhibited by 5-fluorouracil at any of the 
concentrations tested. Taken together, these results imply that the mutation 
reduced the affinity of the active site for uracil. This can be explained from a 
structural basis as caused by loss of hydrogen bonding and repulsive 
electrostatic interactions with the permanent electric dipole at uracil 02 (Figure 
34). In the case of 5-fluorouracil, steric interference and like-charge repulsion 
by the 5-fluorine moiety with the Asp-187 side chain were apparently 
sufficient to preclude binding. If like-charge replusion is a major factor in 5­
fluorouracil binding, one might expect that nonpolar substitutions at residue 
187, such as Leu, would not affect 5-fluorouracil inhibition due to the presence 
of a neutral aliphatic side chain in the active site. 
Previously, biochemical characterization of the Ugi inhibitor protein 
revealed that Ugi binds Ung in a 1:1 stoichiometry (8). Crystallographic data 161 
further demonstrate that both Ung and Ung H187D bind Ugi to form a 1:1 
UngUgi complex (110). Because mutant and wild type Ung bind Ugi in a 1:1 
ratio, one would expect [35S]Ugi to form complex with Ung and Ung H187D in 
a manner directly proportional to the molar ratio of inhibitor to enzyme. 
However, it was observed that only 2/3 and 7/8 of [35S]Ugi was detected in 
complex with Ung and Ung H187D, respectively, at equal molar ratios. 
Several factors may account for this discrepancy. The concentrations of Ung 
and Ung H187D may have been overestimated or the enzyme preparations 
may have been heterogeneous, with a subpopulation incapable of binding to 
Ugi. When purified [3H]Ung was incubated with Ugi-Sepharose, a fraction of 
the preparation was refractory to Ugi-binding even in excess of resin. This 
suggests that the purification process may inactivate a subpopulation of the 
enzyme. However, even at a 5-fold molar excess of enzyme to Ugi it was not 
possible to complex 100% of the [35S]Ugi. This may be a product of 
experimental error and may reflect the limits of detection of this assay. 
Alternatively, it may indicate that a fraction of the inhibitor is also rendered 
incapable of complex formation during the purification process. The Ugi 
purification includes a heat denaturation step; it is likely that some fraction of 
this heat-resistant Ugi protein does not fully renature and thus become 
incapable of complex formation. Regardless, both the mobility shift assay and 
crystallographic analysis indicate that the H187D mutant is able to complex 
with Ugi. Ugi forms a complex with Ung by inserting its 131 edge over the 
DNA binding groove of the enzyme and sequestering the active site pocket 
(79, 110). Although Ung His-187 makes a water-mediated hydrogen bond 
with Ugi Glu-28 and hydrophobic contacts with Ile-22 and Met-56 (110), the 
other interactions between Ung and the Ugi 01 edge appear to be so extensive 
that the Asp-187 mutation has little to no effect on complex formation. 
By using UV-catalyzed protein/DNA cross-linking as a measure of 
DNA binding affinity, the efficiency of Ung His187D cross-linking to the 
oligonucleotide dT20 was determined to be about the same as to dT19-U. Thus, 
the presence of uracil in the 20-mer did not increase the DNA binding affinity 162 
of Ung H187D. Since the turnover rate of the Ung H187D mutant was very 
low (-1 uracil/h), it seemed unlikely that very many AP-sites were created 
during the 30 minute UV-irradiation. Moreover, the extent of UV-catalyzed 
cross-linking to an AP-site-containing oligonucleotide (dT19-AP) was reduced 
about 50% relative to the rate on dT19-U. These results suggested that the 
main factor affecting the uracil-DNA binding affinity of Ung H187D was not 
the recognition of uracil but the Asp-187 y-carboxylate/DNA phosphate 
electrostatic repulsion. This led to speculation that the negative electrostatic 
interaction was more pronounced when the DNA substrate contained an 
abasic site, as the 3' and 5' deoxyribose phosphates were more accessible. 
Unexpectedly, the wild type enzyme was cross-linked by UV-
irradiation less efficiently to the uracil-containing substrate (dT19-U) than to the 
abasic site-containing substrate (dT19-AP) or even to the non-specific substrate, 
dT20. Since the turnover rate of Ung (800 uracils/min) is rapid compared to 
Ung H187D it might be expected that a significant fraction of uracil had been 
excised from dT19-U during the UV-irradiation reaction containing Ung. When 
human uracil-DNA glycosylase was co-crystallized with a 10-basepair double-
stranded DNA containing either a U/A basepair or a U/G mismatch, free 
uracil and a deoxyribose C1' OH were bound in the active site (103). Thus, it 
is conceivable that a portion of the Ung molecules cross-linked to a uracil base 
bound in the active site rather than to the thymine-DNA; such enzyme 
molecules may not be capable of binding DNA. 
Addition of 2 mM uracil to the cross-linking reactions had no effect on 
the efficiency of Ung x dT20 cross-linking, but the efficiency of Ung H187D x 
dT20 cross-linking was reduced several fold. These results demonstrated that 
the affinity of Ung was considerably greater for DNA than for uracil, as even 2 
mM uracil did not disrupt Ung/dT2o binding. These results show further that 
the His to Asp mutation has a greater effect on DNA affinity than on uracil 
binding, assuming that uracil bound in the active site prevents DNA binding. 163 
A comparison of the reaction kinetics of mutant and wild type enzyme 
demonstrated that the H187D mutation had a minor effect on Vmax/Km. At 
standard reaction pH, the values of Vmax/Km for Ung and Ung H187D were 4.4 
x 10-4 and 1.9 x 10' sec-1, respectively. In contrast, kcat was reduced 48,000-fold 
from 12 to 0.00025 sec-1. The data for Vmax/Kn, suggested that the processes 
involved from binding to the first irreversible step of uracil-DNA glycosylase 
action were not affected by the Asp-187 mutation because this value remained 
essentially unchanged. In contrast the large impact of the mutation on kcat 
suggested that the rate limiting step of the reaction had been disrupted. 
Kinetic measurements using a double-stranded 2-aminopurine-containing 27­
mer confirmed this observation. The km of Ung was reduced from 0.59 to 
0.00068 sec-1. During the process of this work, Xiao et al. (153) reported the 
kinetic analysis of an Ung H187Q mutant utilizing a similar substrate. By 
using a double-stranded 19-mer containing a 2-APuU pair, the km for Ung 
H187Q was reduced 160-fold relative to wild type Ung (153). These 
observations suggest that substrate binding and uracil base flipping are 
independent of His-187 while a subsequent reaction step such as catalysis or 
product release involves this active site residue. 
Based on the collection of biochemical and structural data for E. coli 
Ung, it is proposed that His-187 participates in glycosylic bond scission as 
illustrated in Figure 35. Stable active site geometry suggests that His-187 NM 
is a hydrogen bond acceptor to the Ser-189 main chain amide. In the 'closed' 
conformation, movement of the Leu intercalation loop (amino acid residues 
187-195) brings the His-187 NE2 -2 A closer to the uracil 02 where it can act as 
a hydrogen bond donor (103, 110, 127), as previously suggested by Savva et 
al. (116). De localization of electron density across the His-187 imidazole side 
chain contributes to catalysis by stabilization of the oxyanion form of the 
uracil 02 carbonyl and the attendant polarization of the N1-C1' glycosylic 
bond. The side chain of Asn-123 and the main chain of Gln-63 act to further 
stabilize electron delocalization in the uracil ring by forming hydrogen bonds 
with N3 and 04. In addition, the 04' of the deoxyribose, because of its 164 
Figure 35. Scheme of the reaction mechanism for cleavage of the N1-C1 
glycosylic bond by E. coli Ung. Resonance forms of the proposed hydrolysis 
intermediates in the uracil-excision are illustrated. The N1-C1' glycosylic bond 
is polarized by electron density withdrawal from the deoxyribose C1' through 
N1 into the uracil ring. The developing negative charge is distributed about 
the uracil ring by resonance effects involving oxyanion formation at 02 and 
04 and stabilized by hydrogen bonding with the side chains of His-187 and 
Asn-123, and the main chain Gln-63 amide. The catalytic water is bound by 
Asp-64 in the water-activating loop formed by 
64-Asp-Pro-Tyr-His-67 (103). 165 
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electron-withdrawing nature, is proposed to participate in forming a reactive, 
electrophilic C1' since substitution of the less electronegative sulfur atom for 
04' resulted in a uracil nucleotide refractory to hydrolysis as reported by 
Parikh et al. (103). As observed in both the human (103, 127) and the HSV-1 
(116) uracil-DNA glycosylase structures, the side chain of the conserved Asp­
64 appears properly positioned in E. coli Ung to bind the catalytic water (110, 
111). Electron density withdrawal from the deoxyribose C1' renders the N1­
C1' bond vulnerable to nucleophilic attack by the water activated by the y­
carboxylate of Asp-64. In addition, the developing negative charge of the 
uracil base, stabilized by resonance effects and hydrogen bonding to active 
site residues (Gln-63, Asn-123, His-187), makes uracil a good leaving group. 
Abstraction of a proton from solvent by N1 also enhances uracil departure 
and restores electrostatic neutrality to the free uracil base following glycosylic 
bond scission. 
The mechanism proposed here differs from previous proposals in 
several important respects. Recent structural information derived from the 
co-crystallization of human uracil-DNA glycosylase with uracil-DNA (103, 
127) shows that His-268 (Ung His-187) is on the wrong side of the uracil to 
carry out either a direct nucleophilic attack on C1' or to mediate an indirect 
attack by serving as a general base to activate a nucleophilic water, as 
previously proposed (80). Unlike previously proposed mechanisms (116), it 
is unnecessary to require protonation of uracil 02 in order to improve the 
leaving group quality of the base under the current mechanism. Rather, the 
developing negative charge that characterizes the transition state is not 
posited solely in the 02 oxyanion but is distributed among N1, 02 and 04 on 
the uracil ring by the effects of resonance and hydrogen bonding (Figure 34). 
The proximity of the Ser-189 NH to the His-187 imidazole NM in both open 
and closed conformations indicates that NM acts as a hydrogen bond acceptor 
to the main chain amide; accordingly, the His-187 Ne2 is a hydrogen bond 
donor to 02. In this scenario, it is unlikely that the His-187 imidazole binds 
two hydrogens, carries a full positive charge, and protonates 02 to return to 167 
electronic neutrality, as was proposed (116). The aromaticity of the imidazole 
side chain seems uniquely suitable to stabilize any partial charge associated 
with electrostatic interactions with the uracil nucleotide backbone and 
hydrogen bonding with uracil 02. 
The relatively bulky nature of the imidazole side chain of His-187 may 
also contribute to the steric selectivity of the active site. This selectivity pocket 
is thought to distort the N1-C1' glycosylic bond, since an intact extrahelical 
uracil residue in DNA does not easily 'fit' into the active site without torsional 
strain (103, 110). In contrast, the Asp-187 side chain is too small to contribute 
much to steric selectivity. 
Substitution of Asp for His-187 has profound effects on the cleavage of 
the N1-C1' glycosylic bond. Asp-187 does not extend far enough into the 
specificity pocket to allow a protonated side chain to hydrogen bond with 
uracil 02. On the other hand, it is too long to allow a water molecule to act as 
a bridge between the Asp-187 side chain carboxylate and uracil 02 (110). In 
removing the hydrogen bonding interaction of His-187 with uracil 02, the 
Asp-187 mutation not only hampers uracil binding, it also influences the 
stabilization of developing negative charge at 02 that is requisite for N1-C1' 
bond cleavage. Simple removal of the hydrogen bond, as observed in the 
human H268L mutant, reduced the specific activity 300-fold (80); however, 
the specific activity of the E. coli H187D mutant enzyme decreased an 
additional two orders of magnitude. The large effect of the Asp-187 mutation 
on specific activity most likely results from the destabilization of the 
hydrolytic transition state caused by electrostatic repulsion of the developing 
negative charge at uracil 02 by the Asp-187 carboxylate. Reduction of this 
electrostatic repulsion by partial protonation of the Asp-187 side chain may be 
the fundamental influence that shifts the pH optimum of the mutant enzyme 
from 8.0 to 7.0. Hence, the Asp-187 mutation provides a subtle probe of the 
Ung reaction mechanism, indicating how an amino acid residue whose side 
chain is 4.5 A from the nearest atom of the scissile bond can reduce the 
reaction rate by 55,000-fold. 168 
In summary, it is proposed that the imidazole side chain of Ung His-187 
1) facilitates uracil nucleotide flipping by 'pulling' the uracil residue into the 
active site through favorable electrostatic interactions with the 3' and 5' uracil 
deoxyribose phosphates; 2) contributes sterically to the fit and selectivity of 
the uracil binding pocket; and 3) stabilizes the hydrolytic transition state by 
hydrogen-bonding with uracil 02. The reaction mechanism advanced here 
provides a realistic explanation of the properties of the Ung H187D mutant 
enzyme. However, how the release of the uracil-excision reaction products, 
free uracil and AP-site DNA, affects the catalytic efficiency of uracil-DNA 
glycosylase remains to be established. 
4.2  Ugi-Affinity Purification of Mitochondrial Uracil-DNA Glycosylases 
Polyclonal antibody was raised to both Ung and Ugi proteins. In 
addition, Ung- and Ugi-affinity chromatography methods were developed for 
use in conjunction with anti-Ung antibody to purify uracil-DNA glycosylases 
from mitochondrial extracts of mammalian liver tissue. Serum from rabbits 
immunized with Ung or Ugi was able to inhibit enzyme or inhibitor, 
respectively, in a functional assay although complete inhibition of protein 
activity was not achieved. The immune response to Ugi was variable, with 
one sample of antiserum capable of only 16% inhibition. In contrast, a second 
animal had an initially strong response but subsequent injections may have 
induced tolerance. It was observed that the nearly complete inhibition 
detected after the second boost was reduced by approximately 1/3 after 4 
additional injections. As expected due to the greater than 50% amino acid 
identity between human and E. coli uracil-DNA glycosylase, polyclonal 
antiserum raised to Ung inhibited a substantial fraction (52%) of human 
A84UDG activity. This suggested that uracil-DNA glycosylases from different 
species contain similar immunogenic determinants and these anti-Ung 
antiserum preparations would allow for the detection of uracil-DNA 
glycosylase from diverse biological sources. 169 
Ung-Sepharose was utilized for the affinity purification of polyclonal 
antibody to Ung. Serum proteins, including nonspecific IgG, were recovered 
in the flow through and wash fractions. Proteins consistent with the size of 
IgG large and small chains were recovered following a 3.5 M MgC12 elution of 
the Ung-Sepharose column. This recovered antibody preparation was 
reactive to E. coli Ung in immunoassays. Similarly, Ugi-Sepharose affinity 
resin was used to purify uracil-DNA glycosylase from extracts. While Ung 
and Ugi bind very tightly under physiological conditions, it was possible to 
remove Ung bound to Ugi-Sepharose with extremes of pH and salt. The use 
of 100 mM glycine (pH 2.5) for the elution of Ung from Ugi-Sepharose had 
previously been reported by Caradonna and coworkers (15). The results 
presented here indicated that 5 M MgC12 (in 10 mM potassium phosphate (pH 
7.2)) was nearly twice as effective at dissociating the enzyme from the resin. 
Concentrations of NaC1 as high as 1 M had no effect on Ung-Ugi-Sepharose 
interactions, an observation that allowed for the reduction of nonspecific 
protein binding. 
CNBr-activated Sepharose 4B was coupled to enzyme and inhibitor to 
produce Ung- and Ugi-Sepharose affinity resins. It was estimated that 220 
nmol of Ugi coupled per ml of packed Sepharose 4B resin. Because Ung 
complexes with Ugi in a 1:1 stoichiometry, the maximum binding capacity for 
the Ugi-Sepharose resin would be 220 nmol of Ung per ml of Ugi-Sepharose. 
However, upon incubation of Ugi-Sepharose with [3H]Ung, it was observed 
that 90 nmol of enzyme bound per ml of resin. Similarly, the estimate for Ung 
coupling to Sepharose 4B was 97 nmol protein/ml of resin but only 40 nmol of 
[35S]Ugi was observed to bind per ml of Ung-Sepharose. In both instances, the 
amount of protein determined to bind to the affinity resin experimentally was 
2.4-fold less than the amount of protein predicted to bind if 100% of the 
coupled ligand was capable of productive UngUgi complex formation. This 
is not surprising due to the nature of the coupling reaction. CNBr-activated 
Sepharose 4B couples to proteins by reacting with primary amines residing in 
various locations on the coupling ligand. Ung contains nineteen primary 
amines, while Ugi contains six. The reaction between an activated Sepharose 170 
bead and an amine group results in a heterogeneous population of Ung- or 
Ugi-conjugated Sepharose beads with ligand coupled such that the active site 
face of the molecule is presented many different orientations. Some 
orientations may preclude UngUgi complex formation due to steric 
interference with the Sepharose bead. In a similar fashion, the coupling of 
multiple ligand molecules to a single Sepharose bead may result in steric 
interference between ligands which prevents one or all of the conjugated 
molecules from forming UngUgi complex. Ugi interacts with Ung primarily 
through interactions on the Ugi I31-strand and a2-helix (79, 110). Ugi Gln-19, 
Glu-20, Ser-21, and Leu-23 of the 131-strand form hydrogen bonds with the 
Ung DNA binding groove (110). The a2-helix and 131-sheet also form a 
hydrophobic cavity which sequesters the conserved Leu-loop and plays an 
important role in UngUgi complex stability (110). Thus, coupling 
conformations that interfere with the formation of these structures are 
expected to reduce the number of ligands capable of forming UngUgi 
complex. From the data presented, it appears that under the coupling 
conditions used only 41% of the ligand molecules coupled in such a way that 
they were capable of productive complex formation. In determining the 
amount of resin required to purify uracil-DNA glycosylase from crude 
extracts, the experimentally determined binding capacity of 90 nmol/ml of 
packed Ugi-Sepharose was used in order to maximize recovery. 
Ugi-affinity chromatography was utilized to purify E. coli Ung from 95 
jag of whole cell extracts. The SDS-eluted samples were analyzed by 12.5% 
SDS-polyacrylamide gel electrophoresis. Protein bands were not visualized 
upon Coomassie Brilliant Blue staining of the polyacrylamide gel unless the 
extracts were supplemented with 200 pmol of purified E. coli Ung. Based on 
the specific activity of the cell extracts, it is estimated the samples contained 0.3 
pmol of Ung, which is -600-fold lower than the levels of Ung detected in the 
supplemented system. Likewise, when mitochondrial extracts were subjected 
to Ugi-affinity chromatography and the fractions that bound the matrix were 
examined by Western blot analysis, it was not possible to detect background 171 
levels of UDG in the extract samples. However, by this method 0.24 pmol of 
E. coli Ung was detected in purified form or when mixed with mitochondrial 
extract. These results indicated that factors in the mitochondrial extract did 
not inhibit recognition of Ung by Ung antiserum. When the specific activity of 
the mitochondrial extracts is taken into consideration, 100 lig of extract was 
estimated to contain only 0.12 pmol of UDG which is 2-fold lower than the 
limits of detection by the Western blot system described. It appears that 
Western blot analysis is the more sensitive method to detect uracil-DNA 
glycosylase in extracts at physiological concentrations, provided the starting 
material is abundant. 
By using large quantities of mammalian liver tissue (1200 g) as starting 
material, it was possible to purify uracil-DNA glycosylase from mitochondrial 
extracts by Ugi-affinity chromatography. The rat and pig mitochondrial 
sources were greatly enriched for UDG, although the end products were not 
homogeneous. Unlike the rat mitochondrial sample, which contained one 
major band, similar in size (MW -25,000) to E. coli Ung, the porcine sample 
appeared to contain two polypeptide species with apparent molecular weights 
of 28,000 and 48,000. Western blot analysis revealed that the 48,000 molecular 
weight protein was not reactive with Ung antibody; thus, it was unlikely to be 
a uracil-DNA glycosylase. This species may be a protein that co-purified with 
porcine mitochondrial UDG as part of a multi-protein repair complex or it 
may be a protein unrelated to UDG that coincidentally was able to bind Ugi-
Sepharose. Further characterization of this protein is required to determine its 
identity. Previous purification of UDG from rat liver mitochondria resolved 
two distinct activity peaks, designated form I and form II, with virtually 
identical kinetic properties (27). Form I, a single polypeptide with an apparent 
molecular weight of 24,000, constituted approximately 85% of the total activity 
(27). The molecular weight of form II was -29,000 (27). 
The purification of mitochondrial UDG may be useful in the study of 
uracil-initiated BER in mitochondria. The process of BER has been 
reconstituted with mitochondrial enzymes using AP site-containing DNA as a 
substrate for repair (71, 105), but the full pathway, beginning with a uracil 172 
lesion, has not been examined. The methods described here provide a source 
of purified mitochondrial UDG to catalyze the first step of a reconstituted 
repair pathway. 
The current understanding of the mammalian system is that nuclear 
and mitochondrial forms of UDG are encoded by a single gene, share a 
common catalytic domain, and differ in their N-terminal amino acid sequences 
(95, 100). To date, most of the data supporting these predictions has been 
indirect in the form of immunolocalization (89, 125, 126) and 
cytofluorescence (87, 101) studies and analysis of the UNG gene promoter 
and splicing consensus sequences (95, 101). Caradonna and coworkers 
utilized Ugi-affinity chromatography to purify nuclear UDG and the purified 
protein was subjected to direct protein microsequencing (87). The derived 
amino acid sequence indicated that the nuclear UDG corresponded to UNG2, 
as predicted by Nilsen et al. (87, 95). However definitive identification of the 
mitochondrial UDG in the form of direct amino acid sequence determination 
has not been accomplished. The approach described here for the purification 
of mitochondrial UDG lays the groundwork for this analysis. 
Together, Ugi-Sepharose and Ung antibodies are tools which can be 
utilized for the rapid screening of cell or organelle extracts to determine the 
presence, number, size, and activity of uracil-DNA glycosylases from various 
species. Extracts could be depleted of Ung activity by incubation with Ugi-
Sepharose, permitting the study of DNA repair processes in phenotypically 
ung samples. Using less stringent purification methods, it may be possible to 
analyze protein-protein interactions between Ung and other base excision 
repair enzymes by probing crude extracts with Ugi-Sepharose similar to the 
process used by Prasad and colleagues to affinity purify a multiprotein repair 
complex from bovine testis extracts (107). In this regard, Ugi-affinity 
purification has been successfully used to identify a physical interaction 
between PCNA and the cyclin-like UDG in He La cell extracts (88), suggesting 
that this procedure may allow for the identification of proteins that make 
physical associations with uracil-DNA glycosylase. 173 
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